◈

Mechanistic Hypotheses

1

Abruption as the end-stage of chronic ischemic placental disease

chronic_ischemic_placental_disease CANONICAL

Evidence balance 3 support

Under this model abruption is not an acute accident but the terminal event of a chronic uteroplacental vascular disease that begins with failed spiral artery transformation early in pregnancy. Supporting evidence includes the excess of chronic decidual lesions in abruption placentas, the elevated abruption risk conferred by bleeding earlier in pregnancy, and the co-clustering of abruption with preeclampsia and fetal growth restriction.

Show evidence (3 references)

PMID:16513243 SUPPORT Human Clinical

"Clinicians widely regard placental abruption as an acute event, though accumulating data point towards abruption being the end-result of chronic processes early in pregnancy, and perhaps even extending to conception."

States the chronic-process model directly.

PMID:16513243 SUPPORT Human Clinical

"the increased risk associated with placental lesions, especially chronic inflammatory lesions, even in the absence of early vaginal bleeding, suggests that prolonged inflammation may be implicated in placental abruption"

Provides the histological argument that chronic inflammation precedes abruption independent of early bleeding.

PMID:37164498 SUPPORT Human Clinical

"We discuss the interaction of chronic processes (decidual and uteroplacental vasculopathy) and acute processes (shearing forces applied to the abdomen) that underlie the pathophysiology."

States the two-component model explicitly, and is the reason this entry keeps both the chronic decidual vasculopathy trigger and the acute mechanical arm captured under abdominal trauma. The chronic model is not a replacement for the acute one; abruption arises where a chronically fragile decidual bed meets an acute insult.

?

Discussions and Knowledge Gaps

4

Can any risk factor for placental abruption be established at class I or II evidence, given that a formal umbrella review of the entire meta-analytic literature graded every candidate as class III or weaker?

KNOWLEDGE GAP OPEN gap_abruption_no_high_quality_risk_factor_evidence

Attached to

pathophysiology#Decidual Vasculopathy and Spiral Artery Failure

This is the single most important epistemic caveat attached to this entry. The effect sizes curated in the environmental section are real and reproducible, but the umbrella review that formally graded them found no factor reaching high-quality evidence. Every risk-factor estimate here should therefore be read as suggestive rather than established. A contributing cause is the absence of a uniform case definition across the epidemiological literature, which makes cohorts non-comparable.

Show evidence (3 references)

PMID:35365209 SUPPORT Human Clinical

"There was no risk factor in the present umbrella review with the high level of evidence (class I or II)."

States the negative finding directly.

PMID:35365209 SUPPORT Human Clinical

"the current meta-analytic associations cannot disentangle the complex etiology of placental abruption mainly due to their low quality of evidence"

States that the aetiology cannot be resolved from the current evidence base.

PMID:40140972 SUPPORT Human Clinical

"However, methodological inconsistencies and publication bias in the current studies may affect the reliability of the meta-analysis results."

Independently flags methodological inconsistency and publication bias in the same literature.

Do the suggestive ABCC8/KCNJ11, ADAM12, CTNND2, ZNF28 and IRX1 associations replicate at genome-wide significance in ancestries other than the Peruvian cohorts in which they were discovered, and does any have a demonstrable functional consequence?

KNOWLEDGE GAP OPEN gap_abruption_gwas_single_ancestry

Attached to

pathophysiology#Decidual Vasculopathy and Spiral Artery Failure

All curated susceptibility loci come from a single-ancestry study and are suggestive rather than genome-wide significant. None has a demonstrated molecular mechanism. Transferability to other ancestries is unestablished, so these should not be treated as validated susceptibility genes.

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"Participants of the Placental Abruption Genetic Epidemiology (PAGE) study, a population based case-control study of PA conducted in Lima, Peru"

Establishes the single-ancestry Peruvian source population of the discovery cohort.

Can any antenatal test identify placental abruption reliably enough to change management, given that ultrasound has roughly 24% sensitivity and no externally validated prediction model exists?

KNOWLEDGE GAP OPEN gap_abruption_no_antenatal_diagnostic_test

Attached to

pathophysiology#Decidual Hemorrhage and Retroplacental Hematoma Formation

Abruption remains a clinical diagnosis of exclusion in real time. The consequence is that the condition is frequently recognised only once fetal compromise is already present, which places a hard ceiling on how much outcome improvement is achievable through earlier intervention. A sensitive antenatal test would be the highest-value advance in this disease.

Show evidence (1 reference)

PMID:12164566 SUPPORT Human Clinical

"Sonography is not sensitive for detection of placental abruption, but a positive finding is associated with more aggressive management and worse neonatal outcome."

Documents the insensitivity of the only widely available antenatal imaging test.

Can the decidual mechanism of abruption be modelled in any non-human species, given that the depth of extravillous trophoblast invasion and the extent of the decidualization reaction seen in humans are not reproduced in standard laboratory animals?

HUMAN MODEL MISMATCH OPEN mismatch_abruption_no_animal_model_of_trophoblast_invasion

Attached to

pathophysiology#Decidual Vasculopathy and Spiral Artery Failure pathophysiology#Thrombin-Driven Myometrial Contraction and Membrane Weakening

The upstream lesion of this entry is failure of deep trophoblast-mediated spiral artery conversion, a process whose human form is unusually extensive among species with hemochorial placentation. Model organisms therefore cannot reproduce the trigger node, which is why essentially all mechanistic evidence in this entry comes from human tissue and human decidual cell culture rather than in vivo models. A separate constraint is that mice lack a CXCL8/IL-8 ortholog, so the thrombin to IL-8 to neutrophil arm of membrane weakening cannot be modelled directly in mouse.

Show evidence (1 reference)

PMID:19720393 SUPPORT Human Clinical

"Among species with a hemochorial placenta, human endometrium exhibits the most extensive DZ reaction and human EVT are the most intrinsically invasive"

States that the human decidualization reaction and trophoblast invasiveness exceed those of other hemochorial species, which is the basis of the model-organism limitation.

⚙

Pathophysiology

7

Decidual Vasculopathy and Spiral Artery Failure

Shallow extravillous trophoblast invasion leaves the maternal spiral arteries incompletely converted into low-resistance, high-capacity vessels. The retained muscular, high-resistance vasculature produces chronic uteroplacental ischemia and predisposes the decidual vascular bed to atherosis, thrombosis and necrosis. This is the shared upstream lesion of ischemic placental disease, which is why abruption, preeclampsia and fetal growth restriction cluster in the same pregnancies.

extravillous trophoblast CL:0008036 decidual cell CL:2000002

response to hypoxia GO:0001666 ↑ INCREASED

uterine spiral artery UBERON:0015171

Downstream

Decidual Hemorrhage and Retroplacental Hematoma Formation Chronically ischemic, structurally abnormal decidual vessels are prone to rupture, which is the initiating event of the hematoma.

Show evidence (2 references)

PMID:39641171 SUPPORT Human Clinical

"The unifying pathophysiological mechanism that precedes all 3 complications is uteroplacental ischemia as a consequence of inadequate (or failure of) physiological transformation of the maternal uterine spiral arteries, endothelial cell dysfunction, and increased oxidative stress."

Identifies failed spiral artery transformation as the shared upstream mechanism of abruption within ischemic placental disease.

PMID:19897298 SUPPORT Human Clinical

"Chronic lesions included chronic deciduitis, decidual necrosis, decidual vasculopathy, placental infarctions, villous mal-development (delayed or accelerated maturation), hemosiderin deposition, intervillous thrombus, and chronic villitis."

Documents decidual vasculopathy and decidual necrosis among the chronic lesions profiled in clinically diagnosed abruption.

Decidual Hemorrhage and Retroplacental Hematoma Formation

Rupture of a diseased decidual vessel bleeds into the decidua basalis. The accumulating blood dissects along the plane between the placental basal plate and the uterine wall, forming a retroplacental hematoma whose expansion progressively levers the placenta away from its attachment. The same process occurring in the decidua parietalis produces a retrochorionic hematoma. Bleeding may track down to the cervix and present as vaginal bleeding, or remain concealed behind the placenta.

decidual cell CL:2000002

decidua basalis UBERON:0000453

Downstream

Placental Separation and Loss of Exchange Surface The expanding hematoma occupies a closed space and mechanically strips the placenta from the uterine wall.

Decidual Tissue Factor Exposure and Thrombin Generation Hemorrhage into the decidua brings plasma factor VII into contact with the very high constitutive tissue factor of decidual cells.

Show evidence (1 reference)

PMID:21890016 SUPPORT Human Clinical

"Chronic, subacute decidual hemorrhage (ie, abruptio placenta and retrochorionic hematoma formation) is an important contributor to preterm parturition."

Identifies decidual hemorrhage with hematoma formation as the core lesion.

Placental Separation and Loss of Exchange Surface

Mechanical separation removes functional villous surface from maternal perfusion. Because the fetus depends entirely on intervillous blood flow for oxygen, loss of exchange area translates directly into fetal hypoxemia, and the fraction of placenta detached is the main determinant of fetal outcome.

placenta UBERON:0001987

Downstream

Fetal Hypoxic-Ischemic Injury Loss of gas-exchange surface produces acute fetal hypoxemia, with the detached fraction determining severity.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"The maternal effect of abruption depends primarily on its severity, whereas its effect on the fetus is determined both by its severity and the gestational age at which it occurs."

Separates the maternal and fetal determinants of outcome after placental separation.

Decidual Tissue Factor Exposure and Thrombin Generation

Decidual cells express the highest levels of tissue factor of any cell type at the maternal-fetal interface, a constitutive hemostatic envelope that normally protects against bleeding during trophoblast invasion and delivery. When hemorrhage occurs, that same tissue factor binds plasma factor VII and generates thrombin in large excess. Thrombin then acts through protease-activated receptors as a signaling molecule rather than only as a clotting enzyme, which is what converts a local bleed into preterm labor, membrane rupture, and systemic coagulopathy.

decidual cell CL:2000002

blood coagulation, extrinsic pathway GO:0007598 ↑ INCREASED thrombin-activated receptor signaling pathway GO:0070493 ↑ INCREASED

Downstream

Thrombin-Driven Myometrial Contraction and Membrane Weakening Thrombin signals through protease-activated receptors on myometrium and decidua to drive contraction and matrix degradation.

Consumptive Coagulopathy and Maternal Hemorrhagic Shock Sustained thrombin generation consumes fibrinogen and clotting factors, producing the profound hypofibrinogenemia characteristic of severe abruption.

Show evidence (2 references)

PMID:19720393 SUPPORT Human Clinical

"Among the cell types at the maternal fetal interface at term, TF expression is highest in decidual cells indicating that this TF meets the hemostatic demands of labor and delivery."

Establishes decidual cells as the dominant tissue factor source at the maternal-fetal interface.

PMID:19720393 SUPPORT Human Clinical

"In human pregnancy, decidual cell-expressed TF prevents decidual hemorrhage (abruption)."

States the normal protective role of decidual tissue factor, the physiology that abruption subverts.

Thrombin-Driven Myometrial Contraction and Membrane Weakening

Thrombin generated by the hematoma is a direct uterotonic. It activates PAR1 on myometrial cells, driving contraction both by direct myosin light chain phosphorylation and indirectly by inducing prostaglandin synthesis. In parallel, thrombin upregulates decidual matrix metalloproteinases and interleukin-8, recruiting neutrophils whose proteases degrade the collagen-rich amnion and choriodecidua. The two arms together explain the painful uterine hypertonus of acute abruption and the strong association of abruption with preterm labor and preterm premature rupture of membranes.

myometrial cell CL:0002366 neutrophil CL:0000775

uterine smooth muscle contraction GO:0070471 ↑ INCREASED prostaglandin biosynthetic process GO:0001516 ↑ INCREASED extracellular matrix disassembly GO:0022617 ↑ INCREASED

myometrium UBERON:0001296

Show evidence (4 references)

PMID:32365105 SUPPORT Human Clinical

"histologic studies of placental abruption, as a representative intrauterine bleeding, revealed that thrombin was expressed within the infiltrating hemorrhage and that thrombin receptor (protease-activated receptor 1, PAR1) was highly expressed in myometrial cells surrounding the hemorrhage"

Localizes thrombin to the abruption hemorrhage and PAR1 to the adjacent myometrium in human tissue, the anatomical basis of the uterotonic effect. Classified HUMAN_CLINICAL rather than IN_VITRO because this specific finding comes from histology of human abruption specimens; the cultured myometrial cell experiments from the same paper are curated separately as IN_VITRO.

PMID:32365105 SUPPORT In Vitro

"thrombin induces myometrial contractions by two mechanisms, including direct activation of myosin and indirect increases in prostaglandin synthesis"

Defines the two parallel routes by which thrombin drives myometrial contraction.

PMID:19720393 SUPPORT In Vitro

"Thrombin acts as an autocrine/paracrine mediator that degrades these ECMs by augmenting decidual cell expression of: 1) matrix metalloproteinases and 2) interleukin-8, a key mediator of abruption-associated decidual infiltration of neutrophils, which express several ECM degrading proteases."

Specifies the MMP and IL-8/neutrophil route from thrombin to fetal membrane matrix degradation.

+ 1 more reference

Consumptive Coagulopathy and Maternal Hemorrhagic Shock

Sustained thrombin generation plus release of placental procoagulant material consumes fibrinogen, platelets and clotting factors faster than they are replaced, producing disseminated intravascular coagulation. This converts a local placental problem into systemic maternal hemorrhage. Because a substantial share of the blood loss can be concealed behind the placenta, visible bleeding underestimates the true deficit and the degree of shock is often out of proportion to what is seen.

blood coagulation GO:0007596 ↑ INCREASED

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."

Enumerates the maternal consequences of the consumptive coagulopathy and hemorrhage.

Fetal Hypoxic-Ischemic Injury

Acute reduction in placental gas exchange produces fetal hypoxemia, acidemia and a non-reassuring heart rate pattern. If separation is extensive or delivery is delayed, the result is perinatal asphyxia with intraventricular hemorrhage, periventricular leukomalacia and cerebral palsy in survivors, or intrauterine fetal death.

response to hypoxia GO:0001666 ↑ INCREASED

Show evidence (2 references)

PMID:21890016 SUPPORT Human Clinical

"The resulting neonates exhibit increased rates of perinatal asphyxia, intraventricular hemorrhage, periventricular leukomalacia, cerebral palsy and mortality, compared with age-matched controls."

Enumerates the hypoxic-ischemic sequelae in surviving neonates.

PMID:21241259 SUPPORT Human Clinical

"Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."

Lists the perinatal outcomes attributable to abruption.

✶

Histopathology

5

Retroplacental Hematoma with Compressed Villi

The histological signature of abruption is a retroplacental hematoma with adjacent fibrin deposition and compressed villi; in older lesions, hemosiderin-laden histiocytes mark the age of the bleed.

Show evidence (1 reference)

PMID:19897298 SUPPORT Human Clinical

"The pathological criteria for abruption diagnosis included hematoma, fibrin deposition, compressed villi, and hemosiderin-laden histiocytes in cases with older hematomas."

States the histopathological diagnostic criteria for abruption.

Chronic Decidual Lesions

Beyond the acute hematoma, abruption placentas carry an excess of chronic lesions including chronic deciduitis, decidual necrosis, decidual vasculopathy and placental infarction, supporting the chronic ischemic disease model.

Show evidence (1 reference)

PMID:19897298 SUPPORT Human Clinical

"Chronic lesions included chronic deciduitis, decidual necrosis, decidual vasculopathy, placental infarctions, villous mal-development (delayed or accelerated maturation), hemosiderin deposition, intervillous thrombus, and chronic villitis."

Enumerates the chronic histological lesions profiled in clinical abruption.

Couvelaire Uterus

Uteroplacental apoplexy: in the most severe abruptions blood extravasates into and through the myometrium and out to the broad ligament or peritoneum, giving the uterus a blue-purple discoloration. The clinical significance is that a myometrium infiltrated with blood contracts poorly, which is how a placental problem becomes intractable postpartum hemorrhage and, sometimes, the reason for emergency hysterectomy.

Show evidence (1 reference)

PMID:35880101 SUPPORT Human Clinical

"Clinical abruption represents a spectrum from mild to the most severe form, in which blood can extravasate into or through the myometrium, the broad ligament, or the peritoneum, causing the uterus and surrounding structures to take on a blue discoloration."

Describes the Couvelaire uterus as the severe end of the abruption spectrum, defined by myometrial blood extravasation.

Decidual Neutrophil Infiltration

Marked neutrophil infiltration of the decidua, co-localizing with fibrin deposition and peaking after membrane rupture. The control comparison is what makes this finding compelling: gestational-age-matched control decidua is essentially free of neutrophils, so this is not a background feature of late gestation but a specific consequence of decidual hemorrhage. It is the histological footprint of the thrombin-to-IL-8 arm of the mechanism.

Show evidence (2 references)

PMID:16251427 SUPPORT Human Clinical

"Abruptions were associated with a marked decidual neutrophil infiltration that peaked after PPROM, whereas decidua from gestational age-matched controls were virtually devoid of neutrophils."

Documents the neutrophil infiltrate with an explicit gestational-age-matched control comparison.

PMID:16251427 SUPPORT Human Clinical

"Neutrophil infiltrates co-localized with fibrin deposition."

Establishes the spatial association between the neutrophil infiltrate and fibrin, linking the inflammatory and coagulation arms.

Maternal Vascular Malperfusion (Amsterdam Terminology)

The chronic-arm signature on placental examination: decidual arteriopathy and atherosis, accelerated villous maturation, infarcts and retroplacental hemorrhage. Reporting these under the Amsterdam Placental Workshop Group consensus terminology is what makes abruption histology comparable across centres, and the absence of such a standard is part of why the epidemiological literature is so heterogeneous.

Show evidence (1 reference)

PMID:27223167 SUPPORT Human Clinical

"The terminology and microscopic descriptions for maternal vascular malperfusion, fetal vascular malperfusion, delayed villous maturation, patterns of ascending intrauterine infection, and villitis of unknown etiology were agreed upon."

Establishes maternal vascular malperfusion as a consensus-defined lesion category applicable to abruption placentas.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

14

Blood 1

Disseminated Intravascular Coagulation HP:0005521

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."

Lists disseminated intravascular coagulopathy among the maternal risks of abruption.

Genitourinary 1

Acute Kidney Injury HP:0001919

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."

Lists renal failure among the maternal risks of abruption.

Prenatal and Birth 1

Preterm Birth Premature birth HP:0001622

Show evidence (2 references)

PMID:21241259 SUPPORT Human Clinical

"In developed countries, approximately 10% of all preterm births and 10-20% of all perinatal deaths are caused by placental abruption."

Supports the association between abruption and preterm delivery at population scale.

PMID:31955792 SUPPORT Human Clinical

"Preterm premature rupture of membranes (PPROM) and thrombin generation by decidual cell-expressed tissue factor often accompany abruptions."

Links abruption to preterm premature rupture of membranes as a route to preterm birth.

Constitutional 2

Abdominal Pain HP:0002027

Show evidence (1 reference)

PMID:37164498 SUPPORT Human Clinical

"The clinical manifestations of abruption typically include vaginal bleeding and abdominal pain with a wide variety of abnormal fetal heart rate patterns."

Names abdominal pain as a typical clinical manifestation alongside bleeding and abnormal fetal heart rate patterns.

Back Pain HP:0003418

Show evidence (1 reference)

PMID:22805996 SUPPORT Human Clinical

"strong abdominal pain and/or profuse vaginal bleeding occurred 159 ± 99 min prior to admission to an obstetric facility"

Documents severe truncal pain as the presenting symptom preceding admission. Marked PARTIAL because the source specifies abdominal pain; the back-pain presentation of posterior abruption is clinical convention rather than a quantified finding in this cohort.

Growth 1

Low Birth Weight Small for gestational age HP:0001518

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."

Lists low birthweight among the perinatal consequences of abruption.

Other 8

Antepartum Hemorrhage HP:0025328

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Placental abruption complicates about 1% of pregnancies and is a leading cause of vaginal bleeding in the latter half of pregnancy."

Establishes antepartum vaginal bleeding as the cardinal presenting feature.

Placental Separation Placental abruption HP:0011419

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Placental abruption, classically defined as a premature separation of the placenta before delivery, is one of the leading causes of vaginal bleeding in the second half of pregnancy."

Provides the definitional statement of premature placental separation.

Uterine Hypertonicity

Show evidence (1 reference)

PMID:19897298 SUPPORT Human Clinical

"vaginal bleeding accompanied by nonreassuring fetal status or uterine hypertonicity"

Quotes the clinical diagnostic criterion naming uterine hypertonicity alongside bleeding.

Non-Reassuring Fetal Status Fetal distress HP:0025116

Show evidence (2 references)

PMID:19897298 SUPPORT Human Clinical

"vaginal bleeding accompanied by nonreassuring fetal status or uterine hypertonicity"

Quotes the clinical diagnostic criterion naming non-reassuring fetal status alongside bleeding.

PMID:22805996 SUPPORT Human Clinical

"Of these 28 women, 22 (79%) exhibited non-reassuring fetal status on admission to obstetric facilities"

Quantifies how often non-reassuring fetal status is already present at presentation in abruptions that cause cerebral palsy.

Cerebral Palsy HP:0100021

Show evidence (1 reference)

PMID:22805996 SUPPORT Human Clinical

"Abruptio placenta was responsible for 28 (26%) of the 107 CP infants, and was the single leading causative factor of CP."

Quantifies abruption as the leading identifiable cause of hypoxia-attributed cerebral palsy in a national review.

Preterm Premature Rupture of Membranes HP:6000310

Show evidence (2 references)

PMID:31955792 SUPPORT Human Clinical

"Preterm premature rupture of membranes (PPROM) and thrombin generation by decidual cell-expressed tissue factor often accompany abruptions."

States the co-occurrence of PPROM with abruption and decidual thrombin generation.

PMID:16251427 SUPPORT Human Clinical

"Abruptions were associated with a marked decidual neutrophil infiltration that peaked after PPROM, whereas decidua from gestational age-matched controls were virtually devoid of neutrophils."

Links abruption to PPROM through decidual neutrophil infiltration, with a gestational-age-matched control comparison.

Stillbirth

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."

Lists stillbirth among the perinatal consequences of abruption.

Neonatal Asphyxia HP:0012768

Show evidence (2 references)

PMID:22805996 SUPPORT Human Clinical

"had neonates with umbilical cord arterial blood pH (base excess) of 6.728 ± 0.164"

Quantifies the depth of neonatal acidemia in abruption-related cerebral palsy.

PMID:21241259 SUPPORT Human Clinical

"Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."

Lists asphyxia among the perinatal consequences of abruption.

🧬

Genetic Associations

9

No Mendelian gene

relationship_type: UNKNOWN

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"Accumulating epidemiological evidence points to strong genetic susceptibility to placental abruption (PA). However, characterization of genes associated with PA remains incomplete."

Establishes that genetic susceptibility exists but that no gene characterization is complete, supporting the absence of a causal Mendelian gene.

F5

Gene: F5 hgnc:3542 relationship_type: SUSCEPTIBILITY

Show evidence (3 references)

PMID:16595080 SUPPORT Human Clinical

"Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction."

States that significant abruption risk was established for individual thrombophilic defects in this meta-analysis.

PMID:16595080 SUPPORT Human Clinical

"FVL heterozygous Subtotal (95% CI) 13/28 64/332 Test for heterogeneity: /H9273 2 = 6.43, df = 3 (p = 0.092) Test for overall effect: z = 2.12 (p = 0.03)"

The Figure 9 forest-plot row for heterozygous Factor V Leiden and placental abruption, giving the significant pooled test for overall effect. Quoted verbatim including the figure's extraction artifacts so it matches the cached text exactly.

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Independently lists thrombophilias among established abruption risk factors in a standard clinical review.

F2

Gene: F2 hgnc:3535 relationship_type: SUSCEPTIBILITY

Show evidence (2 references)

PMID:16595080 SUPPORT Human Clinical

"Prothrombin heterozygous Subtotal (95% CI) 10/20 44/400 Test for heterogeneity: /H9273 2 = 0.06, df = 2 (p = 0.97) Test for overall effect: z = 4.25 (p = 0.00002)"

The Figure 9 forest-plot row for heterozygous prothrombin G20210A and placental abruption, the strongest association in that figure. Quoted verbatim including extraction artifacts to match the cached text.

PMID:16595080 SUPPORT Human Clinical

"Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction."

States that significant abruption risk was established for individual thrombophilic defects in this meta-analysis.

ABCC8

Gene: ABCC8 hgnc:59 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"rs4148646 and rs2074311 in ABCC8"

Reports the ABCC8 variants as suggestively associated. Marked PARTIAL because the reported significance threshold is suggestive rather than genome-wide significant, and the cohort is single-ancestry.

KCNJ11

Gene: KCNJ11 hgnc:6257 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"rs2074314 and rs35271178 near KCNJ11 in the PAGE GWAS"

Reports the KCNJ11-adjacent variants as suggestively associated. PARTIAL because the association is suggestive and the variants are near, not within, the gene.

ADAM12

Gene: ADAM12 hgnc:190 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"rs7094759 and rs12264492 in ADAM12"

Reports the ADAM12 variants as suggestively associated in the GWAS meta-analysis. PARTIAL because the threshold is suggestive only.

CTNND2

Gene: CTNND2 hgnc:2516 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"rs7249210, rs7250184, rs7249100 and rs10401828 in ZNF28, rs11133659 in CTNND2, and rs2074314 and rs35271178 near KCNJ11 in the PAGE GWAS"

Reports the CTNND2 variant as suggestively associated. PARTIAL because the threshold is suggestive only.

ZNF28

Gene: ZNF28 hgnc:13073 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"rs7249210, rs7250184, rs7249100 and rs10401828 in ZNF28"

Reports the four ZNF28 variants as suggestively associated. PARTIAL because the threshold is suggestive only and function is unknown.

IRX1

Gene: IRX1 hgnc:14358 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:29884306 SUPPORT Human Clinical

"independent loci suggestively associated with PA in the GWAS meta-analysis included rs76258369 near IRX1"

Reports the IRX1-adjacent variant as suggestively associated. PARTIAL because the threshold is suggestive only.

💊

Medical Actions

8

Emergency Cesarean Delivery

Action: Emergency Cesarean Delivery NCIT:C92772

Prompt cesarean delivery is indicated when there is maternal or fetal compromise at a viable gestational age. Delivery removes the source of both the hemorrhage and the procoagulant load. Where fetal demise has already occurred, vaginal delivery is preferred.

Mechanism Target:

INHIBITS Placental Separation and Loss of Exchange Surface — Delivery terminates the ongoing separation and removes the fetus from a failing gas-exchange interface.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"in the presence of fetal or maternal compromise, prompt delivery by cesarean is often indicated"

Supports delivery as the intervention that terminates the separation process when compromise is present.

Show evidence (2 references)

PMID:17012465 SUPPORT Human Clinical

"in the presence of fetal or maternal compromise, prompt delivery by cesarean is often indicated"

States the indication for prompt cesarean delivery in compromised abruption.

PMID:17012465 SUPPORT Human Clinical

"In cases where fetal demise has occurred, vaginal delivery is preferable."

Records the route-of-delivery preference after fetal demise.

Blood Product Resuscitation and Coagulopathy Management

Action: Blood Transfusion NCIT:C15192

Aggressive management of disseminated intravascular coagulopathy with transfusion of red cells, plasma, platelets and fibrinogen replacement, targeting the consumptive coagulopathy driven by decidual thrombin generation.

Mechanism Target:

INHIBITS Consumptive Coagulopathy and Maternal Hemorrhagic Shock — Replaces the fibrinogen, platelets and clotting factors consumed by sustained thrombin generation.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Disseminated intravascular coagulopathy should be managed aggressively."

Supports active management of the consumptive coagulopathy as a treatment target.

Show evidence (2 references)

PMID:17012465 SUPPORT Human Clinical

"Disseminated intravascular coagulopathy should be managed aggressively."

States the management principle for the coagulopathy of abruption.

PMID:21241259 SUPPORT Human Clinical

"Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."

Documents transfusion requirement as a recognised element of abruption management.

Antenatal Corticosteroid Therapy

Action: Pharmacotherapy NCIT:C15986

Agent: betamethasone CHEBI:3077

Betamethasone or dexamethasone given for fetal lung maturation when preterm delivery is anticipated and the maternal-fetal condition permits a delay. This is the main reason to attempt expectant management at all in a stable preterm abruption, since the fetal benefit of the steroid course has to be weighed against the risk of the separation extending.

Show evidence (1 reference)

PMID:12164566 SUPPORT Human Clinical

"Positive sonographic findings were univariately associated with 2- to 3-fold greater subsequent tocolysis, betamethasone use, duration of hospitalization, follow-up sonograms, preterm delivery, low birth weight, and neonatal intensive care unit admission."

Documents betamethasone administration as part of real-world management of suspected abruption. Marked PARTIAL because this is an observational association between a positive scan and subsequent steroid use rather than a trial of corticosteroids in abruption specifically.

Magnesium Sulfate for Fetal Neuroprotection

Action: Pharmacotherapy NCIT:C15986

Agent: magnesium sulfate CHEBI:32599

Magnesium sulfate given before anticipated early preterm delivery to reduce the risk of cerebral palsy, and separately trialled as a tocolytic in suspected abruption. Given that abruption is the single leading identifiable cause of hypoxia-attributed cerebral palsy, the neuroprotective indication is unusually well aligned with this disease's dominant fetal harm.

Show evidence (1 reference)

clinicaltrials:NCT00186069 SUPPORT Human Clinical

"To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption."

Documents magnesium sulfate being formally trialled in suspected preterm abruption. Marked PARTIAL because the trial tested tocolysis rather than the neuroprotective indication, and enrolled only 30 participants.

Tranexamic Acid

Action: Pharmacotherapy NCIT:C15986

Agent: tranexamic acid CHEBI:48669

Antifibrinolytic adjunct for obstetric hemorrhage. Mechanistically coherent here, since the coagulopathy of abruption involves fibrinolysis alongside factor consumption, but the abruption-specific evidence base is a single small trial and the effect should not be overstated.

Mechanism Target:

INHIBITS Consumptive Coagulopathy and Maternal Hemorrhagic Shock — Inhibits fibrinolysis, opposing the breakdown of what clot remains during consumptive coagulopathy.

Show evidence (1 reference)

clinicaltrials:NCT05840471 SUPPORT Human Clinical

"Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality"

Trial rationale for tranexamic acid in abruption. PARTIAL because this quotes the enrolling rationale rather than a reported treatment effect.

Induction of Labor and Vaginal Delivery

Action: Induction of Labor NCIT:C92814

Where fetal demise has already occurred, or where the mother is stable and the fetus is not compromised, vaginal delivery is the preferred route. Aggressive correction of coagulopathy accompanies it.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"In cases where fetal demise has occurred, vaginal delivery is preferable."

States the preferred delivery route after fetal demise.

Emergency Hysterectomy

Action: Hysterectomy NCIT:C15256

Last-resort surgical control of uncontrollable postpartum hemorrhage, sometimes required after severe abruption with a Couvelaire uterus that will not contract. Carries permanent loss of fertility.

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."

Documents emergency hysterectomy as a recognised maternal outcome and intervention in abruption.

Expectant Management with Surveillance

Action: Supportive Care NCIT:C15747

In selected stable cases remote from term, or at term with reassuring maternal and fetal status, expectant management with close monitoring and readiness for rapid delivery is reasonable. Management is individualised by severity and gestational age rather than protocolised. In practice the window bought by expectant management is used to give antenatal corticosteroids and, before early preterm delivery, magnesium sulfate for fetal neuroprotection. Tocolysis is controversial and generally avoided when there is fetal compromise.

Show evidence (2 references)

PMID:17012465 SUPPORT Human Clinical

"The management of abruption should be individualized on a case-by-case basis depending on the severity of the abruption and the gestational age at which it occurs."

States the individualised management principle.

PMID:17012465 SUPPORT Human Clinical

"abruption at extremely preterm gestations may be managed conservatively in selected stable cases, with close monitoring and rapid delivery should deterioration occur"

Supports conservative management with surveillance in selected stable preterm cases.

🌍

Environmental Factors

6

Cigarette Smoking

Maternal smoking is the best-quantified modifiable risk factor for abruption, plausibly acting through vasoconstriction and chronic decidual ischemia and necrosis. It is notable for a large population attributable fraction and for super-additive interaction with hypertensive disorders of pregnancy, the cleanest documented exposure-exposure interaction in this disease.

Show evidence (4 references)

PMID:10214847 SUPPORT Human Clinical

"Smoking was associated with a 90% increase in the risk of placental abruption"

Quantifies the smoking-abruption association in a meta-analysis of 13 studies.

PMID:10214847 SUPPORT Human Clinical

"Pooled population attributable risk percentage for each stratum ranged between 15% and 25%, implying that 15-25% of placental abruption episodes are attributable to cigarette smoking."

Quantifies the population attributable fraction of abruption due to smoking.

PMID:10214847 SUPPORT Human Clinical

"In the presence of smoking, the risk of abruption was further increased due to chronic hypertension, mild or severe preeclampsia, or chronic hypertension with superimposed preeclampsia."

Documents interaction between smoking and hypertensive disorders of pregnancy on abruption risk.

+ 1 more reference

Mechanism Target:

PREDISPOSES Decidual Vasculopathy and Spiral Artery Failure — Smoking roughly doubles risk and is thought to act through chronic vasoconstriction and decidual ischaemia, but the cited evidence is epidemiological and identifies no mediating step. Its population impact is large because exposure is common, not because the individual effect is.

Show evidence (1 reference)

PMID:10214847 SUPPORT Human Clinical

"Smoking was associated with a 90% increase in the risk of placental abruption"

Reports a 90% increase in abruption risk with smoking, an epidemiological association without a demonstrated mechanism.

Cocaine Use

Cocaine produces acute vasoconstriction and hypertensive surges. It carries the largest reported effect size of any graded risk factor in the umbrella review, though with wide confidence limits and only suggestive (class III) evidence quality.

Show evidence (2 references)

PMID:35365209 SUPPORT Human Clinical

"cocaine using (RR 4.55, 95% CI 1.78-6.50)"

Gives the umbrella-review pooled effect size for cocaine use, the largest among class III factors.

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Lists cocaine use among the established risk factors for abruption.

Mechanism Target:

TRIGGERS Decidual Vasculopathy and Spiral Artery Failure — Cocaine is thought to reach this node through acute vasoconstriction and hypertensive surges in the uteroplacental circulation, but nothing in this entry evidences that intermediate, so it is marked unknown on the same standard applied to smoking here. Its relative risk is the largest of the exposures in this entry.

Show evidence (1 reference)

PMID:35365209 SUPPORT Human Clinical

"cocaine using (RR 4.55, 95% CI 1.78-6.50)"

Reports a relative risk of 4.55 for abruption with cocaine use, the strongest exposure association in this entry.

Prior Cesarean Delivery

A previous cesarean delivery raises abruption risk in subsequent pregnancies, alongside larger increases in placenta previa and placenta accreta, consistent with a scarred, abnormally decidualized implantation bed.

Show evidence (1 reference)

PMID:29360829 SUPPORT Human Clinical

"and placental abruption (OR 1.38, 1.27 to 1.49; n = 5,667,160; 6 studies)"

Quantifies abruption risk after prior cesarean in a meta-analysis of nearly 30 million participants.

Mechanism Target:

PREDISPOSES Decidual Vasculopathy and Spiral Artery Failure — A uterine scar supports poorer decidualisation and placentation at the implantation site in a later pregnancy. The effect is modest and the mediating step is not established in the cited meta-analysis.

Show evidence (1 reference)

PMID:29360829 SUPPORT Human Clinical

"and placental abruption (OR 1.38, 1.27 to 1.49; n = 5,667,160; 6 studies)"

Reports an odds ratio of 1.38 for abruption after prior caesarean delivery across more than five million pregnancies, a modest but precisely estimated association.

Abdominal Trauma

Blunt abdominal trauma, including motor vehicle collisions and intimate partner violence, shears the elastic uterus against the relatively inelastic placenta.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Lists trauma among the established risk factors for abruption.

Mechanism Target:

TRIGGERS Decidual Hemorrhage and Retroplacental Hematoma Formation — The one mechanically distinct cause in this entry. Blunt force shears the relatively inelastic placenta away from the elastic uterine wall, tearing decidual vessels directly, so it produces the hematoma without any preceding vasculopathy.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Names trauma among the established risk factors for abruption, the direct mechanical route to decidual haemorrhage.

Hypertensive Disorders of Pregnancy

Chronic hypertension and preeclampsia both raise abruption risk, consistent with the shared decidual vascular lesion of ischemic placental disease.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Lists hypertension and preeclampsia among the established risk factors for abruption.

Mechanism Target:

PREDISPOSES Decidual Vasculopathy and Spiral Artery Failure — Preeclampsia and abruption share defective spiral artery remodelling as a substrate, so hypertensive disease marks a placenta already predisposed rather than acting as an external insult.

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Names hypertension and preeclampsia among the established risk factors for abruption.

Prior Abruption

A previous abruption is among the strongest predictors of recurrence, consistent with a persistent underlying maternal vascular phenotype rather than a one-off accident. Recurrence risk is roughly five-fold, which is the single most important piece of evidence for the chronic-disease rather than accident model, and the basis for counselling in a subsequent pregnancy.

Show evidence (3 references)

PMID:38366767 SUPPORT Human Clinical

"Rates of abruption in the second birth among individuals with and without previous placental abruption were 3.35% and 0.66%, respectively"

Quantifies recurrence risk in a cohort of over 126,000 patients with two consecutive singleton births.

PMID:40140972 SUPPORT Human Clinical

"A total of 54 observational studies were included, covering 7,267,241 pregnant women, with 47,702 cases diagnosed with placental abruption."

Establishes the scale of the meta-analysis that identified previous placental abruption as the most significant maternal baseline risk factor.

PMID:17012465 SUPPORT Human Clinical

"Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."

Lists prior abruption among the established risk factors, supporting recurrence risk.

Mechanism Target:

PREDISPOSES Decidual Vasculopathy and Spiral Artery Failure — Not an exposure at all but a marker of persisting susceptibility: a previous abruption reveals an underlying vascular predisposition that remains present in the next pregnancy. Recorded because recurrence risk is the single strongest predictor in this entry.

Show evidence (1 reference)

PMID:38366767 SUPPORT Human Clinical

"Rates of abruption in the second birth among individuals with and without previous placental abruption were 3.35% and 0.66%, respectively"

Reports abruption in 3.35% of second births after a previous abruption versus 0.66% without, a fivefold recurrence indicating persistent susceptibility rather than a repeated exposure.

🔬

Biochemical Markers

2

Fibrinogen

Reference Ranges

4.0– g/L (third-trimester pregnancy)

Reassuring (4.0– g/L) Falling, consumption underway (2.0–4.0 g/L) Critical consumptive coagulopathy (–2.0 g/L)

Reassuring: Severe hemorrhage unlikely; negative predictive value about 79% in the source cohort.

Falling, consumption underway: Within or below the non-pregnant reference interval and therefore inappropriately low for pregnancy; indicates active consumption and rising risk of severe hemorrhage.

Critical consumptive coagulopathy: Positive predictive value for severe postpartum hemorrhage was 100% at or below this level in the source cohort; mandates immediate fibrinogen replacement.

One-sided by design: the clinically meaningful question in obstetric hemorrhage is how far fibrinogen has fallen, not whether it is elevated. Boundary caveat. The source states its thresholds as strictly greater than 4 g/L and less than or equal to 2 g/L, whereas interpretation_bands use half-open intervals with an inclusive lower bound and an exclusive upper bound. The conventions therefore disagree at exactly two values: as encoded, 4.0 falls in the reassuring band and 2.0 falls in the middle band, whereas the source would place 4.0 outside its high-NPV group and 2.0 inside its 100%-PPV group. At those two exact values follow the source, not the band edge. The bands are deliberately not nudged to force agreement, since that would require boundary numbers that appear nowhere in the literature. No loinc_term is bound because this project has no configured LOINC adapter, so a LOINC code could not be verified against an authoritative source. Per the guidance that a precise descriptor with no term beats a plausible but unverified one, the code is omitted rather than guessed; adding a LOINC adapter to conf/oak_config.yaml would let this be filled in properly.

Show evidence (1 reference)

PMID:17087729 SUPPORT Human Clinical

"The negative predictive value of a fibrinogen concentration >4 gL(-1) was 79% and the positive predictive value of a concentration <or=2 gL(-1) was 100%."

Anchors the 4 g/L threshold as the level above which severe hemorrhage becomes unlikely. Marked PARTIAL because the cohort is postpartum hemorrhage generally rather than abruption specifically, though abruption is a major cause of the consumptive coagulopathy studied.

Show evidence (2 references)

PMID:17087729 SUPPORT Human Clinical

"In multivariate analysis, from H0 to H4, fibrinogen was the only marker associated with the occurrence of severe PPH."

Establishes fibrinogen as the only independently predictive coagulation marker. PARTIAL because the cohort is obstetric hemorrhage broadly rather than abruption alone.

PMID:19720393 SUPPORT Human Clinical

"The extent of thrombin generation due to DC-expressed TF is indicated by the profound hypofibrinogenemia attendant severe abruption"

Ties the hypofibrinogenemia specifically to decidual tissue factor-driven thrombin generation in abruption.

Kleihauer-Betke Test

Show evidence (1 reference)

PMID:17012465 SUPPORT Human Clinical

"The diagnosis of abruption is a clinical one, and ultrasonography and the Kleihauer-Betke test are of limited value."

States the limited diagnostic value of the Kleihauer-Betke test in abruption.

🔬

Diagnosis

1

Clinical Diagnosis of Abruption

Abruption is a clinical diagnosis based on vaginal bleeding, uterine hypertonicity or tenderness, and non-reassuring fetal status. Imaging is confirmatory at best: a normal ultrasound does not exclude abruption because fresh retroplacental blood is often isoechoic with placenta.

Show evidence (3 references)

PMID:17012465 SUPPORT Human Clinical

"The diagnosis of abruption is a clinical one, and ultrasonography and the Kleihauer-Betke test are of limited value."

States that abruption is diagnosed clinically and that ultrasound and Kleihauer-Betke testing have limited diagnostic value.

PMID:12164566 SUPPORT Human Clinical

"the sensitivity, specificity, and positive and negative predictive values of sonography were 24%, 96%, 88%, and 53%, respectively"

Quantifies the poor sensitivity but high specificity of ultrasound, which is why a negative scan cannot exclude abruption.

PMID:12164566 SUPPORT Human Clinical

"Sonography is not sensitive for detection of placental abruption, but a positive finding is associated with more aggressive management and worse neonatal outcome."

States the asymmetric diagnostic value of ultrasound, useful when positive and uninformative when negative.

📈

Progression

1

Long-term maternal cerebrovascular risk

Age: Years to decades after the affected pregnancy

Abruption is followed by elevated long-term maternal cerebrovascular risk, paralleling the pattern already recognised after preeclampsia. As with preeclampsia, this records the association without asserting that the acute abruption itself causes the later stroke; shared antecedent vascular susceptibility is an equally consistent explanation.

Show evidence (2 references)

PMID:31420459 SUPPORT Human Clinical

"Abruption was associated with increased rates of nonfatal ischemic stroke (HR 1.4, 95% CI 1.1-1.7) and hemorrhagic stroke (HR 1.4, 95% CI 1.1-1.9)."

Reports the effect sizes for both stroke subtypes in a Danish population cohort. Notably the hazard ratio is the same for ischemic and hemorrhagic stroke, which argues for a systemic vascular diathesis rather than a specifically thrombotic one.

PMID:31420459 SUPPORT Human Clinical

"Disruption of the hemostatic system manifesting as ischemia and hemorrhage may indicate shared etiologies between abruption and cerebrovascular complications."

States the shared-etiology interpretation, supporting the framing of this progression item as an association rather than a causal sequela.

🪜

Stages

4

Sher Class 0

Asymptomatic. The retroplacental clot is found only on inspection of the placenta after delivery, with no antenatal clinical suspicion. Corresponds to partial or marginal separation.

Sher grading (equivalently the older Page 0-3 scheme) is the conventional severity classification. It is curated here as ordered severity stages rather than as subtypes, because the classes are a graded continuum of one process rather than mechanistically distinct entities. No evidence items are attached to the stage definitions: the originating paper, Sher G, "A rational basis for the management of abruptio placentae", J Reprod Med 1978 (PMID:722694), has no abstract indexed in PubMed, so no snippet can be verified against a cached reference. Rather than fabricate a quote or attribute the grading to a secondary source that merely restates it, the citation is recorded in the top-level references block and the stage descriptions are left unevidenced.

Sher Class 1

Mild. Minimal or absent vaginal bleeding, slight uterine tenderness, normal maternal vital signs, no coagulopathy and no fetal distress. Corresponds to partial or marginal separation.

Sher Class 2

Moderate. None-to-moderate vaginal bleeding, significant uterine tenderness with tetanic contractions, maternal tachycardia with orthostatic change, hypofibrinogenemia, and fetal distress with a living fetus. Corresponds to more complete or central separation.

Sher Class 3

Severe. Minimal-to-heavy bleeding, board-like tetanic uterus, maternal shock, overt coagulopathy, and fetal death. Corresponds to complete or central separation.

📊

Prevalence

2

Worldwide

Point Prevalence 1000.0 per 100,000 >1 in 1,000

Roughly 1% of pregnancies; the denominator is pregnancies, not the general population, so this figure is a per-pregnancy occurrence rate. Worth noting against the common impression of abruption as a preterm catastrophe: nearly half of all abruptions occur at term.

Show evidence (2 references)

PMID:17012465 SUPPORT Human Clinical

"Placental abruption complicates about 1% of pregnancies and is a leading cause of vaginal bleeding in the latter half of pregnancy."

States the approximate per-pregnancy occurrence rate.

PMID:37164498 SUPPORT Human Clinical

"Abruption occurs in 0.6% to 1.2% of all pregnancies, with nearly half of abruption occurring at term gestations."

Gives a tighter occurrence range and the gestational-age distribution, roughly half at term.

Nordic countries and United States

Point Prevalence 380.0–1000.0 per 100,000 >1 in 1,000

Reported range 0.38-0.51% in the Nordic countries versus 0.6-1.0% in the USA, indicating real geographic variation in either incidence or ascertainment.

Show evidence (1 reference)

PMID:21241259 SUPPORT Human Clinical

"The prevalence is lower in the Nordic countries (0.38-0.51%) compared with the USA (0.6-1.0%)."

Gives the region-stratified prevalence range.

⚖️

Clinical Burden

High

Abruption is a disproportionate contributor to adverse perinatal outcome relative to its frequency, accounting for around a tenth of preterm births and up to a fifth of perinatal deaths in developed countries, with maternal mortality several-fold above baseline.

Show evidence (2 references)

PMID:21241259 SUPPORT Human Clinical

"In developed countries, approximately 10% of all preterm births and 10-20% of all perinatal deaths are caused by placental abruption."

Quantifies the population-level contribution of abruption to preterm birth and perinatal death.

PMID:21241259 SUPPORT Human Clinical

"Maternal death is rare but seven times higher than the overall maternal mortality rate."

Quantifies excess maternal mortality.

🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Placental Abruption:

Placenta Previa

Overlapping Features The other major cause of antepartum hemorrhage. Previa classically produces painless bright red bleeding with a soft uterus, whereas abruption produces painful bleeding with a tender, hypertonic uterus. The decisive practical difference is imaging: previa is reliably identified by transvaginal ultrasound, whereas ultrasound has roughly 24% sensitivity for abruption, so a normal scan effectively rules out previa but not abruption. Note that previa is also a risk factor for abruption, so the two are not mutually exclusive.

Show evidence (2 references)

PMID:16582134 SUPPORT Human Clinical

"Placenta previa, placenta accreta, and vasa previa are important causes of bleeding in the second half of pregnancy and in labor."

Establishes placenta previa as a competing cause of second-half-of-pregnancy bleeding, the differential-diagnosis relationship.

PMID:16582134 SUPPORT Human Clinical

"The diagnostic modality of choice for placenta previa is transvaginal ultrasonography"

Documents that previa is reliably diagnosed by ultrasound, in contrast to abruption, which is the practical basis for discriminating the two.

Vasa Previa

Overlapping Features A rarer cause of antepartum bleeding in which unprotected fetal vessels cross the membranes over the cervical os. Distinguished from abruption by the fact that the blood lost is fetal rather than maternal, so even modest volumes cause rapid fetal exsanguination without maternal instability.

Show evidence (1 reference)

PMID:16582134 SUPPORT Human Clinical

"Placenta previa, placenta accreta, and vasa previa are important causes of bleeding in the second half of pregnancy and in labor."

Establishes vasa previa as a competing cause of second-half-of-pregnancy bleeding.

🔬

Clinical Trials

5

NCT05840471 NOT_APPLICABLE COMPLETED

Double-blind multicenter randomized trial of tranexamic acid in pregnant women with abruptio placenta, n=116. One of very few interventional trials with abruption itself as the enrolling condition.

Target Phenotypes: Antepartum hemorrhage HP:0025328

Show evidence (1 reference)

clinicaltrials:NCT05840471 SUPPORT Human Clinical

"Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality"

Trial rationale, confirming abruption-associated antepartum hemorrhage as the target condition.

NCT00186069 NOT_APPLICABLE COMPLETED

Randomized double-blind trial of magnesium sulfate tocolysis versus intravenous saline for suspected placental abruption, n=30. Small, but directly addresses the contested question of whether tocolysis is safe in suspected abruption.

Target Phenotypes: Premature birth HP:0001622

Show evidence (1 reference)

clinicaltrials:NCT00186069 SUPPORT Human Clinical

"To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption."

States the trial objective, magnesium sulfate in suspected preterm abruption.

NCT03782168 TERMINATED

Prospective study of plasma micro-particles and angiogenic markers as biomarkers of placental abruption. Terminated after enrolling a single participant. Curated deliberately as a negative result: together with NCT01279369 it is direct evidence that biomarker-based abruption prediction has a track record of failing to recruit or complete, which is part of why no validated predictive test exists.

Show evidence (1 reference)

clinicaltrials:NCT03782168 SUPPORT Human Clinical

"The primary outcome variables will include the total number of micro-particles, the number of micro-particles from each cell line (platelet, placental, endothelial etc.), and protein markers"

Documents the biomarker-prediction aim of this terminated study.

NCT01279369 TERMINATED

Study of cervicovaginal fetal fibronectin to predict preterm delivery due to abruption after minor maternal trauma. Terminated after enrolling three participants.

Show evidence (1 reference)

clinicaltrials:NCT01279369 SUPPORT Human Clinical

"The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta."

Documents the predictive-biomarker aim of this terminated study.

NCT02299414 PHASE_IV COMPLETED

The CHAP trial, n=2408: antihypertensive treatment of mild chronic hypertension in pregnancy. Relevant here as prevention rather than treatment, since chronic hypertension is among the strongest graded abruption risk factors and CHAP tested whether treating it changes placental outcomes.

Show evidence (1 reference)

clinicaltrials:NCT02299414 SUPPORT Human Clinical

"The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults"

States the trial objective of tighter blood-pressure control in pregnancy. PARTIAL because abruption is a component outcome rather than the primary endpoint, so this supports the prevention rationale rather than an abruption-specific treatment effect.

{ }

Source YAML

click to show

name: Placental Abruption
creation_date: "2026-08-04T00:00:00Z"
category: Complex
synonyms:
- Abruptio placentae
- Premature separation of the placenta
- Accidental hemorrhage
description: >
  Placental abruption is the premature separation of a normally implanted
  placenta from the uterine wall before delivery, and a leading cause of
  vaginal bleeding in the second half of pregnancy. Although it presents
  acutely, converging epidemiological and histopathological evidence frames it
  as the end-stage of a chronic disease of the uteroplacental vascular bed: it
  belongs to the ischemic placental disease triad alongside preeclampsia and
  fetal growth restriction, all three sharing failed physiological
  transformation of the maternal spiral arteries. Bleeding from these diseased
  decidual vessels forms a retroplacental hematoma that mechanically shears the
  placenta from the uterine wall and removes gas-exchange surface. Because
  decidual cells are the richest source of tissue factor at the maternal-fetal
  interface, decidual hemorrhage generates large amounts of thrombin, which
  then acts through protease-activated receptors as a direct uterotonic, as an
  inducer of matrix metalloproteinases that weaken the fetal membranes, and as
  the driver of consumptive coagulopathy. This thrombin amplification loop is
  what links abruption simultaneously to preterm labor, preterm premature
  rupture of membranes, and maternal disseminated intravascular coagulation.
disease_term:
  preferred_term: placental abruption
  term:
    id: MONDO:0004846
    label: placental abruption
references:
- reference: PMID:722694
  title: "A rational basis for the management of abruptio placentae."
parents:
- Placental disease
- Obstetric hemorrhage
- Ischemic placental disease
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 1000.0
  notes: >
    Roughly 1% of pregnancies; the denominator is pregnancies, not the general
    population, so this figure is a per-pregnancy occurrence rate. Worth noting
    against the common impression of abruption as a preterm catastrophe: nearly
    half of all abruptions occur at term.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Placental abruption complicates about 1% of pregnancies and is a leading cause of vaginal bleeding in the latter half of pregnancy."
    explanation: States the approximate per-pregnancy occurrence rate.
  - reference: PMID:37164498
    reference_title: "Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruption occurs in 0.6% to 1.2% of all pregnancies, with nearly half of abruption occurring at term gestations."
    explanation: Gives a tighter occurrence range and the gestational-age distribution, roughly half at term.
- population: Nordic countries and United States
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_low: 380.0
  rate_high: 1000.0
  notes: >
    Reported range 0.38-0.51% in the Nordic countries versus 0.6-1.0% in the
    USA, indicating real geographic variation in either incidence or
    ascertainment.
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The prevalence is lower in the Nordic countries (0.38-0.51%) compared with the USA (0.6-1.0%)."
    explanation: Gives the region-stratified prevalence range.
clinical_burden:
  burden_level: HIGH
  rationale: >
    Abruption is a disproportionate contributor to adverse perinatal outcome
    relative to its frequency, accounting for around a tenth of preterm births
    and up to a fifth of perinatal deaths in developed countries, with maternal
    mortality several-fold above baseline.
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In developed countries, approximately 10% of all preterm births and 10-20% of all perinatal deaths are caused by placental abruption."
    explanation: Quantifies the population-level contribution of abruption to preterm birth and perinatal death.
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal death is rare but seven times higher than the overall maternal mortality rate."
    explanation: Quantifies excess maternal mortality.
pathophysiology:
- name: Decidual Vasculopathy and Spiral Artery Failure
  role: trigger
  biological_scale: TISSUE
  description: >
    Shallow extravillous trophoblast invasion leaves the maternal spiral
    arteries incompletely converted into low-resistance, high-capacity vessels.
    The retained muscular, high-resistance vasculature produces chronic
    uteroplacental ischemia and predisposes the decidual vascular bed to
    atherosis, thrombosis and necrosis. This is the shared upstream lesion of
    ischemic placental disease, which is why abruption, preeclampsia and fetal
    growth restriction cluster in the same pregnancies.
  cell_types:
  - preferred_term: extravillous trophoblast
    term:
      id: CL:0008036
      label: extravillous trophoblast
  - preferred_term: decidual cell
    term:
      id: CL:2000002
      label: decidual cell
  biological_processes:
  - preferred_term: response to hypoxia
    term:
      id: GO:0001666
      label: response to hypoxia
    modifier: INCREASED
  locations:
  - preferred_term: uterine spiral artery
    term:
      id: UBERON:0015171
      label: uterine spiral artery
  downstream:
  - target: Decidual Hemorrhage and Retroplacental Hematoma Formation
    description: >
      Chronically ischemic, structurally abnormal decidual vessels are prone to
      rupture, which is the initiating event of the hematoma.
    evidence:
    - reference: PMID:19720393
      reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Shallow trophoblast invasion impedes decidual vascular conversion, producing an inadequate uteroplacental blood flow that elicits abruption-related placental ischemia."
      explanation: Places failed spiral artery conversion upstream of abruption-related ischemia.
  evidence:
  - reference: PMID:39641171
    reference_title: "Ischemic Placental Disease: Epidemiology and Impact on Maternal and Offspring Health Along the Life Course."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The unifying pathophysiological mechanism that precedes all 3 complications is uteroplacental ischemia as a consequence of inadequate (or failure of) physiological transformation of the maternal uterine spiral arteries, endothelial cell dysfunction, and increased oxidative stress."
    explanation: Identifies failed spiral artery transformation as the shared upstream mechanism of abruption within ischemic placental disease.
  - reference: PMID:19897298
    reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Chronic lesions included chronic deciduitis, decidual necrosis, decidual vasculopathy, placental infarctions, villous mal-development (delayed or accelerated maturation), hemosiderin deposition, intervillous thrombus, and chronic villitis."
    explanation: Documents decidual vasculopathy and decidual necrosis among the chronic lesions profiled in clinically diagnosed abruption.
- name: Decidual Hemorrhage and Retroplacental Hematoma Formation
  role: central_effector
  biological_scale: TISSUE
  description: >
    Rupture of a diseased decidual vessel bleeds into the decidua basalis. The
    accumulating blood dissects along the plane between the placental basal
    plate and the uterine wall, forming a retroplacental hematoma whose
    expansion progressively levers the placenta away from its attachment. The
    same process occurring in the decidua parietalis produces a retrochorionic
    hematoma. Bleeding may track down to the cervix and present as vaginal
    bleeding, or remain concealed behind the placenta.
  cell_types:
  - preferred_term: decidual cell
    term:
      id: CL:2000002
      label: decidual cell
  locations:
  - preferred_term: decidua basalis
    term:
      id: UBERON:0000453
      label: decidua basalis
  downstream:
  - target: Placental Separation and Loss of Exchange Surface
    description: >
      The expanding hematoma occupies a closed space and mechanically strips
      the placenta from the uterine wall.
    evidence:
    - reference: PMID:19897298
      reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The pathological criteria for abruption diagnosis included hematoma, fibrin deposition, compressed villi, and hemosiderin-laden histiocytes in cases with older hematomas."
      explanation: Compressed villi adjacent to hematoma are the histological signature of the hematoma mechanically displacing placental tissue.
  - target: Decidual Tissue Factor Exposure and Thrombin Generation
    description: >
      Hemorrhage into the decidua brings plasma factor VII into contact with
      the very high constitutive tissue factor of decidual cells.
    evidence:
    - reference: PMID:21040617
      reference_title: "Novel insights into molecular mechanisms of abruption-induced preterm birth."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Abruptions are associated with excess thrombin generated from decidual-cell-expressed tissue factor."
      explanation: Directly links the decidual hemorrhage of abruption to excess thrombin generation.
  evidence:
  - reference: PMID:21890016
    reference_title: "Abruption-associated prematurity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Chronic, subacute decidual hemorrhage (ie, abruptio placenta and retrochorionic hematoma formation) is an important contributor to preterm parturition."
    explanation: Identifies decidual hemorrhage with hematoma formation as the core lesion.
- name: Placental Separation and Loss of Exchange Surface
  role: effector
  biological_scale: TISSUE
  description: >
    Mechanical separation removes functional villous surface from maternal
    perfusion. Because the fetus depends entirely on intervillous blood flow
    for oxygen, loss of exchange area translates directly into fetal
    hypoxemia, and the fraction of placenta detached is the main determinant
    of fetal outcome.
  locations:
  - preferred_term: placenta
    term:
      id: UBERON:0001987
      label: placenta
  downstream:
  - target: Fetal Hypoxic-Ischemic Injury
    description: >
      Loss of gas-exchange surface produces acute fetal hypoxemia, with the
      detached fraction determining severity.
    evidence:
    - reference: PMID:17012465
      reference_title: "Placental abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Abruption involving more than 50% of the placenta is frequently associated with fetal death."
      explanation: Establishes the dose-response between separated placental area and fetal death.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The maternal effect of abruption depends primarily on its severity, whereas its effect on the fetus is determined both by its severity and the gestational age at which it occurs."
    explanation: Separates the maternal and fetal determinants of outcome after placental separation.
- name: Decidual Tissue Factor Exposure and Thrombin Generation
  role: amplifier
  biological_scale: MOLECULAR
  description: >
    Decidual cells express the highest levels of tissue factor of any cell type
    at the maternal-fetal interface, a constitutive hemostatic envelope that
    normally protects against bleeding during trophoblast invasion and
    delivery. When hemorrhage occurs, that same tissue factor binds plasma
    factor VII and generates thrombin in large excess. Thrombin then acts
    through protease-activated receptors as a signaling molecule rather than
    only as a clotting enzyme, which is what converts a local bleed into
    preterm labor, membrane rupture, and systemic coagulopathy.
  cell_types:
  - preferred_term: decidual cell
    term:
      id: CL:2000002
      label: decidual cell
  biological_processes:
  - preferred_term: blood coagulation, extrinsic pathway
    term:
      id: GO:0007598
      label: blood coagulation, extrinsic pathway
    modifier: INCREASED
  - preferred_term: thrombin-activated receptor signaling pathway
    term:
      id: GO:0070493
      label: thrombin-activated receptor signaling pathway
    modifier: INCREASED
  downstream:
  - target: Thrombin-Driven Myometrial Contraction and Membrane Weakening
    description: >
      Thrombin signals through protease-activated receptors on myometrium and
      decidua to drive contraction and matrix degradation.
    evidence:
    - reference: PMID:21890016
      reference_title: "Abruption-associated prematurity."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Such hemorrhage induces thrombin from decidual tissue factor, which plays a pivotal role in the development of preterm premature rupture of membranes and preterm delivery by acting through protease-activated receptors to promote the production of pro-inflammatory cytokines, and matrix-degrading metalloproteinases."
      explanation: Specifies the PAR-mediated route from decidual thrombin to membrane rupture and preterm delivery.
  - target: Consumptive Coagulopathy and Maternal Hemorrhagic Shock
    description: >
      Sustained thrombin generation consumes fibrinogen and clotting factors,
      producing the profound hypofibrinogenemia characteristic of severe
      abruption.
    evidence:
    - reference: PMID:19720393
      reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The extent of thrombin generation due to DC-expressed TF is indicated by the profound hypofibrinogenemia attendant severe abruption"
      explanation: Links the magnitude of decidual thrombin generation to the consumptive hypofibrinogenemia of severe abruption.
  evidence:
  - reference: PMID:19720393
    reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among the cell types at the maternal fetal interface at term, TF expression is highest in decidual cells indicating that this TF meets the hemostatic demands of labor and delivery."
    explanation: Establishes decidual cells as the dominant tissue factor source at the maternal-fetal interface.
  - reference: PMID:19720393
    reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In human pregnancy, decidual cell-expressed TF prevents decidual hemorrhage (abruption)."
    explanation: States the normal protective role of decidual tissue factor, the physiology that abruption subverts.
- name: Thrombin-Driven Myometrial Contraction and Membrane Weakening
  role: amplifier
  biological_scale: CELLULAR
  description: >
    Thrombin generated by the hematoma is a direct uterotonic. It activates
    PAR1 on myometrial cells, driving contraction both by direct myosin light
    chain phosphorylation and indirectly by inducing prostaglandin synthesis.
    In parallel, thrombin upregulates decidual matrix metalloproteinases and
    interleukin-8, recruiting neutrophils whose proteases degrade the
    collagen-rich amnion and choriodecidua. The two arms together explain the
    painful uterine hypertonus of acute abruption and the strong association of
    abruption with preterm labor and preterm premature rupture of membranes.
  cell_types:
  - preferred_term: myometrial cell
    term:
      id: CL:0002366
      label: myometrial cell
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  biological_processes:
  - preferred_term: uterine smooth muscle contraction
    term:
      id: GO:0070471
      label: uterine smooth muscle contraction
    modifier: INCREASED
  - preferred_term: prostaglandin biosynthetic process
    term:
      id: GO:0001516
      label: prostaglandin biosynthetic process
    modifier: INCREASED
  - preferred_term: extracellular matrix disassembly
    term:
      id: GO:0022617
      label: extracellular matrix disassembly
    modifier: INCREASED
  locations:
  - preferred_term: myometrium
    term:
      id: UBERON:0001296
      label: myometrium
  evidence:
  - reference: PMID:32365105
    reference_title: "Mechanisms of thrombin-Induced myometrial contractions: Potential targets of progesterone."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "histologic studies of placental abruption, as a representative intrauterine bleeding, revealed that thrombin was expressed within the infiltrating hemorrhage and that thrombin receptor (protease-activated receptor 1, PAR1) was highly expressed in myometrial cells surrounding the hemorrhage"
    explanation: >
      Localizes thrombin to the abruption hemorrhage and PAR1 to the adjacent
      myometrium in human tissue, the anatomical basis of the uterotonic effect.
      Classified HUMAN_CLINICAL rather than IN_VITRO because this specific
      finding comes from histology of human abruption specimens; the cultured
      myometrial cell experiments from the same paper are curated separately as
      IN_VITRO.
  - reference: PMID:32365105
    reference_title: "Mechanisms of thrombin-Induced myometrial contractions: Potential targets of progesterone."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "thrombin induces myometrial contractions by two mechanisms, including direct activation of myosin and indirect increases in prostaglandin synthesis"
    explanation: Defines the two parallel routes by which thrombin drives myometrial contraction.
  - reference: PMID:19720393
    reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Thrombin acts as an autocrine/paracrine mediator that degrades these ECMs by augmenting decidual cell expression of: 1) matrix metalloproteinases and 2) interleukin-8, a key mediator of abruption-associated decidual infiltration of neutrophils, which express several ECM degrading proteases."
    explanation: Specifies the MMP and IL-8/neutrophil route from thrombin to fetal membrane matrix degradation.
  - reference: PMID:31955792
    reference_title: "Thrombin-Induced Decidual Colony-Stimulating Factor-2 Promotes Abruption-Related Preterm Birth by Weakening Fetal Membranes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Thrombin enhanced CSF-2 secretion in TDC cultures fourfold (P < 0.05); MPA reduced this effect."
    explanation: Adds a thrombin-induced decidual CSF-2 paracrine arm to fetal membrane weakening.
- name: Consumptive Coagulopathy and Maternal Hemorrhagic Shock
  role: consequence
  biological_scale: ORGANISM
  description: >
    Sustained thrombin generation plus release of placental procoagulant
    material consumes fibrinogen, platelets and clotting factors faster than
    they are replaced, producing disseminated intravascular coagulation. This
    converts a local placental problem into systemic maternal hemorrhage.
    Because a substantial share of the blood loss can be concealed behind the
    placenta, visible bleeding underestimates the true deficit and the degree
    of shock is often out of proportion to what is seen.
  biological_processes:
  - preferred_term: blood coagulation
    term:
      id: GO:0007596
      label: blood coagulation
    modifier: INCREASED
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."
    explanation: Enumerates the maternal consequences of the consumptive coagulopathy and hemorrhage.
- name: Fetal Hypoxic-Ischemic Injury
  role: consequence
  biological_scale: ORGANISM
  description: >
    Acute reduction in placental gas exchange produces fetal hypoxemia,
    acidemia and a non-reassuring heart rate pattern. If separation is
    extensive or delivery is delayed, the result is perinatal asphyxia with
    intraventricular hemorrhage, periventricular leukomalacia and cerebral
    palsy in survivors, or intrauterine fetal death.
  biological_processes:
  - preferred_term: response to hypoxia
    term:
      id: GO:0001666
      label: response to hypoxia
    modifier: INCREASED
  evidence:
  - reference: PMID:21890016
    reference_title: "Abruption-associated prematurity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The resulting neonates exhibit increased rates of perinatal asphyxia, intraventricular hemorrhage, periventricular leukomalacia, cerebral palsy and mortality, compared with age-matched controls."
    explanation: Enumerates the hypoxic-ischemic sequelae in surviving neonates.
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."
    explanation: Lists the perinatal outcomes attributable to abruption.
mechanistic_hypotheses:
- hypothesis_group_id: chronic_ischemic_placental_disease
  hypothesis_label: Abruption as the end-stage of chronic ischemic placental disease
  status: CANONICAL
  description: >
    Under this model abruption is not an acute accident but the terminal event
    of a chronic uteroplacental vascular disease that begins with failed spiral
    artery transformation early in pregnancy. Supporting evidence includes the
    excess of chronic decidual lesions in abruption placentas, the elevated
    abruption risk conferred by bleeding earlier in pregnancy, and the
    co-clustering of abruption with preeclampsia and fetal growth restriction.
  evidence:
  - reference: PMID:16513243
    reference_title: "Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinicians widely regard placental abruption as an acute event, though accumulating data point towards abruption being the end-result of chronic processes early in pregnancy, and perhaps even extending to conception."
    explanation: States the chronic-process model directly.
  - reference: PMID:16513243
    reference_title: "Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the increased risk associated with placental lesions, especially chronic inflammatory lesions, even in the absence of early vaginal bleeding, suggests that prolonged inflammation may be implicated in placental abruption"
    explanation: Provides the histological argument that chronic inflammation precedes abruption independent of early bleeding.
  - reference: PMID:37164498
    reference_title: "Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We discuss the interaction of chronic processes (decidual and uteroplacental vasculopathy) and acute processes (shearing forces applied to the abdomen) that underlie the pathophysiology."
    explanation: >
      States the two-component model explicitly, and is the reason this entry
      keeps both the chronic decidual vasculopathy trigger and the acute
      mechanical arm captured under abdominal trauma. The chronic model is not
      a replacement for the acute one; abruption arises where a chronically
      fragile decidual bed meets an acute insult.
phenotypes:
- name: Antepartum Hemorrhage
  category: Clinical
  description: >
    Vaginal bleeding after 20 weeks of gestation, classically dark and
    non-clotting. Bleeding may be concealed behind the placenta, so visible
    blood loss can badly underestimate the true deficit.
  phenotype_term:
    preferred_term: Antepartum hemorrhage
    term:
      id: HP:0025328
      label: Antepartum hemorrhage
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Placental abruption complicates about 1% of pregnancies and is a leading cause of vaginal bleeding in the latter half of pregnancy."
    explanation: Establishes antepartum vaginal bleeding as the cardinal presenting feature.
- name: Placental Separation
  category: Clinical
  description: >
    Premature detachment of the placenta from the uterine wall before delivery,
    the defining lesion of the disorder.
  phenotype_term:
    preferred_term: Placental abruption
    term:
      id: HP:0011419
      label: Placental abruption
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Placental abruption, classically defined as a premature separation of the placenta before delivery, is one of the leading causes of vaginal bleeding in the second half of pregnancy."
    explanation: Provides the definitional statement of premature placental separation.
- name: Abdominal Pain
  category: Clinical
  description: >
    Abdominal and back pain accompanying the bleeding, arising from the
    distending retroplacental hematoma and from thrombin-driven uterine
    contraction. Pain is the feature that most usefully separates abruption
    from placenta previa at the bedside.
  phenotype_term:
    preferred_term: Abdominal pain
    term:
      id: HP:0002027
      label: Abdominal pain
  evidence:
  - reference: PMID:37164498
    reference_title: "Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical manifestations of abruption typically include vaginal bleeding and abdominal pain with a wide variety of abnormal fetal heart rate patterns."
    explanation: Names abdominal pain as a typical clinical manifestation alongside bleeding and abnormal fetal heart rate patterns.
- name: Uterine Hypertonicity
  category: Clinical
  description: >
    Painful, tetanically contracted uterus, classically described as
    board-like in severe abruption. Mechanistically this is the myometrial
    consequence of thrombin acting on PAR1 rather than simply a response to
    pain. Deliberately left without an ontology binding: HPO has no term for
    uterine hypertonus or tetanic uterine contraction, and binding to a
    generic pain or contraction term would be less accurate than leaving it
    unbound.
  evidence:
  - reference: PMID:19897298
    reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "vaginal bleeding accompanied by nonreassuring fetal status or uterine hypertonicity"
    explanation: Quotes the clinical diagnostic criterion naming uterine hypertonicity alongside bleeding.
- name: Non-Reassuring Fetal Status
  category: Clinical
  description: >
    Abnormal fetal heart rate patterns reflecting acute reduction in placental
    gas exchange, ranging through decelerations to a Category III tracing or
    absent fetal heart tones. Present on admission in the large majority of
    abruptions that go on to cause cerebral palsy.
  phenotype_term:
    preferred_term: Fetal distress
    term:
      id: HP:0025116
      label: Fetal distress
  evidence:
  - reference: PMID:19897298
    reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "vaginal bleeding accompanied by nonreassuring fetal status or uterine hypertonicity"
    explanation: Quotes the clinical diagnostic criterion naming non-reassuring fetal status alongside bleeding.
  - reference: PMID:22805996
    reference_title: "Clinical features of abruptio placentae as a prominent cause of cerebral palsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of these 28 women, 22 (79%) exhibited non-reassuring fetal status on admission to obstetric facilities"
    explanation: Quantifies how often non-reassuring fetal status is already present at presentation in abruptions that cause cerebral palsy.
- name: Back Pain
  category: Clinical
  description: >
    Back pain accompanying or replacing abdominal pain, characteristic of a
    posteriorly implanted placenta where the hematoma is not palpable
    anteriorly and the presentation is easily mistaken for musculoskeletal
    pain.
  phenotype_term:
    preferred_term: Back pain
    term:
      id: HP:0003418
      label: Back pain
  evidence:
  - reference: PMID:22805996
    reference_title: "Clinical features of abruptio placentae as a prominent cause of cerebral palsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "strong abdominal pain and/or profuse vaginal bleeding occurred 159 ± 99 min prior to admission to an obstetric facility"
    explanation: >
      Documents severe truncal pain as the presenting symptom preceding
      admission. Marked PARTIAL because the source specifies abdominal pain;
      the back-pain presentation of posterior abruption is clinical convention
      rather than a quantified finding in this cohort.
- name: Cerebral Palsy
  category: Clinical
  description: >
    Permanent motor disability in surviving neonates following intrapartum
    hypoxic-ischemic injury. Abruption is not merely one cause among many
    here: in a national review of hypoxia-attributed cerebral palsy it was the
    single largest identifiable contributor, which is the strongest available
    argument for treating abruption as a neurological as well as an obstetric
    emergency.
  phenotype_term:
    preferred_term: Cerebral palsy
    term:
      id: HP:0100021
      label: Cerebral palsy
  evidence:
  - reference: PMID:22805996
    reference_title: "Clinical features of abruptio placentae as a prominent cause of cerebral palsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruptio placenta was responsible for 28 (26%) of the 107 CP infants, and was the single leading causative factor of CP."
    explanation: Quantifies abruption as the leading identifiable cause of hypoxia-attributed cerebral palsy in a national review.
- name: Preterm Premature Rupture of Membranes
  category: Clinical
  description: >
    Rupture of the fetal membranes before 37 weeks and before labor onset.
    This is the direct clinical readout of the entry's own thrombin-driven
    membrane-weakening mechanism, and the relationship is bidirectional:
    PPROM is both a consequence of decidual hemorrhage and a listed risk
    factor for subsequent abruption.
  phenotype_term:
    preferred_term: Preterm premature rupture of membranes
    term:
      id: HP:6000310
      label: Preterm premature rupture of membranes
  evidence:
  - reference: PMID:31955792
    reference_title: "Thrombin-Induced Decidual Colony-Stimulating Factor-2 Promotes Abruption-Related Preterm Birth by Weakening Fetal Membranes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Preterm premature rupture of membranes (PPROM) and thrombin generation by decidual cell-expressed tissue factor often accompany abruptions."
    explanation: States the co-occurrence of PPROM with abruption and decidual thrombin generation.
  - reference: PMID:16251427
    reference_title: "Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruptions were associated with a marked decidual neutrophil infiltration that peaked after PPROM, whereas decidua from gestational age-matched controls were virtually devoid of neutrophils."
    explanation: Links abruption to PPROM through decidual neutrophil infiltration, with a gestational-age-matched control comparison.
- name: Preterm Birth
  category: Clinical
  description: >
    Delivery before 37 weeks, both spontaneous (thrombin-driven preterm labor
    and membrane rupture) and iatrogenic (emergency delivery for maternal or
    fetal compromise). Abruption accounts for roughly a tenth of all preterm
    births in developed countries.
  phenotype_term:
    preferred_term: Premature birth
    term:
      id: HP:0001622
      label: Premature birth
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In developed countries, approximately 10% of all preterm births and 10-20% of all perinatal deaths are caused by placental abruption."
    explanation: Supports the association between abruption and preterm delivery at population scale.
  - reference: PMID:31955792
    reference_title: "Thrombin-Induced Decidual Colony-Stimulating Factor-2 Promotes Abruption-Related Preterm Birth by Weakening Fetal Membranes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Preterm premature rupture of membranes (PPROM) and thrombin generation by decidual cell-expressed tissue factor often accompany abruptions."
    explanation: Links abruption to preterm premature rupture of membranes as a route to preterm birth.
- name: Disseminated Intravascular Coagulation
  category: Clinical
  description: >
    Consumptive coagulopathy driven by massive decidual tissue factor exposure,
    the principal cause of severe maternal morbidity in abruption.
  phenotype_term:
    preferred_term: Disseminated intravascular coagulation
    term:
      id: HP:0005521
      label: Disseminated intravascular coagulation
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."
    explanation: Lists disseminated intravascular coagulopathy among the maternal risks of abruption.
- name: Acute Kidney Injury
  category: Clinical
  description: >
    Acute kidney injury from the combination of hypovolemia, hypoperfusion and
    microvascular fibrin deposition during severe abruption. Bound to the acute
    term rather than the generic renal-insufficiency parent, since the injury
    here is characteristically abrupt and hemodynamic.
  phenotype_term:
    preferred_term: Acute kidney injury
    term:
      id: HP:0001919
      label: Acute kidney injury
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."
    explanation: Lists renal failure among the maternal risks of abruption.
- name: Stillbirth
  category: Clinical
  description: >
    Intrauterine fetal death from acute placental insufficiency; abruption is
    among the leading identifiable causes of stillbirth. Deliberately left
    without an ontology binding because the HPO term for stillbirth
    (HP:0003826) sits outside the HP:0000118 phenotypic-abnormality subtree
    that the PhenotypeTerm dynamic enum is reachable from, so it cannot
    currently be bound here.
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."
    explanation: Lists stillbirth among the perinatal consequences of abruption.
- name: Neonatal Asphyxia
  category: Clinical
  description: >
    Perinatal asphyxia with severe acidemia in the delivered neonate, the
    immediate physiological expression of the interrupted gas exchange.
    Umbilical arterial pH in abruption-related cerebral palsy averages well
    below 6.8, at the extreme end of what is survivable.
  phenotype_term:
    preferred_term: Neonatal asphyxia
    term:
      id: HP:0012768
      label: Neonatal asphyxia
  evidence:
  - reference: PMID:22805996
    reference_title: "Clinical features of abruptio placentae as a prominent cause of cerebral palsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "had neonates with umbilical cord arterial blood pH (base excess) of 6.728 ± 0.164"
    explanation: Quantifies the depth of neonatal acidemia in abruption-related cerebral palsy.
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."
    explanation: Lists asphyxia among the perinatal consequences of abruption.
- name: Low Birth Weight
  category: Clinical
  description: >
    Reduced birthweight reflecting both prematurity and the chronic
    uteroplacental insufficiency that precedes abruption. Bound to the closest
    available HPO concept, Small for gestational age, since HPO has no distinct
    low-birthweight phenotype term.
  phenotype_term:
    preferred_term: Small for gestational age
    term:
      id: HP:0001518
      label: Small for gestational age
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Perinatal consequences include low birthweight, preterm delivery, asphyxia, stillbirth and perinatal death."
    explanation: Lists low birthweight among the perinatal consequences of abruption.
histopathology:
- name: Retroplacental Hematoma with Compressed Villi
  description: >
    The histological signature of abruption is a retroplacental hematoma with
    adjacent fibrin deposition and compressed villi; in older lesions,
    hemosiderin-laden histiocytes mark the age of the bleed.
  evidence:
  - reference: PMID:19897298
    reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The pathological criteria for abruption diagnosis included hematoma, fibrin deposition, compressed villi, and hemosiderin-laden histiocytes in cases with older hematomas."
    explanation: States the histopathological diagnostic criteria for abruption.
- name: Chronic Decidual Lesions
  description: >
    Beyond the acute hematoma, abruption placentas carry an excess of chronic
    lesions including chronic deciduitis, decidual necrosis, decidual
    vasculopathy and placental infarction, supporting the chronic ischemic
    disease model.
  evidence:
  - reference: PMID:19897298
    reference_title: "Diagnosis of placental abruption: relationship between clinical and histopathological findings."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Chronic lesions included chronic deciduitis, decidual necrosis, decidual vasculopathy, placental infarctions, villous mal-development (delayed or accelerated maturation), hemosiderin deposition, intervillous thrombus, and chronic villitis."
    explanation: Enumerates the chronic histological lesions profiled in clinical abruption.
- name: Couvelaire Uterus
  description: >
    Uteroplacental apoplexy: in the most severe abruptions blood extravasates
    into and through the myometrium and out to the broad ligament or
    peritoneum, giving the uterus a blue-purple discoloration. The clinical
    significance is that a myometrium infiltrated with blood contracts poorly,
    which is how a placental problem becomes intractable postpartum hemorrhage
    and, sometimes, the reason for emergency hysterectomy.
  evidence:
  - reference: PMID:35880101
    reference_title: "Multimodal postpartum imaging of a severe case of Couvelaire uterus."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical abruption represents a spectrum from mild to the most severe form, in which blood can extravasate into or through the myometrium, the broad ligament, or the peritoneum, causing the uterus and surrounding structures to take on a blue discoloration."
    explanation: Describes the Couvelaire uterus as the severe end of the abruption spectrum, defined by myometrial blood extravasation.
- name: Decidual Neutrophil Infiltration
  description: >
    Marked neutrophil infiltration of the decidua, co-localizing with fibrin
    deposition and peaking after membrane rupture. The control comparison is
    what makes this finding compelling: gestational-age-matched control decidua
    is essentially free of neutrophils, so this is not a background feature of
    late gestation but a specific consequence of decidual hemorrhage. It is the
    histological footprint of the thrombin-to-IL-8 arm of the mechanism.
  evidence:
  - reference: PMID:16251427
    reference_title: "Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruptions were associated with a marked decidual neutrophil infiltration that peaked after PPROM, whereas decidua from gestational age-matched controls were virtually devoid of neutrophils."
    explanation: Documents the neutrophil infiltrate with an explicit gestational-age-matched control comparison.
  - reference: PMID:16251427
    reference_title: "Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neutrophil infiltrates co-localized with fibrin deposition."
    explanation: Establishes the spatial association between the neutrophil infiltrate and fibrin, linking the inflammatory and coagulation arms.
- name: Maternal Vascular Malperfusion (Amsterdam Terminology)
  description: >
    The chronic-arm signature on placental examination: decidual arteriopathy
    and atherosis, accelerated villous maturation, infarcts and retroplacental
    hemorrhage. Reporting these under the Amsterdam Placental Workshop Group
    consensus terminology is what makes abruption histology comparable across
    centres, and the absence of such a standard is part of why the
    epidemiological literature is so heterogeneous.
  evidence:
  - reference: PMID:27223167
    reference_title: "Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The terminology and microscopic descriptions for maternal vascular malperfusion, fetal vascular malperfusion, delayed villous maturation, patterns of ascending intrauterine infection, and villitis of unknown etiology were agreed upon."
    explanation: Establishes maternal vascular malperfusion as a consensus-defined lesion category applicable to abruption placentas.
diagnosis:
- name: Clinical Diagnosis of Abruption
  description: >
    Abruption is a clinical diagnosis based on vaginal bleeding, uterine
    hypertonicity or tenderness, and non-reassuring fetal status. Imaging is
    confirmatory at best: a normal ultrasound does not exclude abruption
    because fresh retroplacental blood is often isoechoic with placenta.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of abruption is a clinical one, and ultrasonography and the Kleihauer-Betke test are of limited value."
    explanation: States that abruption is diagnosed clinically and that ultrasound and Kleihauer-Betke testing have limited diagnostic value.
  - reference: PMID:12164566
    reference_title: "Clinical utility of sonography in the diagnosis and treatment of placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the sensitivity, specificity, and positive and negative predictive values of sonography were 24%, 96%, 88%, and 53%, respectively"
    explanation: Quantifies the poor sensitivity but high specificity of ultrasound, which is why a negative scan cannot exclude abruption.
  - reference: PMID:12164566
    reference_title: "Clinical utility of sonography in the diagnosis and treatment of placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sonography is not sensitive for detection of placental abruption, but a positive finding is associated with more aggressive management and worse neonatal outcome."
    explanation: States the asymmetric diagnostic value of ultrasound, useful when positive and uninformative when negative.
biochemical:
- name: Fibrinogen
  notes: >
    The single most useful laboratory marker in abruption, and the one whose
    interpretation is most often got wrong. Pregnancy roughly doubles baseline
    fibrinogen, so a value inside the ordinary non-pregnant reference interval
    is already abnormally low in a bleeding obstetric patient. Because decidual
    tissue factor drives sustained thrombin generation, fibrinogen is consumed
    early, which makes it both a diagnostic marker of consumptive coagulopathy
    and the best available predictor of progression to severe hemorrhage.
  reference_ranges:
  - lower_bound: 4.0
    unit: g/L
    population: third-trimester pregnancy
    notes: >
      One-sided by design: the clinically meaningful question in obstetric
      hemorrhage is how far fibrinogen has fallen, not whether it is elevated.

      Boundary caveat. The source states its thresholds as strictly greater
      than 4 g/L and less than or equal to 2 g/L, whereas interpretation_bands
      use half-open intervals with an inclusive lower bound and an exclusive
      upper bound. The conventions therefore disagree at exactly two values: as
      encoded, 4.0 falls in the reassuring band and 2.0 falls in the middle
      band, whereas the source would place 4.0 outside its high-NPV group and
      2.0 inside its 100%-PPV group. At those two exact values follow the
      source, not the band edge. The bands are deliberately not nudged to force
      agreement, since that would require boundary numbers that appear nowhere
      in the literature.

      No loinc_term is bound because this project has no configured LOINC
      adapter, so a LOINC code could not be verified against an authoritative
      source. Per the guidance that a precise descriptor with no term beats a
      plausible but unverified one, the code is omitted rather than guessed;
      adding a LOINC adapter to conf/oak_config.yaml would let this be filled
      in properly.
    evidence:
    - reference: PMID:17087729
      reference_title: "The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The negative predictive value of a fibrinogen concentration >4 gL(-1) was 79% and the positive predictive value of a concentration <or=2 gL(-1) was 100%."
      explanation: >
        Anchors the 4 g/L threshold as the level above which severe hemorrhage
        becomes unlikely. Marked PARTIAL because the cohort is postpartum
        hemorrhage generally rather than abruption specifically, though
        abruption is a major cause of the consumptive coagulopathy studied.
    interpretation_bands:
    - name: Reassuring
      lower_bound: 4.0
      unit: g/L
      abnormal_flag: NORMAL
      interpretation: >
        Severe hemorrhage unlikely; negative predictive value about 79% in the
        source cohort.
    - name: Falling, consumption underway
      lower_bound: 2.0
      upper_bound: 4.0
      unit: g/L
      abnormal_flag: LOW
      severity: MODERATE
      interpretation: >
        Within or below the non-pregnant reference interval and therefore
        inappropriately low for pregnancy; indicates active consumption and
        rising risk of severe hemorrhage.
    - name: Critical consumptive coagulopathy
      upper_bound: 2.0
      unit: g/L
      abnormal_flag: CRITICAL_LOW
      severity: SEVERE
      interpretation: >
        Positive predictive value for severe postpartum hemorrhage was 100% at
        or below this level in the source cohort; mandates immediate fibrinogen
        replacement.
  evidence:
  - reference: PMID:17087729
    reference_title: "The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In multivariate analysis, from H0 to H4, fibrinogen was the only marker associated with the occurrence of severe PPH."
    explanation: >
      Establishes fibrinogen as the only independently predictive coagulation
      marker. PARTIAL because the cohort is obstetric hemorrhage broadly rather
      than abruption alone.
  - reference: PMID:19720393
    reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The extent of thrombin generation due to DC-expressed TF is indicated by the profound hypofibrinogenemia attendant severe abruption"
    explanation: Ties the hypofibrinogenemia specifically to decidual tissue factor-driven thrombin generation in abruption.
- name: Kleihauer-Betke Test
  notes: >
    Quantifies fetomaternal hemorrhage by counting fetal cells in the maternal
    circulation. Its value in abruption is not diagnostic but dosimetric: it is
    used in Rh-negative patients to size the anti-D immune globulin dose. As a
    diagnostic test for abruption itself it performs poorly.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of abruption is a clinical one, and ultrasonography and the Kleihauer-Betke test are of limited value."
    explanation: States the limited diagnostic value of the Kleihauer-Betke test in abruption.
clinical_trials:
- name: NCT05840471
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >
    Double-blind multicenter randomized trial of tranexamic acid in pregnant
    women with abruptio placenta, n=116. One of very few interventional trials
    with abruption itself as the enrolling condition.
  target_phenotypes:
  - preferred_term: Antepartum hemorrhage
    term:
      id: HP:0025328
      label: Antepartum hemorrhage
  evidence:
  - reference: clinicaltrials:NCT05840471
    reference_title: "Tranexamic Acid in Pregnant Women With Abruptio Placenta: A Double-blind, Multicenter Randomized Clinical Trial"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality"
    explanation: Trial rationale, confirming abruption-associated antepartum hemorrhage as the target condition.
- name: NCT00186069
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >
    Randomized double-blind trial of magnesium sulfate tocolysis versus
    intravenous saline for suspected placental abruption, n=30. Small, but
    directly addresses the contested question of whether tocolysis is safe in
    suspected abruption.
  target_phenotypes:
  - preferred_term: Premature birth
    term:
      id: HP:0001622
      label: Premature birth
  evidence:
  - reference: clinicaltrials:NCT00186069
    reference_title: "Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption."
    explanation: States the trial objective, magnesium sulfate in suspected preterm abruption.
- name: NCT03782168
  status: TERMINATED
  description: >
    Prospective study of plasma micro-particles and angiogenic markers as
    biomarkers of placental abruption. Terminated after enrolling a single
    participant. Curated deliberately as a negative result: together with
    NCT01279369 it is direct evidence that biomarker-based abruption
    prediction has a track record of failing to recruit or complete, which is
    part of why no validated predictive test exists.
  evidence:
  - reference: clinicaltrials:NCT03782168
    reference_title: "Plasma Concentration of Biological Markers in Placental Abruption"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The primary outcome variables will include the total number of micro-particles, the number of micro-particles from each cell line (platelet, placental, endothelial etc.), and protein markers"
    explanation: Documents the biomarker-prediction aim of this terminated study.
- name: NCT01279369
  status: TERMINATED
  description: >
    Study of cervicovaginal fetal fibronectin to predict preterm delivery due
    to abruption after minor maternal trauma. Terminated after enrolling three
    participants.
  evidence:
  - reference: clinicaltrials:NCT01279369
    reference_title: "The Use of Fetal Fibronectin (fFN) in Predicting Preterm Delivery Due to Abruptio Placenta in Patients With Minor Maternal Trauma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta."
    explanation: Documents the predictive-biomarker aim of this terminated study.
- name: NCT02299414
  phase: PHASE_IV
  status: COMPLETED
  description: >
    The CHAP trial, n=2408: antihypertensive treatment of mild chronic
    hypertension in pregnancy. Relevant here as prevention rather than
    treatment, since chronic hypertension is among the strongest graded
    abruption risk factors and CHAP tested whether treating it changes
    placental outcomes.
  evidence:
  - reference: clinicaltrials:NCT02299414
    reference_title: "A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults"
    explanation: >
      States the trial objective of tighter blood-pressure control in
      pregnancy. PARTIAL because abruption is a component outcome rather than
      the primary endpoint, so this supports the prevention rationale rather
      than an abruption-specific treatment effect.
stages:
- name: Sher Class 0
  description: >
    Asymptomatic. The retroplacental clot is found only on inspection of the
    placenta after delivery, with no antenatal clinical suspicion. Corresponds
    to partial or marginal separation.
  notes: >
    Sher grading (equivalently the older Page 0-3 scheme) is the conventional
    severity classification. It is curated here as ordered severity stages
    rather than as subtypes, because the classes are a graded continuum of one
    process rather than mechanistically distinct entities. No evidence items
    are attached to the stage definitions: the originating paper, Sher G, "A
    rational basis for the management of abruptio placentae", J Reprod Med
    1978 (PMID:722694), has no abstract indexed in PubMed, so no snippet can be
    verified against a cached reference. Rather than fabricate a quote or
    attribute the grading to a secondary source that merely restates it, the
    citation is recorded in the top-level references block and the stage
    descriptions are left unevidenced.
- name: Sher Class 1
  description: >
    Mild. Minimal or absent vaginal bleeding, slight uterine tenderness, normal
    maternal vital signs, no coagulopathy and no fetal distress. Corresponds to
    partial or marginal separation.
- name: Sher Class 2
  description: >
    Moderate. None-to-moderate vaginal bleeding, significant uterine tenderness
    with tetanic contractions, maternal tachycardia with orthostatic change,
    hypofibrinogenemia, and fetal distress with a living fetus. Corresponds to
    more complete or central separation.
- name: Sher Class 3
  description: >
    Severe. Minimal-to-heavy bleeding, board-like tetanic uterus, maternal
    shock, overt coagulopathy, and fetal death. Corresponds to complete or
    central separation.
genetic:
- name: No Mendelian gene
  notes: >
    Stated affirmatively rather than left blank: placental abruption has no
    Mendelian form, no OMIM phenotype entry, and no gene with definitive
    ClinGen gene-disease validity. Susceptibility is polygenic and, unusually,
    involves two genomes, since maternal and fetal/placental genotypes both
    contribute. An empty genetic block would otherwise read as an uncurated
    section rather than a real negative finding.
  relationship_type: UNKNOWN
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Accumulating epidemiological evidence points to strong genetic susceptibility to placental abruption (PA). However, characterization of genes associated with PA remains incomplete."
    explanation: Establishes that genetic susceptibility exists but that no gene characterization is complete, supporting the absence of a causal Mendelian gene.
- name: F5
  notes: >
    Factor V Leiden. Heterozygous FVL is significantly associated with
    placental abruption in the TREATS meta-analysis (Figure 9, z = 2.12,
    p = 0.03). The homozygous subgroup is not significant, but that estimate
    rests on three cases and is not evidence against the heterozygous
    association. Screening caveat, which is about clinical utility rather than
    about the validity of the association: thrombophilia panels are not
    recommended for placenta-mediated pregnancy complications, so this entry
    records FVL as a susceptibility factor without implying that testing for it
    is indicated.
  gene_term:
    preferred_term: F5
    term:
      id: hgnc:3542
      label: F5
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:16595080
    reference_title: "Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction."
    explanation: States that significant abruption risk was established for individual thrombophilic defects in this meta-analysis.
  - reference: PMID:16595080
    reference_title: "Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "FVL heterozygous Subtotal (95% CI) 13/28 64/332 Test for heterogeneity: /H9273 2 = 6.43, df = 3 (p = 0.092) Test for overall effect: z = 2.12 (p = 0.03)"
    explanation: >
      The Figure 9 forest-plot row for heterozygous Factor V Leiden and
      placental abruption, giving the significant pooled test for overall
      effect. Quoted verbatim including the figure's extraction artifacts so it
      matches the cached text exactly.
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
    explanation: Independently lists thrombophilias among established abruption risk factors in a standard clinical review.
- name: F2
  notes: >
    Prothrombin G20210A. Heterozygous prothrombin G20210A carries the strongest
    thrombophilia association with placental abruption in the TREATS
    meta-analysis (Figure 9, z = 4.25, p = 0.00002), stronger than heterozygous
    Factor V Leiden. Mechanistically coherent given that this entry's central
    axis is decidual thrombin generation, though the meta-analytic cell counts
    are small. Same screening caveat as F5: the association is not in question,
    but thrombophilia panels are not recommended in placenta-mediated
    complications.
  gene_term:
    preferred_term: F2
    term:
      id: hgnc:3535
      label: F2
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:16595080
    reference_title: "Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Prothrombin heterozygous Subtotal (95% CI) 10/20 44/400 Test for heterogeneity: /H9273 2 = 0.06, df = 2 (p = 0.97) Test for overall effect: z = 4.25 (p = 0.00002)"
    explanation: >
      The Figure 9 forest-plot row for heterozygous prothrombin G20210A and
      placental abruption, the strongest association in that figure. Quoted
      verbatim including extraction artifacts to match the cached text.
  - reference: PMID:16595080
    reference_title: "Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction."
    explanation: States that significant abruption risk was established for individual thrombophilic defects in this meta-analysis.
- name: ABCC8
  notes: >
    Suggestive GWAS association only. ABCC8 encodes the SUR1 subunit of the
    ATP-sensitive potassium channel whose pore subunit is encoded by the
    physically adjacent KCNJ11, so these two signals are plausibly one locus
    rather than two independent ones. Biologically plausible via vascular
    smooth muscle tone, but no functional mechanism has been demonstrated.
  gene_term:
    preferred_term: ABCC8
    term:
      id: hgnc:59
      label: ABCC8
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rs4148646 and rs2074311 in ABCC8"
    explanation: >
      Reports the ABCC8 variants as suggestively associated. Marked PARTIAL
      because the reported significance threshold is suggestive rather than
      genome-wide significant, and the cohort is single-ancestry.
- name: KCNJ11
  notes: >
    Suggestive GWAS association, physically adjacent to ABCC8 and encoding the
    Kir6.2 pore subunit of the same ATP-sensitive potassium channel.
  gene_term:
    preferred_term: KCNJ11
    term:
      id: hgnc:6257
      label: KCNJ11
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rs2074314 and rs35271178 near KCNJ11 in the PAGE GWAS"
    explanation: >
      Reports the KCNJ11-adjacent variants as suggestively associated. PARTIAL
      because the association is suggestive and the variants are near, not
      within, the gene.
- name: ADAM12
  notes: >
    Suggestive GWAS association in the meta-analysis. ADAM12 is a placental
    metalloprotease that also serves as a first-trimester serum marker of
    placental function, so a genetic and a biochemical signal converge on the
    same gene, making it the most mechanistically interesting candidate.
  gene_term:
    preferred_term: ADAM12
    term:
      id: hgnc:190
      label: ADAM12
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rs7094759 and rs12264492 in ADAM12"
    explanation: >
      Reports the ADAM12 variants as suggestively associated in the GWAS
      meta-analysis. PARTIAL because the threshold is suggestive only.
- name: CTNND2
  notes: >
    Suggestive GWAS association. CTNND2 encodes delta-catenin, an adhesion and
    junctional protein; no functional consequence has been demonstrated.
  gene_term:
    preferred_term: CTNND2
    term:
      id: hgnc:2516
      label: CTNND2
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rs7249210, rs7250184, rs7249100 and rs10401828 in ZNF28, rs11133659 in CTNND2, and rs2074314 and rs35271178 near KCNJ11 in the PAGE GWAS"
    explanation: >
      Reports the CTNND2 variant as suggestively associated. PARTIAL because
      the threshold is suggestive only.
- name: ZNF28
  notes: >
    Suggestive GWAS association across four SNPs; gene function in this context
    is unknown.
  gene_term:
    preferred_term: ZNF28
    term:
      id: hgnc:13073
      label: ZNF28
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rs7249210, rs7250184, rs7249100 and rs10401828 in ZNF28"
    explanation: >
      Reports the four ZNF28 variants as suggestively associated. PARTIAL
      because the threshold is suggestive only and function is unknown.
- name: IRX1
  notes: >
    Suggestive GWAS association in the meta-analysis. IRX1 is a developmental
    homeobox transcription factor; no functional consequence demonstrated.
  gene_term:
    preferred_term: IRX1
    term:
      id: hgnc:14358
      label: IRX1
  relationship_type: SUSCEPTIBILITY
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "independent loci suggestively associated with PA in the GWAS meta-analysis included rs76258369 near IRX1"
    explanation: >
      Reports the IRX1-adjacent variant as suggestively associated. PARTIAL
      because the threshold is suggestive only.
environmental:
- name: Cigarette Smoking
  exposure_term:
    preferred_term: exposure to cigarette smoking
    term:
      id: ECTO:0100003
      label: exposure to cigarette smoking
  influences_mechanisms:
  - target: Decidual Vasculopathy and Spiral Artery Failure
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Smoking roughly doubles risk and is thought to act through chronic
      vasoconstriction and decidual ischaemia, but the cited evidence is
      epidemiological and identifies no mediating step. Its population impact
      is large because exposure is common, not because the individual effect
      is.
    evidence:
    - reference: PMID:10214847
      reference_title: "Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Smoking was associated with a 90% increase in the risk of placental abruption"
      explanation: >-
        Reports a 90% increase in abruption risk with smoking, an
        epidemiological association without a demonstrated mechanism.
  description: >
    Maternal smoking is the best-quantified modifiable risk factor for
    abruption, plausibly acting through vasoconstriction and chronic decidual
    ischemia and necrosis. It is notable for a large population attributable
    fraction and for super-additive interaction with hypertensive disorders of
    pregnancy, the cleanest documented exposure-exposure interaction in this
    disease.
  evidence:
  - reference: PMID:10214847
    reference_title: "Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Smoking was associated with a 90% increase in the risk of placental abruption"
    explanation: Quantifies the smoking-abruption association in a meta-analysis of 13 studies.
  - reference: PMID:10214847
    reference_title: "Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pooled population attributable risk percentage for each stratum ranged between 15% and 25%, implying that 15-25% of placental abruption episodes are attributable to cigarette smoking."
    explanation: Quantifies the population attributable fraction of abruption due to smoking.
  - reference: PMID:10214847
    reference_title: "Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In the presence of smoking, the risk of abruption was further increased due to chronic hypertension, mild or severe preeclampsia, or chronic hypertension with superimposed preeclampsia."
    explanation: Documents interaction between smoking and hypertensive disorders of pregnancy on abruption risk.
  - reference: PMID:35365209
    reference_title: "The environmental risk factors prior to conception associated with placental abruption: an umbrella review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "maternal smoking (OR 1.80, 95% CI 1.75-1.85)"
    explanation: Gives the umbrella-review pooled effect size for maternal smoking, graded class III (suggestive).
- name: Cocaine Use
  exposure_term:
    preferred_term: exposure to cocaine
    term:
      id: ECTO:9000265
      label: exposure to cocaine
  influences_mechanisms:
  - target: Decidual Vasculopathy and Spiral Artery Failure
    environmental_effect: TRIGGERS
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Cocaine is thought to reach this node through acute vasoconstriction and
      hypertensive surges in the uteroplacental circulation, but nothing in this
      entry evidences that intermediate, so it is marked unknown on the same
      standard applied to smoking here. Its relative risk is the largest of the
      exposures in this entry.
    evidence:
    - reference: PMID:35365209
      reference_title: "The environmental risk factors prior to conception associated with placental abruption: an umbrella review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "cocaine using (RR 4.55, 95% CI 1.78-6.50)"
      explanation: >-
        Reports a relative risk of 4.55 for abruption with cocaine use, the
        strongest exposure association in this entry.
  description: >
    Cocaine produces acute vasoconstriction and hypertensive surges. It carries
    the largest reported effect size of any graded risk factor in the umbrella
    review, though with wide confidence limits and only suggestive (class III)
    evidence quality.
  chemicals:
  - cocaine
  evidence:
  - reference: PMID:35365209
    reference_title: "The environmental risk factors prior to conception associated with placental abruption: an umbrella review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cocaine using (RR 4.55, 95% CI 1.78-6.50)"
    explanation: Gives the umbrella-review pooled effect size for cocaine use, the largest among class III factors.
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
    explanation: Lists cocaine use among the established risk factors for abruption.
- name: Prior Cesarean Delivery
  influences_mechanisms:
  - target: Decidual Vasculopathy and Spiral Artery Failure
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      A uterine scar supports poorer decidualisation and placentation at the
      implantation site in a later pregnancy. The effect is modest and the
      mediating step is not established in the cited meta-analysis.
    evidence:
    - reference: PMID:29360829
      reference_title: "Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "and placental abruption (OR 1.38, 1.27 to 1.49; n = 5,667,160; 6 studies)"
      explanation: >-
        Reports an odds ratio of 1.38 for abruption after prior caesarean
        delivery across more than five million pregnancies, a modest but
        precisely estimated association.
  description: >
    A previous cesarean delivery raises abruption risk in subsequent
    pregnancies, alongside larger increases in placenta previa and placenta
    accreta, consistent with a scarred, abnormally decidualized implantation
    bed.
  evidence:
  - reference: PMID:29360829
    reference_title: "Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "and placental abruption (OR 1.38, 1.27 to 1.49; n = 5,667,160; 6 studies)"
    explanation: Quantifies abruption risk after prior cesarean in a meta-analysis of nearly 30 million participants.
- name: Abdominal Trauma
  influences_mechanisms:
  - target: Decidual Hemorrhage and Retroplacental Hematoma Formation
    environmental_effect: TRIGGERS
    causal_link_type: DIRECT
    description: >-
      The one mechanically distinct cause in this entry. Blunt force shears
      the relatively inelastic placenta away from the elastic uterine wall,
      tearing decidual vessels directly, so it produces the hematoma without
      any preceding vasculopathy.
    evidence:
    - reference: PMID:17012465
      reference_title: "Placental abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
      explanation: >-
        Names trauma among the established risk factors for abruption, the
        direct mechanical route to decidual haemorrhage.
  description: >
    Blunt abdominal trauma, including motor vehicle collisions and intimate
    partner violence, shears the elastic uterus against the relatively
    inelastic placenta.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
    explanation: Lists trauma among the established risk factors for abruption.
- name: Hypertensive Disorders of Pregnancy
  influences_mechanisms:
  - target: Decidual Vasculopathy and Spiral Artery Failure
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Preeclampsia and abruption share defective spiral artery remodelling as
      a substrate, so hypertensive disease marks a placenta already
      predisposed rather than acting as an external insult.
    evidence:
    - reference: PMID:17012465
      reference_title: "Placental abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
      explanation: >-
        Names hypertension and preeclampsia among the established risk factors
        for abruption.
  description: >
    Chronic hypertension and preeclampsia both raise abruption risk,
    consistent with the shared decidual vascular lesion of ischemic placental
    disease.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
    explanation: Lists hypertension and preeclampsia among the established risk factors for abruption.
- name: Prior Abruption
  influences_mechanisms:
  - target: Decidual Vasculopathy and Spiral Artery Failure
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Not an exposure at all but a marker of persisting susceptibility: a
      previous abruption reveals an underlying vascular predisposition that
      remains present in the next pregnancy. Recorded because recurrence risk
      is the single strongest predictor in this entry.
    evidence:
    - reference: PMID:38366767
      reference_title: "Placental abruption: Incidence and risk of recurrence in subsequent pregnancies."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Rates of abruption in the second birth among individuals with and without previous placental abruption were 3.35% and 0.66%, respectively"
      explanation: >-
        Reports abruption in 3.35% of second births after a previous abruption
        versus 0.66% without, a fivefold recurrence indicating persistent
        susceptibility rather than a repeated exposure.
  description: >
    A previous abruption is among the strongest predictors of recurrence,
    consistent with a persistent underlying maternal vascular phenotype rather
    than a one-off accident. Recurrence risk is roughly five-fold, which is the
    single most important piece of evidence for the chronic-disease rather than
    accident model, and the basis for counselling in a subsequent pregnancy.
  evidence:
  - reference: PMID:38366767
    reference_title: "Placental abruption: Incidence and risk of recurrence in subsequent pregnancies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rates of abruption in the second birth among individuals with and without previous placental abruption were 3.35% and 0.66%, respectively"
    explanation: Quantifies recurrence risk in a cohort of over 126,000 patients with two consecutive singleton births.
  - reference: PMID:40140972
    reference_title: "Independent risk factors for placental abruption: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A total of 54 observational studies were included, covering 7,267,241 pregnant women, with 47,702 cases diagnosed with placental abruption."
    explanation: >
      Establishes the scale of the meta-analysis that identified previous
      placental abruption as the most significant maternal baseline risk factor.
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk factors for abruption include prior abruption, smoking, trauma, cocaine use, multifetal gestation, hypertension, preeclampsia, thrombophilias, advanced maternal age, preterm premature rupture of the membranes, intrauterine infections, and hydramnios."
    explanation: Lists prior abruption among the established risk factors, supporting recurrence risk.
progression:
- phase: Long-term maternal cerebrovascular risk
  age_range: Years to decades after the affected pregnancy
  notes: >
    Abruption is followed by elevated long-term maternal cerebrovascular risk,
    paralleling the pattern already recognised after preeclampsia. As with
    preeclampsia, this records the association without asserting that the acute
    abruption itself causes the later stroke; shared antecedent vascular
    susceptibility is an equally consistent explanation.
  evidence:
  - reference: PMID:31420459
    reference_title: "Cerebrovascular disease after placental abruption: A population-based prospective cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruption was associated with increased rates of nonfatal ischemic stroke (HR 1.4, 95% CI 1.1-1.7) and hemorrhagic stroke (HR 1.4, 95% CI 1.1-1.9)."
    explanation: >
      Reports the effect sizes for both stroke subtypes in a Danish population
      cohort. Notably the hazard ratio is the same for ischemic and hemorrhagic
      stroke, which argues for a systemic vascular diathesis rather than a
      specifically thrombotic one.
  - reference: PMID:31420459
    reference_title: "Cerebrovascular disease after placental abruption: A population-based prospective cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Disruption of the hemostatic system manifesting as ischemia and hemorrhage may indicate shared etiologies between abruption and cerebrovascular complications."
    explanation: >
      States the shared-etiology interpretation, supporting the framing of this
      progression item as an association rather than a causal sequela.
treatments:
- name: Emergency Cesarean Delivery
  description: >
    Prompt cesarean delivery is indicated when there is maternal or fetal
    compromise at a viable gestational age. Delivery removes the source of both
    the hemorrhage and the procoagulant load. Where fetal demise has already
    occurred, vaginal delivery is preferred.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Emergency Cesarean Delivery
    term:
      id: NCIT:C92772
      label: Emergency Cesarean Delivery
  target_mechanisms:
  - target: Placental Separation and Loss of Exchange Surface
    treatment_effect: INHIBITS
    description: >
      Delivery terminates the ongoing separation and removes the fetus from a
      failing gas-exchange interface.
    evidence:
    - reference: PMID:17012465
      reference_title: "Placental abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "in the presence of fetal or maternal compromise, prompt delivery by cesarean is often indicated"
      explanation: Supports delivery as the intervention that terminates the separation process when compromise is present.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "in the presence of fetal or maternal compromise, prompt delivery by cesarean is often indicated"
    explanation: States the indication for prompt cesarean delivery in compromised abruption.
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In cases where fetal demise has occurred, vaginal delivery is preferable."
    explanation: Records the route-of-delivery preference after fetal demise.
- name: Blood Product Resuscitation and Coagulopathy Management
  description: >
    Aggressive management of disseminated intravascular coagulopathy with
    transfusion of red cells, plasma, platelets and fibrinogen replacement,
    targeting the consumptive coagulopathy driven by decidual thrombin
    generation.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Blood Transfusion
    term:
      id: NCIT:C15192
      label: Blood Transfusion
  target_mechanisms:
  - target: Consumptive Coagulopathy and Maternal Hemorrhagic Shock
    treatment_effect: INHIBITS
    description: >
      Replaces the fibrinogen, platelets and clotting factors consumed by
      sustained thrombin generation.
    evidence:
    - reference: PMID:17012465
      reference_title: "Placental abruption."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Disseminated intravascular coagulopathy should be managed aggressively."
      explanation: Supports active management of the consumptive coagulopathy as a treatment target.
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Disseminated intravascular coagulopathy should be managed aggressively."
    explanation: States the management principle for the coagulopathy of abruption.
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."
    explanation: Documents transfusion requirement as a recognised element of abruption management.
- name: Antenatal Corticosteroid Therapy
  description: >
    Betamethasone or dexamethasone given for fetal lung maturation when preterm
    delivery is anticipated and the maternal-fetal condition permits a delay.
    This is the main reason to attempt expectant management at all in a stable
    preterm abruption, since the fetal benefit of the steroid course has to be
    weighed against the risk of the separation extending.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: betamethasone
      term:
        id: CHEBI:3077
        label: betamethasone
  evidence:
  - reference: PMID:12164566
    reference_title: "Clinical utility of sonography in the diagnosis and treatment of placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Positive sonographic findings were univariately associated with 2- to 3-fold greater subsequent tocolysis, betamethasone use, duration of hospitalization, follow-up sonograms, preterm delivery, low birth weight, and neonatal intensive care unit admission."
    explanation: >
      Documents betamethasone administration as part of real-world management
      of suspected abruption. Marked PARTIAL because this is an observational
      association between a positive scan and subsequent steroid use rather
      than a trial of corticosteroids in abruption specifically.
- name: Magnesium Sulfate for Fetal Neuroprotection
  description: >
    Magnesium sulfate given before anticipated early preterm delivery to reduce
    the risk of cerebral palsy, and separately trialled as a tocolytic in
    suspected abruption. Given that abruption is the single leading identifiable
    cause of hypoxia-attributed cerebral palsy, the neuroprotective indication
    is unusually well aligned with this disease's dominant fetal harm.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: magnesium sulfate
      term:
        id: CHEBI:32599
        label: magnesium sulfate
  evidence:
  - reference: clinicaltrials:NCT00186069
    reference_title: "Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption."
    explanation: >
      Documents magnesium sulfate being formally trialled in suspected preterm
      abruption. Marked PARTIAL because the trial tested tocolysis rather than
      the neuroprotective indication, and enrolled only 30 participants.
- name: Tranexamic Acid
  description: >
    Antifibrinolytic adjunct for obstetric hemorrhage. Mechanistically coherent
    here, since the coagulopathy of abruption involves fibrinolysis alongside
    factor consumption, but the abruption-specific evidence base is a single
    small trial and the effect should not be overstated.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: tranexamic acid
      term:
        id: CHEBI:48669
        label: tranexamic acid
  target_mechanisms:
  - target: Consumptive Coagulopathy and Maternal Hemorrhagic Shock
    treatment_effect: INHIBITS
    description: >
      Inhibits fibrinolysis, opposing the breakdown of what clot remains during
      consumptive coagulopathy.
  evidence:
  - reference: clinicaltrials:NCT05840471
    reference_title: "Tranexamic Acid in Pregnant Women With Abruptio Placenta: A Double-blind, Multicenter Randomized Clinical Trial"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality"
    explanation: >
      Trial rationale for tranexamic acid in abruption. PARTIAL because this
      quotes the enrolling rationale rather than a reported treatment effect.
- name: Induction of Labor and Vaginal Delivery
  description: >
    Where fetal demise has already occurred, or where the mother is stable and
    the fetus is not compromised, vaginal delivery is the preferred route.
    Aggressive correction of coagulopathy accompanies it.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Induction of Labor
    term:
      id: NCIT:C92814
      label: Induction of Labor
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In cases where fetal demise has occurred, vaginal delivery is preferable."
    explanation: States the preferred delivery route after fetal demise.
- name: Emergency Hysterectomy
  description: >
    Last-resort surgical control of uncontrollable postpartum hemorrhage,
    sometimes required after severe abruption with a Couvelaire uterus that
    will not contract. Carries permanent loss of fertility.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Hysterectomy
    term:
      id: NCIT:C15256
      label: Hysterectomy
  evidence:
  - reference: PMID:21241259
    reference_title: "Placental abruption: epidemiology, risk factors and consequences."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal risks include obstetric hemorrhage, need for blood transfusions, emergency hysterectomy, disseminated intravascular coagulopathy and renal failure."
    explanation: Documents emergency hysterectomy as a recognised maternal outcome and intervention in abruption.
- name: Expectant Management with Surveillance
  description: >
    In selected stable cases remote from term, or at term with reassuring
    maternal and fetal status, expectant management with close monitoring and
    readiness for rapid delivery is reasonable. Management is individualised by
    severity and gestational age rather than protocolised. In practice the
    window bought by expectant management is used to give antenatal
    corticosteroids and, before early preterm delivery, magnesium sulfate for
    fetal neuroprotection. Tocolysis is controversial and generally avoided
    when there is fetal compromise.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The management of abruption should be individualized on a case-by-case basis depending on the severity of the abruption and the gestational age at which it occurs."
    explanation: States the individualised management principle.
  - reference: PMID:17012465
    reference_title: "Placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "abruption at extremely preterm gestations may be managed conservatively in selected stable cases, with close monitoring and rapid delivery should deterioration occur"
    explanation: Supports conservative management with surveillance in selected stable preterm cases.
discussions:
- discussion_id: gap_abruption_no_high_quality_risk_factor_evidence
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Can any risk factor for placental abruption be established at class I or II
    evidence, given that a formal umbrella review of the entire meta-analytic
    literature graded every candidate as class III or weaker?
  rationale: >-
    This is the single most important epistemic caveat attached to this entry.
    The effect sizes curated in the environmental section are real and
    reproducible, but the umbrella review that formally graded them found no
    factor reaching high-quality evidence. Every risk-factor estimate here
    should therefore be read as suggestive rather than established. A
    contributing cause is the absence of a uniform case definition across the
    epidemiological literature, which makes cohorts non-comparable.
  attaches_to:
  - pathophysiology#Decidual Vasculopathy and Spiral Artery Failure
  evidence:
  - reference: PMID:35365209
    reference_title: "The environmental risk factors prior to conception associated with placental abruption: an umbrella review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There was no risk factor in the present umbrella review with the high level of evidence (class I or II)."
    explanation: States the negative finding directly.
  - reference: PMID:35365209
    reference_title: "The environmental risk factors prior to conception associated with placental abruption: an umbrella review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the current meta-analytic associations cannot disentangle the complex etiology of placental abruption mainly due to their low quality of evidence"
    explanation: States that the aetiology cannot be resolved from the current evidence base.
  - reference: PMID:40140972
    reference_title: "Independent risk factors for placental abruption: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, methodological inconsistencies and publication bias in the current studies may affect the reliability of the meta-analysis results."
    explanation: Independently flags methodological inconsistency and publication bias in the same literature.
- discussion_id: gap_abruption_gwas_single_ancestry
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Do the suggestive ABCC8/KCNJ11, ADAM12, CTNND2, ZNF28 and IRX1 associations
    replicate at genome-wide significance in ancestries other than the Peruvian
    cohorts in which they were discovered, and does any have a demonstrable
    functional consequence?
  rationale: >-
    All curated susceptibility loci come from a single-ancestry study and are
    suggestive rather than genome-wide significant. None has a demonstrated
    molecular mechanism. Transferability to other ancestries is unestablished,
    so these should not be treated as validated susceptibility genes.
  attaches_to:
  - pathophysiology#Decidual Vasculopathy and Spiral Artery Failure
  evidence:
  - reference: PMID:29884306
    reference_title: "Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Participants of the Placental Abruption Genetic Epidemiology (PAGE) study, a population based case-control study of PA conducted in Lima, Peru"
    explanation: Establishes the single-ancestry Peruvian source population of the discovery cohort.
- discussion_id: gap_abruption_no_antenatal_diagnostic_test
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Can any antenatal test identify placental abruption reliably enough to
    change management, given that ultrasound has roughly 24% sensitivity and no
    externally validated prediction model exists?
  rationale: >-
    Abruption remains a clinical diagnosis of exclusion in real time. The
    consequence is that the condition is frequently recognised only once fetal
    compromise is already present, which places a hard ceiling on how much
    outcome improvement is achievable through earlier intervention. A
    sensitive antenatal test would be the highest-value advance in this
    disease.
  attaches_to:
  - pathophysiology#Decidual Hemorrhage and Retroplacental Hematoma Formation
  evidence:
  - reference: PMID:12164566
    reference_title: "Clinical utility of sonography in the diagnosis and treatment of placental abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sonography is not sensitive for detection of placental abruption, but a positive finding is associated with more aggressive management and worse neonatal outcome."
    explanation: Documents the insensitivity of the only widely available antenatal imaging test.
- discussion_id: mismatch_abruption_no_animal_model_of_trophoblast_invasion
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Can the decidual mechanism of abruption be modelled in any non-human
    species, given that the depth of extravillous trophoblast invasion and the
    extent of the decidualization reaction seen in humans are not reproduced in
    standard laboratory animals?
  rationale: >-
    The upstream lesion of this entry is failure of deep trophoblast-mediated
    spiral artery conversion, a process whose human form is unusually extensive
    among species with hemochorial placentation. Model organisms therefore
    cannot reproduce the trigger node, which is why essentially all mechanistic
    evidence in this entry comes from human tissue and human decidual cell
    culture rather than in vivo models. A separate constraint is that mice lack
    a CXCL8/IL-8 ortholog, so the thrombin to IL-8 to neutrophil arm of
    membrane weakening cannot be modelled directly in mouse.
  attaches_to:
  - pathophysiology#Decidual Vasculopathy and Spiral Artery Failure
  - pathophysiology#Thrombin-Driven Myometrial Contraction and Membrane Weakening
  evidence:
  - reference: PMID:19720393
    reference_title: "Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among species with a hemochorial placenta, human endometrium exhibits the most extensive DZ reaction and human EVT are the most intrinsically invasive"
    explanation: >
      States that the human decidualization reaction and trophoblast
      invasiveness exceed those of other hemochorial species, which is the
      basis of the model-organism limitation.
differential_diagnoses:
- name: Placenta Previa
  description: >
    The other major cause of antepartum hemorrhage. Previa classically produces
    painless bright red bleeding with a soft uterus, whereas abruption produces
    painful bleeding with a tender, hypertonic uterus. The decisive practical
    difference is imaging: previa is reliably identified by transvaginal
    ultrasound, whereas ultrasound has roughly 24% sensitivity for abruption,
    so a normal scan effectively rules out previa but not abruption. Note that
    previa is also a risk factor for abruption, so the two are not mutually
    exclusive.
  evidence:
  - reference: PMID:16582134
    reference_title: "Placenta previa, placenta accreta, and vasa previa."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Placenta previa, placenta accreta, and vasa previa are important causes of bleeding in the second half of pregnancy and in labor."
    explanation: Establishes placenta previa as a competing cause of second-half-of-pregnancy bleeding, the differential-diagnosis relationship.
  - reference: PMID:16582134
    reference_title: "Placenta previa, placenta accreta, and vasa previa."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnostic modality of choice for placenta previa is transvaginal ultrasonography"
    explanation: >
      Documents that previa is reliably diagnosed by ultrasound, in contrast to
      abruption, which is the practical basis for discriminating the two.
- name: Vasa Previa
  description: >
    A rarer cause of antepartum bleeding in which unprotected fetal vessels
    cross the membranes over the cervical os. Distinguished from abruption by
    the fact that the blood lost is fetal rather than maternal, so even modest
    volumes cause rapid fetal exsanguination without maternal instability.
  evidence:
  - reference: PMID:16582134
    reference_title: "Placenta previa, placenta accreta, and vasa previa."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Placenta previa, placenta accreta, and vasa previa are important causes of bleeding in the second half of pregnancy and in labor."
    explanation: Establishes vasa previa as a competing cause of second-half-of-pregnancy bleeding.
notes: >
  Ontology note: MONDO:0004846 currently carries the definition "Vaginal
  bleeding preceding the 20th week of gestation" (inherited from NCIT:P378),
  which is incorrect. Abruption is separation of a normally implanted placenta
  in the second half of pregnancy; bleeding before 20 weeks is classified as
  threatened or spontaneous abortion. The HPO definition for HP:0011419
  ("Separation of the placenta from the uterus wall before delivery") is
  correct, as is the Tikkanen definition quoted in this entry. This
  discrepancy should be reported upstream to MONDO.

  Curation note on Xogenesis: the terminal output of the core mechanism is the
  formation of a pathological anatomical structure, the retroplacental
  hematoma, at UBERON:0000453 decidua basalis. In the OGMS framing this is an
  OGMS:0000078 pathological anatomical structure arising by OGMS:0000081
  pathological derivation, process genus OGMS:0000061. No MPATH species term is
  recorded, as MPATH is deprecated for this project. If a hematoma-forming
  mechanism module is later factored out, this entry is a candidate conformer
  alongside the existing thrombogenesis module.

📚

References & Deep Research

References

1

PMID:722694

A rational basis for the management of abruptio placentae.

No top-level findings curated for this source.

Deep Research

1

Claude Code ▸

Placental Abruption (Abruptio Placentae) — Comprehensive Research Report

claude-haiku-4-5-20251001, claude-opus-5[1m] 46 citations 2026-08-04T14:16:06.989765

Placental Abruption (Abruptio Placentae) — Comprehensive Research Report

Target: Placental Abruption · MONDO:0004846 · Category: Complex (multifactorial, non-Mendelian) Report date: 2026-08-04 · Evidence cutoff: literature through mid-2026 Verification note: every PMID below was retrieved from NCBI E-utilities during this session and every quoted snippet is a verbatim substring of the retrieved PubMed abstract. Every ontology CURIE was resolved live against EBI OLS4 (HP/GO/CL/UBERON/CHEBI/NCIT/MONDO) or the HGNC REST API. Items I could not verify are explicitly flagged as UNVERIFIED.

1. Disease Information

1.1 Overview

Placental abruption is the premature separation of a normally implanted placenta from the uterine wall before delivery of the fetus. It is an obstetric rather than a constitutional disease: the affected "organ" is a transient fetomaternal organ, the disease exists only during a pregnancy, and it has two patients (the pregnant person and the fetus) whose risks diverge. Mechanistically it is a hemorrhagic disease of the decidua basalis — rupture of maternal decidual vessels produces a retroplacental hematoma that dissects the maternal–fetal interface, destroying gas-exchange surface acutely and generating a large local thrombin burst that drives inflammation, membrane weakening and uterine contraction.

Two clinically and mechanistically distinct presentations exist and should be modeled as separate arms:

Acute abruption — often trauma- or shear-triggered, with sudden hemorrhage, uterine hypertonus, fetal compromise, coagulopathy.
Chronic/ischemic abruption — the culmination of long-standing uteroplacental vasculopathy, sharing risk profile and placental lesions with preeclampsia and fetal growth restriction under the "ischemic placental disease" umbrella.

Brandt & Ananth (AJOG 2023, PMID:37164498) — the current definitive review — states: "Placental abruption is the premature separation of the placenta from its uterine attachment before the delivery of a fetus." They emphasize both chronic processes (vasculopathy) and acute triggers (abdominal trauma), and report a prevalence of 0.6%–1.2% of pregnancies.

The MeSH scope note (D000037, retrieved from NCBI MeSH) is a compact and citable definition:

"Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH."

1.2 Key identifiers (all retrieved live)

Resource	Identifier	Notes
MONDO	`MONDO:0004846`	label: `placental abruption`
HPO	`HP:0011419`	label: `Placental abruption` — usable as a phenotype of other disorders
MeSH	`D000037` (`MESH:D000037`)	Abruptio Placentae; tree numbers C12.050.703.420.078, C12.050.703.590.132
NCIT	`NCIT:C26685`	via MONDO xref
DOID	`DOID:9667`
EFO	`EFO:1001754`
SNOMED CT	`415105001` (`SCTID:415105001`)
UMLS	`C0000832`
MedGen	`49`
ICD-10-CM	`O45` (`O45.0-` with coagulation defect; `O45.8-`; `O45.9-`)	ICD-9: 641.20, 640.0, 640.03
ICD-11	reported as `JA8C` "Maternal care related to premature separation of placenta"	UNVERIFIED — from a secondary web source only; confirm in the WHO ICD-11 browser before curating
OMIM	none	no Mendelian entry; this is a complex trait
Orphanet	none	not a rare disease (prevalence ≫ 1/2000)

Data-quality flag for curators: the MONDO textual definition currently retrieved from OLS4 and the Monarch API for MONDO:0004846 reads "Vaginal bleeding preceding the 20th week of gestation." This is wrong — that describes threatened abortion, not abruption, and it contradicts MONDO's own synonym set. Worth an upstream MONDO issue; do not propagate this definition into the dismech entry.

1.3 Synonyms

abruptio placentae · abruption of placenta · premature separation of placenta · Abruptio placentae, premature separation of placenta · placental abruption (disease) · accidental hemorrhage (historical British usage) · ablatio placentae (historical) · retroplacental hematoma (the lesion, not strictly the disease) · Couvelaire uterus / uteroplacental apoplexy (a severe complication, not a synonym).

1.4 Nature of the evidence base

Almost all data are aggregated disease-level epidemiology from administrative/registry sources (National Inpatient Sample, Nordic birth registries, Kaiser Permanente EHR, NJ vital records) and from placental pathology series. This has a specific and important consequence for a knowledge base: abruption is ascertained by ICD code or clinician gestalt in most large studies, with no uniform case definition. Downes et al. (PMID:28329897) name this explicitly: "There was also considerable variation in, or absence of, the reporting of abruption definitions." Effect estimates below should be curated with that caveat attached.

Individual-patient EHR-derived work does exist (Oyelese/Kaiser, PMID:38366767; PACER/NJ vital-record linkage, PMID:38273776) and is the best source for recurrence and life-course outcomes.

2. Etiology

2.1 Causal architecture

Abruption is a final common pathway, not a single disease. Four upstream routes converge on decidual vessel rupture:

Chronic uteroplacental vasculopathy / ischemic placental disease. Shallow trophoblast invasion → failure of spiral-artery conversion → high-resistance, high-velocity maternal flow into the intervillous space, decidual necrosis and vessel fragility. This is the route shared with preeclampsia and fetal growth restriction (PMID:24836823).
Acute mechanical shear. Blunt abdominal trauma, sudden uterine decompression (rupture of membranes with polyhydramnios, delivery of a first twin), short umbilical cord traction, external cephalic version. The uterus is elastic and the placenta is not; deformation shears them apart at the basal plate.
Inflammation/infection. Chorioamnionitis and PPROM co-travel with abruption; decidual inflammation and hemorrhage are jointly the major decidual contributors to preterm delivery (PMID:15998775).
Hemostatic/thrombotic. Decidual tissue-factor-dependent hemostasis failure, thrombophilia, and decidual thrombosis with infarction.

2.2 Risk factors — quantitative

Primary source A — Chen et al., BMC Pregnancy Childbirth 2025 (PMID:40140972). Systematic review + meta-analysis, 54 observational studies, 7,267,241 pregnancies, 47,702 abruption cases, PROSPERO CRD42024546514.

"A total of 54 observational studies were included, covering 7,267,241 pregnant women, with 47,702 cases diagnosed with placental abruption."

"Among these, previous placental abruption (AOR = 2.72, 95% CI [2.16, 3.42]) was found to be the most significant risk factor."

"Of these, placenta previa (AOR = 7.31, 95% CI [4.78, 11.19]) was identified as the most significant risk factor."

The 18 maternal baseline factors identified (verbatim from abstract): "maternal age ≥ 35 years, black race, low prepregnancy BMI (< 18.5 kg/m²), unmarried status, smoking during pregnancy, alcohol consumption, inadequate prenatal care (< 4 visits), marijuana use, multiple pregnancy, parity ≥ 3, anemia (hemoglobin < 11 g/dL), previous placental abruption, previous cesarean section, previous miscarriage, previous stillbirth, cervical incompetence, habitual abortions, and assisted reproductive technology."

The 7 pregnancy-complication factors: "preterm premature rupture of membranes, preeclampsia, small for gestational age, polyhydramnios, antepartum hemorrhage, gestational hypertension, and placenta previa."

Primary source B — Jenabi et al., Syst Rev 2022 umbrella review (PMID:35365209). Meta-analysis-of-meta-analyses with formal evidence grading. This is the single most important source for evidence quality, because its headline finding is negative:

"There was no risk factor in the present umbrella review with the high level of evidence (class I or II)."

Class III (suggestive) factors, with effect sizes verbatim:

Factor	Effect
Cocaine use	RR 4.55 (95% CI 1.78–6.50)
Chronic hypertension	OR 3.13 (95% CI 2.04–4.80)
Assisted reproductive technology	OR 1.87 (95% CI 1.70–2.06)
Maternal smoking	OR 1.80 (95% CI 1.75–1.85); RR 1.65 (1.51–1.80)
Advanced maternal age	OR 1.44 (95% CI 1.35–1.54)
Endometriosis	OR 1.40 (95% CI 1.12–1.76)
Prior cesarean section	RR 1.38 (95% CI 1.35–1.42)
Maternal asthma	RR 1.29 (95% CI 1.14–1.47)

Class IV (weak): uterine leiomyoma OR 2.63 (1.38–3.88); marijuana use OR 1.78 (1.32–2.40); preeclampsia OR 1.73 (1.47–2.04); pre-pregnancy underweight OR 1.38 (1.12–1.70).

Primary source C — Ananth, Smulian & Vintzileos, Obstet Gynecol 1999 (PMID:10214847). The landmark smoking meta-analysis, 13 studies, 1,358,083 pregnancies:

"Smoking was associated with a 90% increase in the risk of placental abruption (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.8, 2.0)."

"Pooled population attributable risk percentage for each stratum ranged between 15% and 25%, implying that 15-25% of placental abruption episodes are attributable to cigarette smoking."

"In the presence of smoking, the risk of abruption was further increased due to chronic hypertension, mild or severe preeclampsia, or chronic hypertension with superimposed preeclampsia."

That last sentence is a directly citable gene-free interaction claim (smoking × hypertensive disorder super-additivity) and is the cleanest documented exposure–exposure interaction in this disease.

Primary source D — prior cesarean. Keag, Norman & Stock, PLoS Med 2018 (PMID:29360829), 79 cohort studies + 1 RCT, 29,928,274 participants:

"Pregnancy following cesarean delivery was associated with increased risk of placenta previa (OR 1.74, 1.62 to 1.87; n = 7,101,692; 10 studies), placenta accreta (OR 2.95, 1.32 to 6.60; n = 705,108; 3 studies), and placental abruption (OR 1.38, 1.27 to 1.49; n = 5,667,160; 6 studies)."

Primary source E — recent NIS analysis. Wright, Friedman, Ananth & Wen, Am J Perinatol 2026 (PMID:40940025), 80.2 million deliveries 2000–2020: "Abruption was associated with multiple gestations, hypertensive diagnoses, diabetes, asthma, and Medicaid insurance."

2.3 Genetic risk factors

No causal Mendelian gene. Susceptibility is polygenic and, critically, two-genome: maternal and fetal/placental genotypes both contribute, and their interaction matters.

Workalemahu et al., Placenta 2018 (PMID:29884306) — GWAS + GWAS meta-analysis, Peruvian PAGE and PAPE cohorts (959 cases / 1553 controls in meta-analysis):

"Accumulating epidemiological evidence points to strong genetic susceptibility to placental abruption (PA). However, characterization of genes associated with PA remains incomplete."

"Independent loci (linkage-disequilibrium<0.80) suggestively associated with PA (P-value<5e-5) included rs4148646 and rs2074311 in ABCC8, rs7249210, rs7250184, rs7249100 and rs10401828 in ZNF28, rs11133659 in CTNND2, and rs2074314 and rs35271178 near KCNJ11 in the PAGE GWAS. Similarly, independent loci suggestively associated with PA in the GWAS meta-analysis included rs76258369 near IRX1, and rs7094759 and rs12264492 in ADAM12."

"Functional analyses of these genes showed trophoblast-like cell interaction, as well as networks involved in endocrine system disorders, cardiovascular diseases, and cellular function."

Curatorial caution: these are suggestive (P < 5×10⁻⁵), not genome-wide significant (5×10⁻⁸), in a modest sample. Curate them as SUSCEPTIBILITY with the significance threshold recorded, and consider a KNOWLEDGE_GAP discussion noting that no locus has reached genome-wide significance or been replicated in an independent ancestry.

Workalemahu et al., Int J Mol Epidemiol Genet 2013 (PMID:24046805) — 470 cases / 473 controls, Cardio-Metabo Chip:

"The top hit in the GWAS analyses was rs1238566 (empirical P-value=1.04e-4 and FDR-adjusted P-value=5.65E-04) in FLI-1 gene, a megakaryocyte-specific transcription factor."

"SNPs known to regulate MB (e.g. CAMK2B, NR1H3, PPARG, PRKCA, and THRB) and OP (e.g., COX5A, and NDUF family of genes) were associated with PA risk (P-value <0.05)."

FLI1 is a megakaryocyte/endothelial transcription factor — biologically coherent with a hemostatic-failure model.

Verified HGNC identifiers (HGNC REST API, this session; note dismech convention is lowercase hgnc:):

Gene	HGNC	Role
ABCC8	`hgnc:59`	GWAS suggestive locus (SUR1, K-ATP channel)
KCNJ11	`hgnc:6257`	GWAS suggestive locus (Kir6.2, K-ATP channel)
ZNF28	`hgnc:13073`	GWAS suggestive locus
CTNND2	`hgnc:2516`	GWAS suggestive locus (δ-catenin)
ADAM12	`hgnc:190`	GWAS meta-analysis locus; also a placental serum analyte
IRX1	`hgnc:14358`	GWAS meta-analysis locus
FLI1	`hgnc:3749`	top candidate hit, megakaryocytic TF
F5	`hgnc:3542`	Factor V Leiden thrombophilia
F2	`hgnc:3535`	prothrombin G20210A; also the thrombin effector
F3	`hgnc:3541`	decidual tissue factor — the central hemostatic effector
F2R	`hgnc:3537`	PAR-1, the thrombin receptor mediating inflammation
MTHFR	`hgnc:7436`	homocysteine/folate route (weak/inconsistent)
SERPINE1	`hgnc:8583`	PAI-1, thrombin-induced
MMP1	`hgnc:7155`	thrombin-induced collagenase → PPROM
CXCL8	`hgnc:6025`	IL-8, thrombin-induced neutrophil chemoattractant
PGR	`hgnc:8910`	progesterone receptor — functional withdrawal target
CSF2	`hgnc:2434`	GM-CSF, thrombin-induced membrane weakening
IL11	`hgnc:5966`	thrombin/IL-1β-induced decidual cytokine
PAPPA	`hgnc:8602`	first-trimester predictive analyte
AFP	`hgnc:317`	second-trimester predictive analyte

Thrombophilia. The best-quality synthesis is the TREATS HTA (Wu et al., Health Technol Assess 2006, PMID:16595080), 72 pregnancy studies:

"Significant risks for individual thrombophilic defects were also established for early, recurrent and late pregnancy loss; preeclampsia; placental abruption; and intrauterine growth restriction."

Note the counter-current: contemporary obstetric practice has largely abandoned thrombophilia screening for placenta-mediated complications because trials of anticoagulation have not shown benefit. Curate the association as real-but-small and flag the therapeutic-inference gap explicitly (a KNOWLEDGE_GAP discussion is appropriate: association ≠ actionable). The enoxaparin trial NCT00986765 ("Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe…", COMPLETED, Phase 3) is the relevant trial anchor.

2.4 Protective factors

Only three protective factors reached significance in Chen 2025 (the abstract does not name them individually; the full text is needed — flag as a retrieval gap). Practically supported protective exposures:

Smoking cessation before/early in pregnancy — implied by the 15–25% population attributable fraction (PMID:10214847). NCIT: NCIT:C17427 Smoking Cessation.
Treatment of mild chronic hypertension. This is now RCT-grade. The CHAP trial (Tita et al., NEJM 2022, PMID:35363951; NCT02299414) used placental abruption inside its primary composite: "The primary outcome was a composite of preeclampsia with severe features, medically indicated preterm birth at less than 35 weeks' gestation, placental abruption, or fetal or neonatal death." Result: "The incidence of a primary-outcome event was lower in the active-treatment group than in the control group (30.2% vs. 37.0%), for an adjusted risk ratio of 0.82 (95% confidence interval [CI], 0.74 to 0.92; P<0.001)." Caveat for curators: this is a composite-outcome benefit, not a demonstrated abruption-specific reduction. Do not curate as "antihypertensives prevent abruption" without that qualifier.
Adequate prenatal care (≥4 visits) — the inverse of the "inadequate prenatal care" risk factor.

No protective genetic variant has been identified. State this as absent, not as unknown.

2.5 Gene–environment interaction

Genuinely thin literature. The strongest documented interaction is maternal genome × placental genome, not gene × exposure: Workalemahu et al. showed that variations in the placental genome and interactions between maternal–placental genetic variations may contribute to PA risk (companion study, PMC4280220). The best-quantified exposure × exposure interaction is smoking × hypertensive disorders (PMID:10214847, quoted in §2.2).

This is a legitimate KNOWLEDGE_GAP for the entry: no GxE study of adequate power exists for abruption.

3. Phenotypes

3.1 Maternal clinical presentation

Phenotype	HPO term (verified)	Category	Frequency	Notes
Vaginal bleeding	`HP:0034263` Abnormal vaginal bleeding	Clinical sign	FREQUENT (~70–80%)	20–30% concealed — blood trapped retroplacentally; absence does not exclude
Abdominal pain	`HP:0002027` Abdominal pain	Symptom	FREQUENT	Classically "out of proportion to the volume of bleeding" when concealed (Merck Manual Professional)
Uterine tenderness / hypertonus	(no precise HP term; MeSH scope note calls it "uterine MUSCLE HYPERTONIA")	Clinical sign	FREQUENT	"board-like" tetanic uterus in severe cases; use `preferred_term: Uterine tenderness and hypertonus` with no `term:` or map to a broad parent
Back pain	`HP:0003418` Back pain	Symptom	OCCASIONAL	Prominent with posterior placenta
Fetal distress (non-reassuring FHR)	`HP:0025116` Fetal distress	Clinical sign	FREQUENT	79% in the CP-causing cohort (PMID:22805996)
Hypovolemic shock	`HP:0031274` Hypovolemic shock	Clinical sign	OCCASIONAL	Sher class 3
Disseminated intravascular coagulation	`HP:0005521` Disseminated intravascular coagulation (acute: `HP:0011880`)	Lab/clinical	OCCASIONAL	OR 6.30 (6.00–6.61) vs no abruption (PMID:40940025)
Hypofibrinogenemia	`HP:0011900` Hypofibrinogenemia	Lab abnormality	OCCASIONAL	"Serum fibrinogen and fibrin-split products (the most sensitive indicator)" (Merck Manual Professional)
Thrombocytopenia	`HP:0001873` Thrombocytopenia	Lab abnormality	OCCASIONAL	consumptive
Anemia	`HP:0001903` Anemia	Lab abnormality	FREQUENT	both a risk factor and a consequence
Post-partum hemorrhage	`HP:0011891` Post-partum hemorrhage	Complication	OCCASIONAL	OR 1.76 (1.72–1.80) (PMID:40940025)
Acute kidney injury	`HP:0001919` Acute kidney injury	Complication	RARE	listed by Downes 2017 (PMID:28329897)
Preeclampsia (co-occurring)	`HP:0100602` Preeclampsia	Comorbid	OCCASIONAL	ischemic placental disease overlap
Uterine rupture	`HP:0100718` Uterine rupture	Differential/complication	RARE

Couvelaire uterus (uteroplacental apoplexy) — blood dissecting into the myometrium producing a bruised, boggy, poorly contractile uterus — has no HPO term and no obvious ontology anchor. Curate as free-text preferred_term with a histopathology entry; it is a candidate for the Xogenesis-style open-ontology treatment.

3.2 Fetal / neonatal phenotypes

Phenotype	HPO term (verified)	Frequency	Notes
Premature birth	`HP:0001622` Premature birth	VERY FREQUENT	the dominant fetal consequence
Stillbirth	`HP:0003826` Stillbirth	FREQUENT within abruption	"The majority of deaths (77%) occurred in utero" (PMID:23072758)
Neonatal death	`HP:0003811` Neonatal death	OCCASIONAL
Small for gestational age	`HP:0001518` Small for gestational age	FREQUENT	with chronic abruption
Intrauterine growth retardation	`HP:0001511` Intrauterine growth retardation	FREQUENT
Neonatal asphyxia	`HP:0012768` Neonatal asphyxia	FREQUENT in severe abruption	umbilical arterial pH 6.728 ± 0.164 in the CP cohort (PMID:22805996)
Cerebral palsy	`HP:0100021` Cerebral palsy	OCCASIONAL (long-term)	see §11
Oligohydramnios	`HP:0001562` Oligohydramnios	OCCASIONAL	chronic abruption
Preterm premature rupture of membranes	`HP:6000310` Preterm premature rupture of membranes	FREQUENT	bidirectional with abruption

Downes et al. 2017 (PMID:28329897) enumerate the full outcome set verbatim:

"Abruption was associated with elevated risk of cesarean delivery, postpartum hemorrhage and transfusion, preterm birth, intrauterine growth restriction or low birth weight, perinatal mortality, and cerebral palsy. Additional maternal outcomes included relaparotomy, hysterectomy, sepsis, amniotic fluid embolism, venous thromboembolism, acute kidney injury, and maternal intensive care unit admission. Additional perinatal outcomes included acidosis, encephalopathy, severe respiratory disorders, necrotizing enterocolitis, acute kidney injury, need for resuscitation, chronic lung disease, infant death, and epilepsy."

3.3 Severity grading (Sher classification)

Widely used; from StatPearls (NBK482335). Curate as a Subtype set or as a severity scale:

Class 0 (asymptomatic): retroplacental clot found only on post-delivery placental inspection.
Class 1 (mild): minimal/no vaginal bleeding, slight uterine tenderness, normal maternal vitals, no fetal distress.
Class 2 (moderate): none-to-moderate bleeding, significant uterine tenderness with tetanic contractions, maternal tachycardia and orthostatic change, fetal distress, hypofibrinogenemia.
Class 3 (severe): minimal-to-heavy bleeding, board-like tetanic uterus, maternal shock, coagulopathy, fetal death.

Classes 0–1 correspond to partial/marginal separation; classes 2–3 to complete/central separation. StatPearls notes ~70% of cases are low-risk. Page grading (0–3) is an equivalent older scheme.

3.4 Quality-of-life impact

Under-studied and a real evidence gap. Documented domains, mostly indirect:

Maternal: ICU admission, transfusion, emergency hysterectomy (permanent loss of fertility), and — for those with fetal death — bereavement and subsequent-pregnancy anxiety. No abruption-specific EQ-5D/SF-36/PROMIS instrument exists.
Offspring: cerebral palsy (HP:0100021) and epilepsy carry lifelong functional burden; chronic lung disease of prematurity.
Recurrence anxiety in subsequent pregnancy is clinically salient given the ~5× recurrence odds (PMID:38366767) but is unmeasured in the literature.

Curate as KNOWLEDGE_GAP: no validated disease-specific QoL instrument.

4. Genetic / Molecular Information

4.1 Causal genes

None. Placental abruption has no Mendelian form, no OMIM phenotype entry, and no gene with definitive ClinGen gene–disease validity. This should be stated affirmatively in the entry — an empty genetic: block invites a reviewer to think it was simply not curated.

4.2 Susceptibility loci

See §2.3 for the verified list. Summary for the genetic: block, all relationship_type: SUSCEPTIBILITY:

ABCC8 (hgnc:59) rs4148646, rs2074311 — and the physically adjacent KCNJ11 (hgnc:6257) rs2074314, rs35271178. These two encode the SUR1/Kir6.2 subunits of the same ATP-sensitive potassium channel; the two "independent" signals are likely one locus. Biologically plausible via vascular smooth-muscle tone and trophoblast metabolism.
ZNF28 (hgnc:13073) — four SNPs, function unknown.
CTNND2 (hgnc:2516) rs11133659 — δ-catenin, adhesion/junctional.
ADAM12 (hgnc:190) rs7094759, rs12264492 — placental metalloprotease, also a first-trimester serum marker of placental function. The convergence of a genetic and a biochemical signal on the same gene makes ADAM12 the most interesting single candidate.
IRX1 (hgnc:14358) rs76258369 — developmental homeobox TF.
FLI1 (hgnc:3749) rs1238566 — megakaryocyte/endothelial TF (PMID:24046805).

Variant classification: all are common non-coding/intronic SNPs, not ACMG-classifiable pathogenic variants. Do not attempt ACMG classification; record as GWAS-suggestive association only. Allele frequencies are common (this is a common-variant disease); the cohorts were Peruvian, so transferability to other ancestries is unestablished — a genuine KNOWLEDGE_GAP.

Somatic vs germline: germline (maternal and/or fetal). No somatic contribution.

Functional consequence: unknown for all loci; none has a demonstrated molecular mechanism. Say so.

4.3 Thrombophilia variants

F5 (hgnc:3542) c.1601G>A p.Arg534Gln — Factor V Leiden, rs6025. A small case-control series reported 8/46 (18%) abruption cases vs 1/46 (2%) controls carrying FVL with APC resistance (secondary report; verify the primary PMID before curating — I could not retrieve it directly this session).
F2 (hgnc:3535) c.*97G>A — prothrombin G20210A, rs1799963.
MTHFR (hgnc:7436) c.665C>T p.Ala222Val (rs1801133, the "C677T") — hyperhomocysteinemia route; associations are weak and inconsistent, and TREATS found MTHFR/hyperhomocysteinaemia not associated with postoperative VTE, undercutting the general thrombophilia framing for this variant.

Curate these as SUSCEPTIBILITY with frequency bands, anchored on TREATS (PMID:16595080), and add the therapeutic-inference caveat from §2.3.

4.4 Modifier genes

None established.

4.5 Epigenetics

No abruption-specific methylation or histone study of adequate quality was identified in this search. Adjacent evidence exists for ischemic placental disease broadly (shared epigenetic regulation between preeclampsia and IUGR was reported in placental microarray work), but nothing abruption-specific. Flag as an explicit gap — an obvious high-value target given the acute-on-chronic model.

4.6 Chromosomal abnormalities

Not applicable. No aneuploidy, translocation, or CNV association. Chromosomal microarray, karyotype and FISH have no role in abruption workup (they may be indicated for an associated stillbirth, which is a different indication).

5. Environmental Information

5.1 Chemical / toxicant exposures

Tobacco smoke / nicotine (CHEBI:18723 nicotine). Strongest modifiable factor: OR 1.9 (1.8–2.0), 15–25% population attributable fraction, with a documented dose–response — "the OR increased with increasing number of cigarettes smoked" (PMID:10214847). Mechanism: nicotine-mediated vasoconstriction plus carbon-monoxide-driven chronic hypoxia → decidual necrosis and vessel fragility.
Cocaine (CHEBI:27958). RR 4.55 (1.78–6.50) — the largest single effect size for any exposure (PMID:35365209). Mechanism: acute catecholaminergic vasospasm and hypertensive surge causing decidual vessel rupture. James & Coles (PMID:1765257): "It not only poses a health risk to the pregnant woman, but can precipitate premature labor and abruptio placentae."
Cannabis/marijuana. OR 1.78 (1.32–2.40), class IV weak evidence.
Alcohol. Identified as an independent risk factor in Chen 2025.
Air pollution / preconception environmental exposures. Covered in the Jenabi umbrella review's remit (PMID:35365209); no exposure reached class I/II evidence. Treat any PM2.5–abruption claim as preliminary.

5.2 Physical / mechanical

Blunt abdominal trauma — motor vehicle crashes, falls, intimate partner violence. Abruption can occur with deceleration injury and without direct uterine impact, and can present up to 24 h after the event, which is why post-trauma cardiotocographic monitoring is standard. Trauma screening should include tactful assessment for abuse (StatPearls).
Sudden uterine decompression — membrane rupture with polyhydramnios (HP:0001561), delivery of the first twin.
Short umbilical cord / velamentous cord insertion. Ananth 2005 (PMID:15672024) identified "short umbilical cord, and velamentous cord insertion" among the determinants tracking the temporal trend in abruption.

5.3 Lifestyle / demographic

Advanced maternal age ≥35 (OR 1.44), parity ≥3, pre-pregnancy underweight BMI <18.5 (OR 1.38), unmarried status, inadequate prenatal care <4 visits, Medicaid insurance (PMID:40940025) — the last two being markers of access rather than biology, and important to curate as such rather than as causal.

5.4 Infectious agents

No single pathogen causes abruption. Chorioamnionitis (ascending polymicrobial intraamniotic infection — Ureaplasma, Mycoplasma hominis, Gardnerella, group B Streptococcus, Fusobacterium, E. coli) is both a determinant of abruption trends (PMID:15672024) and a co-traveler with PPROM. Simhan & Canavan (PMID:15715592): "PPROM is associated with significant maternal and neonatal morbidity and mortality from infection, umbilical cord compression, placental abruption and preterm birth." They report "The frequency of positive cultures obtained by transabdominal amniocentesis at the time of presentation with PPROM in the absence of labour is 25-40%."

The best mechanistic bridge between infection and abruption is the thrombin×TLR4 synergy documented by Mhatre et al. (PMID:27108773) — see §6.4.

6. Mechanism / Pathophysiology

This is the section that should carry the pathograph. I propose an eight-node chain with two upstream triggers converging, plus an inflammatory amplification limb.

6.1 The causal chain (proposed pathophysiology nodes)

Trigger A — Impaired spiral artery remodeling / decidual vasculopathy · biological_scale: TISSUE Shallow extravillous trophoblast invasion leaves maternal spiral arteries incompletely converted, retaining vasoreactivity and delivering high-velocity flow into the intervillous space. Decidual arterioles develop atherosis and necrosis. This is the chronic arm. - Cell types: CL:0008036 extravillous trophoblast; CL:2000002 decidual cell; endothelial cell of the spiral artery - Processes: GO:0061450 trophoblast cell migration (modifier: DECREASED); GO:0071456 cellular response to hypoxia (INCREASED) - Anatomy: UBERON:0000453 decidua basalis - Evidence: PMID:24836823 (ischemic placental disease framework); PMID:28178056 (first-trimester analyte abnormalities predict abruption)

Trigger B — Acute mechanical shear or vasospasm · biological_scale: TISSUE Trauma, sudden decompression, or cocaine-induced vasospasm mechanically or hemodynamically ruptures decidual vessels. StatPearls: "Since the uterus is elastic but the placenta is not, sudden uterine stretching causes the vascular structures connecting them to tear."

Node 1 — Decidual vessel rupture and hemorrhage into the decidua basalis · biological_scale: TISSUE The defining lesion. Normally prevented by constitutive decidual tissue factor. Lockwood et al. (PMID:19720393): "In human pregnancy, decidual cell-expressed tissue factor (TF) prevents decidual hemorrhage (abruption)." and "TF expression is highest in decidual cells" — i.e. the decidua is a hemostatically privileged tissue, and abruption is the failure of that privilege. - Gene: F3 (hgnc:3541) - Anatomy: UBERON:0000453 decidua basalis - Cell type: CL:2000002 decidual cell

Node 2 — Retroplacental hematoma formation and placental separation · biological_scale: TISSUE Accumulating blood dissects the basal plate, propagating separation and further vessel disruption — a positive-feedback loop. This is the Xogenesis-shaped node of the entry: a pathological structure (retroplacental hematoma) forms at a defined anatomical site. If the granuloma_formation/thrombogenesis Xogenesis convention is applied, the anchors would be an OGMS pathological-formation process at UBERON:0000453 decidua basalis, forming a hematoma continuant. Note that thrombogenesis (kb/modules/thrombogenesis) is a plausible partial conformance target for the clot itself, though the causal direction is inverted here (hemorrhage first, clot second). - Processes: GO:0007596 blood coagulation; GO:0030168 platelet activation

Node 3 — Loss of gas-exchange surface and acute fetoplacental hypoxia · biological_scale: ORGANISM The separated area is functionally excluded from maternal perfusion. Fetal compromise scales with the fraction separated; classical teaching is that >50% separation is generally incompatible with fetal survival. - Phenotype: HP:0025116 Fetal distress; HP:0012768 Neonatal asphyxia - Process: GO:0071456 cellular response to hypoxia (INCREASED)

Node 4 — Local thrombin generation (the mechanistic hub) · biological_scale: MOLECULAR Decidual TF/FVIIa cleaves prothrombin; the retroplacental clot is a thrombin factory. Everything downstream of node 4 in this entry is thrombin-driven — this is the node other diseases would conforms_to. - Genes: F3 (hgnc:3541), F2 (hgnc:3535) - Process: GO:0007596 blood coagulation (INCREASED)

Node 5 — PAR-1-mediated decidual and endothelial inflammatory activation · biological_scale: CELLULAR Thrombin signals through protease-activated receptor 1 (F2R, hgnc:3537), converting a hemostatic signal into an inflammatory one. Mhatre et al. (PMID:27108773):

"Thrombin significantly and synergistically augmented LPS-induced HEEC secretion of interleukin (IL)-6, IL-8, granulocyte colony-stimulating factor (G-CSF), and growth-regulated oncogene-alpha (GRO-α), and significantly augmented monocyte chemotactic protein (MCP)-1, tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF) secretion additively."

"Similar to thrombin, a PAR1 agonist synergistically augmented the LPS-induced HEEC secretion of inflammatory IL-6, IL-8, G-CSF, and GRO-α."

"…suggesting a mechanism by which intrauterine abruption and bacterial infection may together be associated with an aggravated uterine inflammatory response."

This synergy is the mechanistic explanation for the epidemiological co-occurrence of abruption and chorioamnionitis and is worth curating as its own edge. - Process: GO:0070493 thrombin-activated receptor signaling pathway (INCREASED); GO:0006954 inflammatory response (INCREASED) - Cell types: CL:2000002 decidual cell; endothelial cell (human endometrial endothelial cell) - Evidence source: IN_VITRO

Node 6 — Decidual neutrophil recruitment via thrombin-induced IL-8 · biological_scale: CELLULAR Lockwood et al., Am J Pathol 2005 (PMID:16251427) — the cleanest in-vivo-plus-in-vitro pairing in this literature:

"Abruptions were associated with a marked decidual neutrophil infiltration that peaked after PPROM, whereas decidua from gestational age-matched controls were virtually devoid of neutrophils."

"Neutrophil infiltrates co-localized with fibrin deposition."

"…thrombin (0.1 to 2.5 U/ml) elicited a dose-dependent elevation in secreted IL-8 (P<0.05) with 2.5 U/ml of thrombin increasing IL-8 levels by >14-fold in E2 and E2+medroxyprogesterone incubations."

Gene: CXCL8 (hgnc:6025)
Process: GO:0030593 neutrophil chemotaxis (INCREASED)
Cell type: neutrophil (CL:0000775 neutrophil — verify label before curating)
Evidence: the immunostaining arm is HUMAN_CLINICAL; the decidual-cell culture arm is IN_VITRO. Split into two evidence items with different evidence_source values.

Node 7 — Matrix metalloproteinase-driven membrane weakening → PPROM · biological_scale: MOLECULAR Rosen et al. (PMID:12380602):

"MPA strongly inhibited MMP-1 levels in endometrial stromal and term decidual cells. However, thrombin overcame this suppression, producing MMP-1 levels that were several-fold higher than control levels."

"Extrapolation of thrombin-enhanced MMP-1 expression in cultured endometrial stromal and decidual cells to the in vivo pregnant state provides an explanation for the strong association between placental abruption and preterm membrane rupture."

Norwitz et al. (PMID:17403427) tested and excluded the alternative plasminogen-activator route, concluding: "abruption-associated decidual proteolysis and preterm labor is mediated primarily by thrombin-enhanced matrix metalloproteinase expression rather than an indirect effect on the plasminogen activator/inhibitor system." That is a useful REFUTE/negative evidence item — thrombin raised PAI-1 without raising uPA or tPA. - Genes: MMP1 (hgnc:7155); SERPINE1 (hgnc:8583) for the PAI-1 arm - Process: GO:0022617 extracellular matrix disassembly (INCREASED); GO:0042730 fibrinolysis - Phenotype: HP:6000310 Preterm premature rupture of membranes - Evidence source: IN_VITRO

Node 8 — Functional progesterone withdrawal and myometrial activation → preterm delivery · biological_scale: CELLULAR Lockwood et al., Am J Pathol 2012 (PMID:23058370):

"In cultured DCs, thrombin inhibited PR but not GR mRNA levels, reduced PR binding to DNA and [(3)H]progesterone binding to PR, and enhanced phosphorylated but not total ERK1/2 levels."

"Thus, abruption-associated PTD is initiated by functional progesterone withdrawal, as indicated by significantly reduced DC nuclear expression of PR-A and PR-B. Functional withdrawal of progesterone results in increased p-ERK1/2, and is thus one pathway initiating abruption-associated PTD."

Genes: PGR (hgnc:8910)
Process: GO:0070471 uterine smooth muscle contraction (INCREASED)
Phenotype: HP:0001622 Premature birth
Evidence source: mixed IN_VITRO (culture) + HUMAN_CLINICAL (immunohistochemistry on abruption vs control placentas)

Node 9 — Consumptive coagulopathy / DIC · biological_scale: ORGANISM Massive thromboplastin (tissue factor) release from the disrupted decidua into the maternal circulation consumes fibrinogen and platelets. Abruption is the classic obstetric cause of DIC. - Phenotypes: HP:0005521 DIC (acute HP:0011880); HP:0011900 Hypofibrinogenemia; HP:0001873 Thrombocytopenia; HP:0031274 Hypovolemic shock - Evidence: PMID:40940025 (DIC OR 6.30, 95% CI 6.00–6.61)

6.2 Additional cytokine mediators

Cakmak et al. (PMID:15998775) add IL-11 (hgnc:5966) to the thrombin-responsive set, with a striking magnitude:

"IL-1beta and thrombin elevated IL-11 output during incubations with E2 [24-fold (P < 0.05) and 120-fold (P < 0.05), respectively]. These increases were blunted by the addition of MPA [13-fold (P < 0.05) and 36-fold (P < 0.05), respectively]."

"Because excess IL-1beta and thrombin generation are associated with chorioamnionitis- and abruption-related PTD, respectively, these findings add to our understanding of the genesis of inflammation- and abruption-associated prematurity."

Note the clean mechanistic dissociation the authors draw: IL-1β is the chorioamnionitis signal; thrombin is the abruption signal, converging on the same decidual effectors. That is a good candidate for two mechanistic_hypotheses groups or for a shared downstream node with two distinct upstream edges.

CSF2/GM-CSF (hgnc:2434) is a further thrombin-induced decidual mediator implicated in fetal-membrane weakening (Am J Pathol, "Thrombin-Induced Decidual Colony-Stimulating Factor-2 Promotes Abruption-Related Preterm Birth by Weakening Fetal Membranes" — PMID not retrieved this session; verify before curating).

6.3 Immune involvement

Bączkowska et al., Int J Mol Sci 2021 (PMID:34205566) — systematic review, 708 records screened, 22 analyzed:

"The available evidence indicates that the disruption of the immunological processes on the maternal-fetal interface plays a crucial role in the pathophysiology of placental abruption. The features of chronic non-infectious inflammation and augmented immunological cytotoxic response were found to be present in placental abruption samples in the reviewed studies. Various molecules participate in this process, with only a few being examined. More advanced research is needed to fully explain this complicated process."

That final sentence is an ideal anchor for a KNOWLEDGE_GAP discussion. Decidual NK cells (CL:0002343 decidual natural killer cell, human; CL:4052028 uterine natural killer cell) are the obvious cell population to name, given their established role in spiral-artery remodeling.

6.4 Tissue damage mechanisms

Ischemia (loss of maternal perfusion to the separated segment), hemorrhage, decidual necrosis, infarction, and — for the fetus — hypoxic-ischemic injury. Oxidative stress is implicated via the ischemic placental disease framework and via the mitochondrial-biogenesis/OXPHOS candidate genes of PMID:24046805 (CAMK2B, NR1H3, PPARG, PRKCA, THRB; COX5A and NDUF-family).

6.5 Molecular profiling

Transcriptomics: no abruption-specific placental RNA-seq dataset of note was located. The Bączkowska review's 22-study base is candidate-molecule immunohistochemistry, not unbiased omics. Substantial gap. Adjacent resources: GTEx (no placenta), Human Cell Atlas maternal–fetal interface reference (Vento-Tormo et al.).
Proteomics / metabolomics / lipidomics: none abruption-specific identified.
Single-cell / spatial: none abruption-specific. The maternal–fetal interface single-cell atlas would be the natural reference tissue for a first study; note as an opportunity, not a finding.
Functional genomics screens: none.

Be explicit in the entry that the omics layer for this disease is essentially empty. That is itself a curatable fact.

7. Anatomical Structures Affected

7.1 Organ level

Primary: UBERON:0001987 placenta — specifically the maternal/basal aspect.
Primary (maternal): UBERON:0002450 decidua, and precisely UBERON:0000453 decidua basalis — the site of the initiating hemorrhage. Brandt & Ananth locate the lesion at "the interface between the decidua… and the placenta." StatPearls: "The histologic finding most strongly associated with acute abruption is hemorrhage in the decidua basalis with underlying parenchymal indentation."
Also relevant: UBERON:8600019 placental basal plate; UBERON:0010008 placental cotyledon; UBERON:0006878 decidua parietalis (uninvolved comparator).
Secondary maternal: uterus/myometrium (Couvelaire uterus), systemic coagulation system, kidney (HP:0001919 AKI), pituitary (Sheehan syndrome after massive hemorrhage), cerebrovasculature (long-term, §11).
Secondary fetal: brain (hypoxic-ischemic injury), lung (prematurity), gut (necrotizing enterocolitis).
Body systems: reproductive, cardiovascular/hematologic, and — downstream — nervous and respiratory.

7.2 Tissue and cell level

Cell / tissue	CL term (verified)	Role
Decidual cell	`CL:2000002`	tissue-factor-expressing hemostatic guardian; thrombin-responsive effector
Stromal cell of endometrium	`CL:0002255`	precursor of decidual cells; used in the culture models
Extravillous trophoblast	`CL:0008036`	spiral-artery remodeling; deficient invasion is Trigger A
Placental villous trophoblast	`CL:2000060`	gas exchange surface lost on separation
Anchoring trophoblast	`CL:0002219`	basal-plate attachment
Decidual natural killer cell (human)	`CL:0002343`	immune arm of spiral-artery remodeling
Uterine natural killer cell	`CL:4052028`	as above
Decidual pericyte	`CL:0008033`	vessel-wall stability
Endothelial cell (endometrial/spiral artery)	human endometrial endothelial cell — no exact CL term; use a parent endothelial CL	thrombin/PAR-1 inflammatory amplifier
Neutrophil	`CL:0000775` (verify label)	thrombin/IL-8-recruited effector; co-localizes with fibrin
Uterine smooth muscle cell / myometrium		hypertonus, Couvelaire infiltration

7.3 Subcellular level

No distinctive subcellular pathology. Relevant GO cellular components if needed: plasma membrane (PAR-1 signaling), extracellular region/extracellular matrix (MMP-1 substrate), mitochondrion (OXPHOS candidate genes, PMID:24046805).

7.4 Localization and laterality

The lesion is focal within a single organ. The clinically meaningful spatial axes are:

Marginal vs central separation. Marginal (edge) separation → revealed bleeding, lower risk. Central separation → concealed hematoma, higher risk, and can be entirely occult. This is the anatomical basis of the concealed-vs-revealed dichotomy and should be curated.
Anterior vs posterior placental location. Posterior placentation makes sonographic detection harder and produces back-predominant pain — a real diagnostic-performance modifier.
Fraction of placental surface separated — the principal determinant of fetal outcome.

Laterality in the conventional sense (unilateral/bilateral) does not apply.

8. Temporal Development

8.1 Onset

Age of onset: not applicable in the usual sense. Onset is defined by gestational age, which is the correct time axis for this entry. Merck Manual Professional states incidence peaks at 24–26 weeks. StatPearls: "Most cases develop before 37 weeks gestation." Brandt & Ananth (PMID:37164498) is specifically devoted to the late-preterm (34–36 wk) and term (≥37 wk) window, which behaves differently — better fetal outcomes, but a substantial share of the total burden.
Onset pattern: bimodal. Acute abruption is abrupt (minutes). Chronic abruption is insidious, presenting as "continued or intermittent dark brown spotting" (Merck Manual Professional), sometimes with oligohydramnios and growth restriction — the "chronic abruption–oligohydramnios sequence."

The strongest evidence that the disease begins long before it presents is the biomarker work. Ananth et al., Obstet Gynecol 2017 (PMID:28178056), 35,307 women / 250 abruption cases from the FASTER cohort:

"We hypothesized that the origins of abruption may extend to the stages of placental implantation; however, there are no reliable markers to predict its development."

"Women with an abnormally low pregnancy-associated plasma protein A (fifth percentile or less) were at increased risk of abruption compared with those without abruption (9.6% compared with 5.3%; RR 1.9, 95% CI, 1.2-2.8)."

"Women with all three abnormal pregnancy-associated plasma protein A, maternal serum alpha-fetoprotein, and inhibin-A analytes were at 8.8-fold (95% CI 2.3-34.3) risk of abruption."

"These data provide support for our hypothesis that the origins of placental abruption may extend to the early stages of pregnancy."

Curatorial note: this is the key evidence for modeling a first-trimester origin node upstream of everything in §6 — abruption at 32 weeks may be the terminal event of a process initiated at implantation. It also justifies MECHANISTIC_HYPOTHESIS framing for any early-pregnancy prediction algorithm.

8.2 Progression

Stages: Sher classes 0→3 (§3.3) function as severity stages. Progression from class 1 to class 3 can occur over minutes to hours.
Rate: highly variable. Yamada et al. (PMID:22805996) give a chilling quantification of the acute time course in the subset that caused cerebral palsy: "strong abdominal pain and/or profuse vaginal bleeding occurred 159 ± 99 min prior to admission to an obstetric facility, and the interval until delivery after admission was 47 ± 31 min." The authors conclude: "New strategies to shorten the interval until admission to an obstetric facility after onset of symptoms are urgently needed."
Course pattern: acute abruption is a single catastrophic event; chronic abruption is intermittent/relapsing over weeks.
Duration: self-limited by delivery. This is the disease's defining temporal property — abruption resolves absolutely at delivery of the placenta. There is no chronic abruption state postpartum. What persists is (a) the maternal cardiovascular risk trajectory (§11), (b) offspring sequelae, and (c) elevated recurrence risk in future pregnancies.

8.3 Patterns

Remission: not applicable within a pregnancy. Small chronic abruptions may stabilize and the pregnancy continue, with the hematoma organizing.
Recurrence across pregnancies: ~5-fold. Oyelese et al., J Obstet Gynaecol Res 2024 (PMID:38366767), Kaiser Permanente Southern California, 126,264 patients with two consecutive singleton births over 30 years:

"Rates of abruption in the second birth among individuals with and without previous placental abruption were 3.35% and 0.66%, respectively, giving an approximately five-fold increased odds of abruption in a second pregnancy in individuals who had abruption in their first birth when compared with those who did not have placental abruption in their first birth (aOR: 4.95, 95% confidence interval: 3.35-7.31, p < 0.00001)."

"Interpregnancy interval had no statistically significant association with recurrence."

(StatPearls quotes a recurrence rate of 4–12%; the Kaiser figure of 3.35% is the best contemporary population estimate for a second birth specifically.)

Critical intervention windows:
Preconception/first trimester — the only window for modifying implantation-stage determinants (smoking cessation, blood-pressure control, ART practice).
<16 weeks — the window in which low-dose aspirin is effective for placental disease generally.
24–34 weeks — antenatal corticosteroids for fetal lung maturity; magnesium sulfate for neuroprotection.
The acute event, minutes to hours — the decisive window. Yamada's ~47 min admission-to-delivery interval defines the operational target.

9. Inheritance and Population

9.1 Epidemiology

Measure	Value	Population	Source
Overall incidence	0.64% (8,724 / 1,358,623)	pooled, 13 studies	PMID:10214847
Prevalence	0.6%–1.2% of pregnancies	contemporary review	PMID:37164498
Delivery hospitalizations	1.2% (2000) → 1.6% (2020), AAPC 1.6% (95% CI 1.3%, 2.0%)	US National Inpatient Sample, 80.2M deliveries, 1.1M with abruption	PMID:40940025
Cohort prevalence	1.1% (33,058 / 3,093,241 deliveries)	New Jersey, 1993–2020	PMID:38273776
First-birth rate	0.63%; second-birth rate 0.68%	Kaiser Permanente S. California, 1991–2021	PMID:38366767
Range (Merck)	0.4%–1.5%	all pregnancies	Merck Manual Professional
Nordic vs US	0.38–0.51% (Nordic) vs 0.6–1.0% (US)		secondary review source

Structured prevalence block guidance (dismech convention): use measure_type: POINT_PREVALENCE per delivery, prevalence_class: ABOVE_1_IN_1000, rate_per_100000: 640 for the classic Ananth pooled figure (0.64% × 1000), or rate_per_100000: 1600 for the 2020 US NIS figure. Keep the verbatim phrasing in notes. Do not mix the incidence-per-delivery denominator with a population denominator.

9.2 Temporal trends and disparities

Ananth et al., AJOG 2005 (PMID:15672024), National Hospital Discharge Survey 1979–2001:

"The rate of abruption increased 92% (95% CI, 88, 96) among black women between 1979-1981 (0.76%; n = 13,584 women) and 1999-2001 (1.43%; n = 18,960 women). Among white women, the rate increased by 15% (95% CI, 14,16) over the same period, from 0.82% (n = 66,186 women) in 1979-1981 to 0.94% (n = 59,284 women) in 1999-2001."

"The temporal increase in rates of abruption may reflect a true increase in risk or may be the result of improved diagnosis of both abruption and its determinants."

Curate the racial disparity as a social/structural exposure, not a biological one. "Black race" appears as a risk factor in Chen 2025, and Medicaid insurance in Wright 2026; both are markers of differential exposure, access, and chronic stress burden. An entry that curates "black race" as a biological risk factor without that framing is both scientifically wrong and harmful. Ananth's own hedge — that some of the trend may be ascertainment — should be preserved.

9.3 Inheritance

Pattern: multifactorial / polygenic. HPO mode-of-inheritance term HP:0010982 Polygenic inheritance is the appropriate binding, paired with relationship_type: SUSCEPTIBILITY gene typing per the dismech digenic/oligogenic SOP. Do not use HP:0010984/HP:0010983.
Penetrance / expressivity / anticipation / mosaicism / founder effects / consanguinity / carrier frequency: all not applicable — there is no Mendelian allele. Say so explicitly rather than leaving blank.
Two-genome caveat worth curating: susceptibility resides in both the maternal and the fetal/placental genome; Workalemahu et al. specifically examined "Placental Genome and Maternal-Placental Genetic Interactions." This is unusual enough to merit a note.

9.4 Demographics

Sex ratio: the affected pregnant person is by definition female (HP:0010982 context). For the fetus, Tikkanen et al. (PMID:23072758) found male fetal sex an independent risk factor for abruption-related perinatal mortality: "Prematurity, low birthweight, male fetal sex and maternal smoking were independent risk factors for placental abruption-related perinatal mortality."
Age distribution: rises with maternal age ≥35 (OR 1.44) but also elevated at the young extreme in some series; the relationship is J-shaped.
Geography: higher reported rates in the US than Nordic countries; whether that is true risk or coding practice is unresolved.
Variant geography: the GWAS loci were discovered in a Peruvian (Andean-admixed) population and have not been replicated elsewhere — a hard limit on generalizability.

10. Diagnostics

10.1 Diagnostic status

There is no confirmatory antenatal test. StatPearls: "No definitive diagnostic test exists." Abruption is a clinical diagnosis, confirmed (or refuted) retrospectively by placental examination. This should be stated in the entry's definitions section rather than buried.

Hurd et al. (PMID:6828278) show the ceiling of clinical detection: "Diagnosis was confirmed by placental inspection in 59 (1.3%) of 4545 deliveries. Among the 50 patients admitted with a living fetus, the diagnosis was made antenatally in 31 (62%)." — i.e. roughly a third of abruptions with a live fetus were not diagnosed before delivery.

10.2 Imaging

Ultrasound is used to exclude placenta previa, not to confirm abruption. Glantz & Purnell, J Ultrasound Med 2002 (PMID:12164566) — still the definitive performance study, 149 consecutive patients:

"Of 55 patients who gave birth within 14 days of sonography, 8 (15%) had scans consistent with abruption, and 29 (53%) had abruption at delivery; the sensitivity, specificity, and positive and negative predictive values of sonography were 24%, 96%, 88%, and 53%, respectively."

"Sonography is not sensitive for detection of placental abruption, but a positive finding is associated with more aggressive management and worse neonatal outcome."

The physical reason: acute retroplacental hemorrhage is isoechoic with placental tissue, so a fresh hematoma is often invisible. MRI has higher sensitivity but is impractical in an emergency. A negative scan does not exclude abruption — this is the single most important diagnostic caveat in the entry and should be curated as a formal distinguishing_features or KNOWLEDGE_GAP statement.

Relevant NCIT/LOINC: use NCIT:C92929 Fetal Heart Monitoring and NCIT:C92836 Non-Stress Test for the monitoring modalities; there is no clean NCIT obstetric-ultrasound clinical-action term reachable from NCIT:C25218 in the search performed — verify before binding.

10.3 Fetal monitoring

Continuous electronic fetal heart rate monitoring is the most informative single test. Category I / II / III tracings guide urgency; a Category III tracing in the setting of bleeding and uterine hypertonus is an indication for immediate delivery. Uterine tocodynamometry showing high-frequency, low-amplitude contractions is characteristic.

10.4 Laboratory

Test	Purpose	Notes
Complete blood count	anemia, thrombocytopenia
Fibrinogen	the key coagulopathy marker	Merck: "Serum fibrinogen and fibrin-split products (the most sensitive indicator)". A low fibrinogen in an obstetric hemorrhage is both diagnostic of consumptive coagulopathy and prognostic
PT / aPTT	coagulopathy
Fibrin degradation products / D-dimer	DIC
Type and screen / crossmatch	transfusion readiness
Kleihauer-Betke	quantifies fetomaternal hemorrhage	Essential in Rh-negative patients to dose anti-D immune globulin
BUN/creatinine	AKI

A dismech reference_ranges block with interpretation_bands on fibrinogen would be well-motivated here: pregnancy raises fibrinogen substantially, so a "normal" non-pregnant value is abnormally low in a bleeding obstetric patient. Curate the pregnancy-specific interval with evidence, and band the values by severity.

10.5 Histopathology (the reference standard)

Sampling and lesion definitions should follow the Amsterdam Placental Workshop Group Consensus Statement (Khong et al., Arch Pathol Lab Med 2016, PMID:27223167):

"The group agreed on sets of uniform sampling criteria, placental gross descriptors, pathologic terminologies, and diagnostic criteria. The terminology and microscopic descriptions for maternal vascular malperfusion, fetal vascular malperfusion, delayed villous maturation, patterns of ascending intrauterine infection, and villitis of unknown etiology were agreed upon."

Findings to curate under histopathology: - Adherent retroplacental hematoma with underlying parenchymal indentation/compression of the maternal surface — the most specific acute finding. - Decidual hemorrhage / decidual necrosis in the decidua basalis. - Maternal vascular malperfusion features (Amsterdam terminology): decidual arteriopathy/atherosis, accelerated villous maturation, infarcts, retroplacental hemorrhage — the chronic-arm signature. - Decidual neutrophil infiltration co-localizing with fibrin (PMID:16251427) — with the crucial control observation that gestational-age-matched control decidua is "virtually devoid of neutrophils." - Hemosiderin deposition and organizing hematoma in chronic abruption, dating the process to days–weeks before delivery. - Concurrent acute chorioamnionitis in the infection-associated subgroup.

10.6 Genetic and omics diagnostics

None indicated. WGS, WES, gene panels, single-gene testing, CMA, karyotype, FISH, mtDNA testing and repeat-expansion testing all have no role in diagnosing or managing placental abruption. Thrombophilia panels are not recommended for placenta-mediated complications on current evidence. RNA-seq, proteomics, metabolomics, epigenomics and liquid biopsy have no validated diagnostic application here. State each of these as explicitly not applicable — this is more useful to a downstream consumer than an omitted field.

10.7 Differential diagnosis

Condition	Distinguishing features
Placenta previa (`HP:0430070`)	Painless, bright red, external bleeding; soft, relaxed uterus; placenta over the internal os on ultrasound. StatPearls contrast: abruption gives "pain intense/acute; firm, board-like uterus" vs previa "no pain; soft, relaxed uterus"
Vasa previa	Bleeding at membrane rupture, rapid fetal exsanguination, fetal (not maternal) blood
Uterine rupture (`HP:0100718`)	Prior uterine scar, loss of station, abnormal contraction pattern, sudden FHR deterioration
Preterm labor	Contractions without hemorrhage or hypertonus
Cervical/vaginal lesion, cervicitis, post-coital bleeding	Visualized on speculum exam
Circumvallate placenta / marginal sinus bleed	Milder, often self-limited
Non-obstetric acute abdomen (appendicitis, ovarian torsion, nephrolithiasis)	Absent bleeding, different pain character

10.8 Screening

There is no validated screening test for abruption in asymptomatic pregnancies. The biomarker combination from PMID:28178056 (low PAPP-A + high MSAFP + abnormal inhibin-A, RR 8.8) is the closest candidate but has never been prospectively validated as a screening instrument — its positive predictive value at population prevalence of ~1% would be poor. If curating a definitions entry for a serum-analyte-based case-finding rule, mark it derivation_basis: MECHANISTIC_HYPOTHESIS with validation_status.status: PROPOSED, and attaches_to the early-implantation origin node.

Trial anchors for prediction: NCT03455387 (sFlt-1/PlGF for placental complications), NCT03782168 (plasma biomarkers in placental abruption — TERMINATED), NCT01279369 (fetal fibronectin to predict abruption delivery — TERMINATED). Two terminated prediction studies is itself informative and worth noting.

11. Outcome / Prognosis

11.1 Perinatal mortality

Tikkanen et al., Acta Obstet Gynecol Scand 2013 (PMID:23072758) — Finnish national registers, 618,735 women / 1.14 million pregnancies / 4,336 abruptions:

"Overall perinatal mortality with abruption was 119 per 1000 births. Placental abruption explained 7% of all perinatal deaths."

"The mortality among singleton births (125 per 1000) was higher than among multiple births (40 per 1000). The majority of deaths (77%) occurred in utero."

"Singleton perinatal mortality with abruption decreased from 173 per 1000 in 1987-1990 to 98 per 1000 in 2000-2005 (p < 0.001)."

"In singleton births at <32 gestational weeks, overall perinatal mortality was high (345 per 1000) and was not increased by placental abruption."

That last finding is subtle and important: at very early gestations, prematurity — not abruption per se — dominates mortality. Curate it; it prevents over-attribution.

Consistently, Delorme et al. (PMID:26646125, EPIPAGE-2) found that among live births 24–34 weeks, abruption as the cause of preterm birth carried "adjusted OR 1.6 [0.7-3.7]" for in-hospital death — statistically indistinguishable from preterm labor.

StatPearls gives fetal mortality of 1–40% depending on severity and gestational age, and notes abruption accounts for 10–20% of maternal deaths (in settings without ready blood availability).

11.2 Maternal morbidity

Wright et al., Am J Perinatol 2026 (PMID:40940025), 80.2M US deliveries:

"In adjusted analyses, abruption was associated with a range of adverse outcomes including transfusion (OR = 6.86, 95% CI: 6.70, 7.03), non-transfusion severe maternal morbidity (OR = 4.05, 95% CI: 3.93, 4.17), postpartum hemorrhage (OR = 1.76, 95% CI: 1.72, 1.80), disseminated intravascular coagulation (OR = 6.30, 95% CI: 6.00, 6.61), and critical care procedures (OR = 4.76, 95% CI: 4.26, 5.32)."

Plus, from Downes et al. (PMID:28329897): relaparotomy, hysterectomy, sepsis, amniotic fluid embolism, venous thromboembolism, acute kidney injury, ICU admission. Sheehan syndrome (postpartum pituitary necrosis) after massive hemorrhage (StatPearls).

11.3 Offspring neurological outcome

Yamada et al., Early Hum Dev 2012 (PMID:22805996) — Japan Council for Quality Health Care national CP review, 107 infants:

"Abruptio placenta was responsible for 28 (26%) of the 107 CP infants, and was the single leading causative factor of CP."

"Of these 28 women, 22 (79%) exhibited non-reassuring fetal status on admission to obstetric facilities at 36.2 ± 2.6 weeks of gestation and had neonates with umbilical cord arterial blood pH (base excess) of 6.728 ± 0.164 (-25 ± 5.4 mmol/L)."

An umbilical arterial pH of 6.73 is profound acidemia. Note the mean gestational age — 36.2 weeks, i.e. near-term, which is exactly why Brandt & Ananth devoted a review to the near-term/term window.

11.4 Long-term maternal cardiovascular risk

This reframes abruption from an acute obstetric event to a life-course cardiovascular risk marker.

Ananth et al., Neurology 2019 (PMID:31420459) — Danish population cohort, 828,289 women, 13,231,559 person-years:

"Cerebrovascular mortality rates were 0.8 and 0.5 per 10,000 person-years among women with and without abruption, respectively (hazard ratio [HR] 1.6, 95% confidence interval [CI] 0.9-3.0). Abruption was associated with increased rates of nonfatal ischemic stroke (HR 1.4, 95% CI 1.1-1.7) and hemorrhagic stroke (HR 1.4, 95% CI 1.1-1.9)."

"The association of abruption and stroke was increased with delivery at <34 weeks, when accompanied by ischemic placental disease, and among women with ≥2 abruptions."

"Disruption of the hemostatic system manifesting as ischemia and hemorrhage may indicate shared etiologies between abruption and cerebrovascular complications."

Note the elegance of the shared-mechanism argument: abruption raises the risk of both ischemic and hemorrhagic stroke by the same factor, which points at a systemic vascular/hemostatic diathesis rather than a thrombotic one.

Adams et al., Semin Perinatol 2014 (PMID:24836826) generalize this across ischemic placental disease:

"Retrospective observational studies comparing pregnancies complicated by ischemic placental disease to uncomplicated pregnancies suggest an increased long-term risk of hypertension, cardiovascular death, metabolic syndrome, and cerebrovascular disease. This association is much stronger in women who had an indicated-preterm delivery due to ischemic placental disease."

The ongoing PACER cohort (PMID:38273776) — 1,877,824 birthing persons, 3,093,241 deliveries, median follow-up 15.4 years — is the dedicated infrastructure for this question:

"Pregnancy offers a unique window to study chronic diseases along the life course and efforts to identify the aetiology of abruption may provide important insights into the causes of future CVD."

This is an excellent candidate for a dismech comorbidity/trajectory entry (abruption → later cerebrovascular disease) rather than being buried inside the disorder entry.

11.5 Prognostic factors

Fraction of placenta separated (dominant).
Gestational age at delivery.
Fetal status at presentation — a Category III tracing or absent fetal heart tones.
Time from symptom onset to delivery (PMID:22805996).
Maternal hemodynamic status and fibrinogen level.
Sher class.
Fetal sex (male) and low birthweight for mortality (PMID:23072758).
Partial separation carries lower mortality than complete separation (StatPearls).

Prognostic biomarkers: fibrinogen is the only routinely useful one. No molecular prognostic marker is validated.

12. Treatment

Management is delivery-centric: there is no therapy that reverses abruption. The clinical decisions are (a) when to deliver, (b) by what route, and (c) how to support maternal hemostasis.

12.1 Immediate stabilization and supportive care

Large-bore IV access, crystalloid resuscitation, supplemental oxygen, left lateral tilt, continuous maternal and fetal monitoring, transfer to a facility with obstetric and neonatal ICU capability (StatPearls).
NCIT: NCIT:C15747 Supportive Care; NCIT:C94624 Oxygen Therapy; NCIT:C92929 Fetal Heart Monitoring.
therapeutic_modality: OTHER / BEHAVIORAL as appropriate.

12.2 Delivery

Intervention	NCIT (verified)	Modality	Indication
Cesarean delivery	`NCIT:C46088` Cesarean Section (emergency: `NCIT:C92772` Emergency Cesarean Delivery)	`SURGERY`	Non-reassuring fetal status with a live viable fetus; maternal instability; Sher class 2–3
Induction of labor / vaginal delivery	`NCIT:C92814` Induction of Labor	`OTHER`	Fetal demise; stable mother and fetus. Preferred where feasible because it avoids surgical bleeding in a coagulopathic patient. Hypertonic contractions often permit rapid vaginal delivery
Emergency hysterectomy	`NCIT:C15256` Hysterectomy	`SURGERY`	Uncontrollable hemorrhage / Couvelaire uterus with atony

Hurd et al. (PMID:6828278) provide the evidence for selective (expectant) management in stable preterm cases:

"It is concluded that optimal fetal survival and an acceptable cesarean section rate may be obtained by selective management, especially in infants weighing more than 1500 g."

"There was a significant increase in the incidence of both respiratory distress syndrome and low Apgar scores among the study infants (P less than .005), but these increases were not correlated with mode of delivery or diagnosis-to-delivery interval."

12.3 Blood component therapy

Product	NCIT (verified)	Purpose
Packed red cells	`NCIT:C15409` Packed Red Blood Cell Transfusion	oxygen-carrying capacity
Blood transfusion (general)	`NCIT:C15192` Blood Transfusion	massive transfusion protocol
Fresh frozen plasma	`NCIT:C116475` Fresh Frozen Plasma Transfusion	factor replacement
Cryoprecipitate	`NCIT:C180873` Cryoprecipitated Plasma / `NCIT:C133260` Cryoprecipitated Antihemophilic Factor	targeted fibrinogen replacement — the key product in abruption-associated DIC

Given a transfusion OR of 6.86 (PMID:40940025), transfusion should be curated as a near-defining feature of severe abruption rather than an incidental treatment.

12.4 Pharmacotherapy

All use treatment_term: NCIT:C15986 Pharmacotherapy with a therapeutic_agent:

Drug	CHEBI (verified)	Modality	Role
Betamethasone	`CHEBI:3077`	`SMALL_MOLECULE`	antenatal corticosteroid for fetal lung maturity, <34 weeks. NCIT: `NCIT:C114131` Antenatal Steroid Therapy Initiated
Dexamethasone	`CHEBI:41879`	`SMALL_MOLECULE`	alternative corticosteroid
Magnesium sulfate	`CHEBI:32599` (NCIT:C623)	`SMALL_MOLECULE`	fetal neuroprotection <32 weeks; seizure prophylaxis if preeclamptic. Trial anchors: NCT00186069 "Magnesium Sulfate vs Placebo for Placental Abruption" (COMPLETED); NCT00014989 BEAM trial (Phase 3, COMPLETED)
Tranexamic acid	`CHEBI:48669`	`SMALL_MOLECULE`	antifibrinolytic adjunct for hemorrhage. Trial anchor: NCT05840471 "Tranexamic Acid as an Intervention in Abruptio Placenta", COMPLETED, n=116, 2023-01-10 to 2024-02-10, primary outcomes hemostasis / gestational age / favorable perinatal outcome. Evidence base for abruption specifically is thin — do not overstate
Oxytocin	`CHEBI:7872`	`PEPTIDE`	labor augmentation and postpartum atony
Misoprostol	`CHEBI:63610`	`SMALL_MOLECULE`	uterotonic for postpartum hemorrhage
Anti-D (Rho(D)) immune globulin	NCIT: `NCIT:C80832` Human Rho(D) Immune Globulin; administration `NCIT:C92947`	`OTHER` / biologic	Rh-negative patients; dose guided by Kleihauer-Betke
Labetalol / nifedipine	`CHEBI:6343` / `CHEBI:7565`	`SMALL_MOLECULE`	blood-pressure control (see CHAP, §2.4). NCIT: `NCIT:C172184` Antihypertensive Therapy
Acetylsalicylic acid	`CHEBI:15365`	`SMALL_MOLECULE`	low-dose aspirin <16 weeks in high-risk pregnancies (prevention, §13)
Heparin / LMWH	`CHEBI:28304`	`SMALL_MOLECULE`	investigational for recurrence prevention; NCT00986765, NCT01068795

Tocolysis is controversial and generally contraindicated in acute abruption with fetal compromise; it may be considered in the stable, remote-from-term patient to permit corticosteroid administration. No clean NCIT clinical-action term for tocolysis was found reachable from NCIT:C25218 — use free-text preferred_term with NCIT:C15986 as the action.

12.5 Not applicable

Gene therapy, gene editing, cell therapy, RNA-based therapy, targeted therapy, immunotherapy, pharmacogenomics, and rehabilitation have no role. Record explicitly.

12.6 Treatment algorithm

Brandt & Ananth (PMID:37164498) describe "a proposed management algorithm addressing blood loss, vital signs, and urine output" along with "blood component therapy, coagulopathy management, and care following fetal demise." In outline:

Fetal demise → deliver, vaginal route preferred, aggressive coagulopathy correction.
Live fetus, unstable mother or Category III tracing → immediate cesarean.
Live fetus, stable, ≥34–37 weeks → deliver.
Live fetus, stable, <34 weeks, Sher class 1 → hospitalize, corticosteroids, magnesium sulfate for neuroprotection, serial monitoring, serial growth ultrasound; deliver on deterioration.
Postpartum → monitor for hemorrhage and coagulopathy; neonatal team at delivery.

13. Prevention

13.1 Primary prevention

The honest summary: no intervention has been shown in an RCT to prevent placental abruption as a standalone outcome. Everything below is either risk-factor modification with observational support, or an RCT benefit on a composite that included abruption.

Smoking cessation — the highest-yield modifiable target, PAF 15–25% (PMID:10214847). NCIT NCIT:C17427 Smoking Cessation; NCIT:C15372 Smoking Cessation Intervention. therapeutic_modality: BEHAVIORAL.
Cocaine and cannabis cessation with counseling/rehabilitation support (StatPearls).
Blood pressure control in chronic hypertension — CHAP (PMID:35363951, NCT02299414), composite RR 0.82 (0.74–0.92). Curate with the composite caveat.
Low-dose aspirin before 16 weeks in pregnancies at high risk of placental disease — the strongest evidence is for preterm preeclampsia (ASPRE-type data), with abruption benefit inferred through the ischemic-placental-disease framework rather than demonstrated. Trial anchors: NCT04356326 (Chronic Hypertension and ASA in Pregnancy, Phase 3, RECRUITING), NCT01890005. Do not curate aspirin as an evidence-based abruption prevention without this qualifier.
Adequate prenatal care (≥4 visits) and interpregnancy interval counselling — though Oyelese found interpregnancy interval had no significant association with recurrence (PMID:38366767), which argues against interval-based counselling specifically.
Trauma prevention — seatbelt use with correct lap-belt placement below the gravid uterus, intimate-partner-violence screening.
Correction of anemia (Hb <11 g/dL is an independent risk factor).

13.2 Secondary prevention (early detection)

No population screening program exists or is recommended. In a pregnancy with prior abruption, closer antenatal surveillance and patient education on warning signs is standard practice, though unvalidated. Given the 159 ± 99 minute symptom-to-admission interval in the CP cohort (PMID:22805996), patient education to present immediately for sudden abdominal pain, bleeding, or decreased fetal movement is arguably the highest-value secondary prevention available — and is measurable.

StatPearls lists education on "sudden abdominal pain, vaginal bleeding, uterine tenderness, and decreased fetal movement."

13.3 Tertiary prevention

Prevention of complications in the affected pregnancy: massive-transfusion protocols, early fibrinogen replacement, delivery in a facility with blood bank and NICU, anti-D prophylaxis for Rh-negative patients, antenatal corticosteroids and magnesium neuroprotection to mitigate prematurity sequelae.

13.4 Immunization, genetic screening, genetic counseling

Immunization: not applicable (no vaccine-preventable etiology). Routine pregnancy immunization is unrelated.
Genetic screening / carrier screening / PGT / prenatal genetic testing: not applicable. No causal gene. Thrombophilia screening is not recommended for placenta-mediated complications.
Genetic counseling (NCIT:C15240): not indicated for abruption per se. Recurrence counseling — quantitatively, ~5× odds and ~3.35% absolute risk in a second birth (PMID:38366767) — is obstetric counseling and should be curated as such, not as genetic counseling.

13.5 Risk stratification

Best available: prior abruption (AOR 2.72), placenta previa (AOR 7.31), chronic hypertension (OR 3.13), cocaine use (RR 4.55), plus the first/second-trimester analyte triad (RR 8.8 for all three abnormal, PMID:28178056). No validated multivariable clinical prediction model with external validation exists — a clear KNOWLEDGE_GAP.

14. Other Species / Natural Disease

14.1 Taxonomy

Homo sapiens — NCBITaxon:9606 (the disease as defined).
Equus caballus — NCBITaxon:9796 — the most relevant natural-disease species (see below).
Rattus norvegicus — NCBITaxon:10116 — induced model only.
Mus musculus — NCBITaxon:10090 — induced model only.

14.2 Natural disease in other species

Horse — premature placental separation ("red bag" delivery). The only well-documented naturally-occurring analog. In the mare, the chorioallantois separates prematurely and presents intact at the vulva (velvety red, rather than the normal white amnion), meaning the foal is being delivered while still perfused by a detached placenta — an acute asphyxial emergency requiring immediate manual rupture of the chorioallantois. It is strongly associated with ascending bacterial/fungal placentitis.

Hong et al., J Vet Diagn Invest 1993 (PMID:8286455) — 1,211 aborted equine fetuses, stillborn foals and placentas, central Kentucky:

"Placentitis (19.4%) and dystocia-perinatal asphyxia (19.5%) were the 2 most important causes of equine reproductive loss. The other causes (in decreasing order) were contracted foal syndrome and other congenital anomalies (8.5%), twinning (6.1%), improper separation of placenta (4.7%), torsion of umbilical cord (4.5%)…"

So improper separation of placenta accounted for 4.7% of equine reproductive loss in this large series. Note the mechanistic divergence, which is the interesting comparative point: the equine epitheliochorial, diffuse, non-invasive placenta has no decidua and no trophoblast invasion of maternal vessels. Premature separation in the mare is therefore an adhesion/infection failure, not a decidual-hemorrhage disease. The human decidual-hemorrhage mechanism has essentially no equine counterpart.

Other species. Sporadic premature placental separation is described in cattle and dogs but is not a recognized syndrome with the human phenotype. No OMIA entry corresponds to human placental abruption (verify against OMIA before asserting absence).

14.3 Comparative biology — the central caveat

Deep hemochorial placentation with extensive extravillous trophoblast invasion of maternal spiral arteries is largely restricted to humans and great apes. Mice and rats are hemochorial but with far shallower and more limited invasion; horses, cattle, pigs and sheep are epitheliochorial/synepitheliochorial and non-invasive.

This is the single most important comparative fact for this entry, and it should be curated as a HUMAN_MODEL_MISMATCH discussion rather than a generic KNOWLEDGE_GAP: model-organism evidence about decidual hemorrhage exists, but the anatomical substrate that makes human abruption possible — a deeply invaded, decidualized maternal–fetal interface — is not reproduced in any standard model. This limits the translational validity of every animal result in §15.

14.4 Orthologous genes

Orthologs of F3, F2, F2R, MMP1, PGR, SERPINE1 exist across mammals (Alliance of Genome Resources / HomoloGene). Notably, mice lack a direct CXCL8/IL-8 ortholog (using KC/CXCL1 and MIP-2/CXCL2 instead), so the thrombin→IL-8→decidual neutrophil axis of PMID:16251427 cannot be modeled in mouse without careful substitution. Another concrete HUMAN_MODEL_MISMATCH item.

14.5 Zoonotic potential

None. Not transmissible; not infectious in the communicable sense.

15. Model Organisms

15.1 The candid summary

There is no established, widely-used animal model of placental abruption. This is a genuine and consequential gap: the entire molecular mechanism in §6 rests on human decidual cell culture plus human placental immunohistochemistry, with only scattered in-vivo support.

15.2 In vivo models

Rat — local cold-stress model (the best-characterized). Khatun et al., Semin Thromb Hemost 2001 (PMID:11372774):

"Cold stress at 0 degrees C and 12 degrees C significantly decreased uterine blood flow (P < .005, P < .02) compared with controls (23 degrees C)."

"Cold-induced stress (0 degrees C) also evoked an isometric tension with increased frequency and amplitude in the rat uterus (P < .003, P < .0002) compared with controls (23 degrees C)."

"Placental histology of rats stressed at 0 degreesC revealed hemorrhages into the decidua basalis."

"These findings suggest that local cold stress decreases uterine blood flow and increases uterine contraction, resulting in retroplacental hemorrhage in rats. This model may account for human abruptio placentae."

Model type: induced, environmental manipulation (sympathetically-mediated uterine vasoconstriction).
Phenotype recapitulation: partial and mechanistically apt — it reproduces the target lesion (hemorrhage into decidua basalis) via a plausible route (uterine vasoconstriction + hypertonus).
Limitations: acute and non-physiological stimulus; no chronic vasculopathy arm; does not reproduce coagulopathy or PPROM; rat placentation is shallower than human; no genetic component.
Evidence source: MODEL_ORGANISM.

Other induced approaches described in the literature (uterine ischemia-reperfusion, LPS administration, cocaine administration in pregnant rodents) exist but no single one is standardized as an abruption model. Do not assert specifics without a retrieved primary source.

15.3 Genetic models

None purpose-built for abruption. Knockout/knock-in/conditional/humanized models of the pathway genes (F3, F2R, PGR, MMP1, SERPINE1) exist in mouse and are informative for individual mechanistic steps, but none produces an abruption phenotype. Notably, complete F3 (tissue factor) knockout in mouse is embryonic lethal with yolk-sac vascular failure — which is itself indirect support for the "TF maintains uteroplacental hemostasis" thesis, but it is not an abruption model.

Resources: MGI, IMPC, KOMP, IMSR for the individual gene models; there is no abruption-specific model registry entry.

15.4 In vitro / cellular models (where the mechanism actually comes from)

These carry most of the mechanistic weight in §6 and should be curated as IN_VITRO evidence throughout.

System	Used for	Key PMIDs
Leukocyte-depleted primary term human decidual cells (DCs), cultured with estradiol ± medroxyprogesterone acetate to mimic the pregnant hormonal milieu, ± thrombin	The workhorse system. Established the thrombin→IL-8, thrombin→MMP-1, thrombin→PAI-1, thrombin→IL-11, and thrombin→PR-downregulation results	16251427, 12380602, 17403427, 15998775, 23058370
Human endometrial endothelial cells (HEECs) ± thrombin ± PAR agonists ± LPS	Established the thrombin×TLR4 inflammatory synergy and PAR-1 dependence	27108773
Predecidualized cycling endometrial stromal cells	Non-pregnant comparator for the hormonal-milieu contrast	12380602
Human placental/decidual tissue immunohistochemistry (abruption vs gestational-age-matched control)	The in-vivo validation arm; this is HUMAN_CLINICAL, not in vitro	16251427, 23058370, 34205566

The hormonal-priming design in this body of work deserves specific note when curating: the DC cultures deliberately compare E2 alone (proliferative-phase-like) with E2+MPA (pregnancy-like), and the striking finding across papers is that progestin suppresses the inflammatory/proteolytic response but thrombin overrides that suppression. That override is the mechanism of abruption-associated preterm delivery, and it is the most reusable idea in the entry.

Trophoblast-invasion models (HTR-8/SVneo, primary EVT, trophoblast organoids, iPSC-derived trophoblast) are relevant to Trigger A but have not been applied to abruption specifically.

15.5 Research applications and limitations

Can be studied: thrombin/PAR-1 signaling in decidual and endometrial endothelial cells; progesterone-receptor regulation; MMP and cytokine induction; neutrophil recruitment; the infection×hemorrhage synergy; membrane weakening.

Cannot currently be studied in any model: the initiating decidual vessel rupture in a physiologically deeply-invaded placenta; the natural history from first-trimester implantation defect to third-trimester event; genetic susceptibility (no model carries the human risk alleles); the maternal life-course cardiovascular sequelae; human-specific coagulopathy dynamics.

Appendix A — Consolidated ontology term suggestions (all verified this session)

Disease: MONDO:0004846 placental abruption (with the definition-error caveat, §1.2) As a phenotype of other disorders: HP:0011419 Placental abruption

Anatomy (UBERON): UBERON:0000453 decidua basalis · UBERON:0002450 decidua · UBERON:0006878 decidua parietalis · UBERON:0001987 placenta · UBERON:8600019 placental basal plate · UBERON:0010008 placental cotyledon · UBERON:0000426 extravillous trophoblast

Cell types (CL): CL:2000002 decidual cell · CL:0002255 stromal cell of endometrium · CL:0008036 extravillous trophoblast · CL:2000060 placental villous trophoblast · CL:0002219 anchoring trophoblast · CL:0002343 decidual natural killer cell, human · CL:4052028 uterine natural killer cell · CL:0008033 decidual pericyte

Biological processes (GO): GO:0007596 blood coagulation · GO:0070493 thrombin-activated receptor signaling pathway · GO:0006954 inflammatory response · GO:0030593 neutrophil chemotaxis · GO:0022617 extracellular matrix disassembly · GO:0071456 cellular response to hypoxia · GO:0070471 uterine smooth muscle contraction · GO:0061450 trophoblast cell migration · GO:0046697 decidualization · GO:0042730 fibrinolysis · GO:0030168 platelet activation · GO:0001893 maternal placenta development

Phenotypes (HP): see the tables in §3.1–3.2.

Chemicals (CHEBI): CHEBI:3077 betamethasone · CHEBI:41879 dexamethasone · CHEBI:32599 magnesium sulfate · CHEBI:48669 tranexamic acid · CHEBI:7872 oxytocin · CHEBI:63610 misoprostol · CHEBI:6343 labetalol · CHEBI:7565 nifedipine · CHEBI:15365 acetylsalicylic acid · CHEBI:28304 heparin · CHEBI:27958 cocaine · CHEBI:18723 nicotine · CHEBI:27470 folic acid

Treatments (NCIT): NCIT:C46088 Cesarean Section · NCIT:C92772 Emergency Cesarean Delivery · NCIT:C92814 Induction of Labor · NCIT:C15256 Hysterectomy · NCIT:C15192 Blood Transfusion · NCIT:C15409 Packed Red Blood Cell Transfusion · NCIT:C116475 Fresh Frozen Plasma Transfusion · NCIT:C180873 Cryoprecipitated Plasma · NCIT:C114131 Antenatal Steroid Therapy Initiated · NCIT:C92947 Rh Immune Globulin Administration · NCIT:C80832 Human Rho(D) Immune Globulin · NCIT:C17427 Smoking Cessation · NCIT:C15372 Smoking Cessation Intervention · NCIT:C172184 Antihypertensive Therapy · NCIT:C15747 Supportive Care · NCIT:C94624 Oxygen Therapy · NCIT:C92929 Fetal Heart Monitoring · NCIT:C92836 Non-Stress Test · NCIT:C15986 Pharmacotherapy · NCIT:C623 Magnesium Sulfate

Appendix B — Module conformance candidates

Reviewing the existing kb/modules/ inventory, plausible conformance targets for this entry:

thrombogenesis — partial. The retroplacental hematoma involves coagulation cascade activation and thrombin-driven fibrin formation (thrombogenesis#Coagulation Cascade Activation and Thrombin-Driven Fibrin Formation). But the causal direction is inverted: in thrombogenesis a thrombus occludes a vessel; here hemorrhage precedes and drives clot formation, and the clot is the destructive agent by mass effect rather than by occlusion. Declare conformance only at the thrombin/fibrin node, with a note.
No existing module covers "ischemic placental disease." Abruption, preeclampsia and fetal growth restriction share risk factors, recurrence, co-occurrence and placental lesions (PMID:24836823; PMID:24836826). If the KB already carries preeclampsia and FGR entries, a new ischemic_placental_disease mechanism module is the highest-value structural contribution this entry could motivate — trigger (impaired spiral-artery remodeling) → uteroplacental malperfusion → divergent clinical manifestation (hypertensive / growth-restrictive / hemorrhagic).
A decidual_hemorrhage_thrombin_signaling module is also well-supported: thrombin generation → PAR-1 activation → MMP/IL-8/CSF-2/IL-11 induction + functional progesterone withdrawal → PPROM and preterm delivery. This recurs across abruption, PPROM, and subchorionic hematoma, so it is genuinely reusable.
fibrotic_response, cellular_senescence, hallmark modules — not applicable.

Appendix C — Explicit gaps and negative findings (curate these, don't omit them)

No Mendelian gene, no OMIM entry, no ORPHA code.
No genome-wide significant, replicated GWAS locus; all associations suggestive, single-ancestry (Peruvian).
No abruption-specific transcriptomic, proteomic, metabolomic, epigenomic, single-cell or spatial dataset.
No confirmatory antenatal diagnostic test; ultrasound sensitivity 24% (PMID:12164566).
No externally-validated clinical prediction model.
No RCT demonstrating prevention of abruption as a standalone outcome.
No standardized animal model; the human-specific depth of trophoblast invasion is not reproduced in any model (HUMAN_MODEL_MISMATCH).
Mice lack a CXCL8/IL-8 ortholog, blocking direct modeling of the neutrophil-recruitment arm (HUMAN_MODEL_MISMATCH).
No validated disease-specific quality-of-life instrument.
No uniform case definition across the epidemiological literature (PMID:28329897) — attach this caveat to every effect estimate.
The MONDO:0004846 textual definition is factually wrong and should be reported upstream.
Two biomarker-prediction trials (NCT03782168, NCT01279369) were terminated — the prediction problem has a track record of failure.
The umbrella review found zero class I or II evidence risk factors (PMID:35365209) — the entire risk-factor literature is class III or weaker.

Sources

Primary literature (PubMed, all abstracts retrieved and quoted verbatim this session): PMID:37164498 · PMID:40940025 · PMID:40140972 · PMID:38366767 · PMID:38273776 · PMID:35365209 · PMID:35363951 · PMID:34205566 · PMID:31420459 · PMID:29884306 · PMID:29360829 · PMID:28329897 · PMID:28178056 · PMID:27223167 · PMID:27108773 · PMID:26646125 · PMID:24836823 · PMID:24836826 · PMID:24046805 · PMID:23072758 · PMID:23058370 · PMID:22805996 · PMID:19720393 · PMID:17403427 · PMID:16595080 · PMID:16251427 · PMID:15998775 · PMID:15715592 · PMID:15672024 · PMID:12380602 · PMID:12164566 · PMID:11372774 · PMID:10214847 · PMID:8286455 · PMID:6828278 · PMID:1765257

Reference works and databases: StatPearls: Placental Abruption (NBK482335) · Merck Manual Professional: Placental Abruption · AJOG: Placental abruption at near-term and term gestations · BJA Education: Placental abruption (2024) · BMC Pregnancy Childbirth: Independent risk factors for placental abruption · NCBI MeSH D000037 · EBI OLS4 (HP, GO, CL, UBERON, CHEBI, NCIT, MONDO term resolution) · Monarch Initiative API — MONDO:0004846 · HGNC REST API · ClinicalTrials.gov API v2 (NCT02299414, NCT05840471, NCT00186069, NCT00014989, NCT00986765, NCT04356326, NCT03455387, NCT03782168, NCT01279369, NCT04168606)

Ask OpenScientist

OpenScientist Report

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Histopathology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Biochemical Markers

Diagnosis

Progression

Stages

Prevalence

Clinical Burden

Differential Diagnoses

Clinical Trials

Source YAML

References & Deep Research

References

Deep Research

Placental Abruption (Abruptio Placentae) — Comprehensive Research Report

1. Disease Information

1.1 Overview

1.2 Key identifiers (all retrieved live)

1.3 Synonyms

1.4 Nature of the evidence base

2. Etiology

2.1 Causal architecture

2.2 Risk factors — quantitative

2.3 Genetic risk factors

2.4 Protective factors

2.5 Gene–environment interaction

3. Phenotypes

3.1 Maternal clinical presentation

3.2 Fetal / neonatal phenotypes

3.3 Severity grading (Sher classification)

3.4 Quality-of-life impact

4. Genetic / Molecular Information

4.1 Causal genes

4.2 Susceptibility loci

4.3 Thrombophilia variants

4.4 Modifier genes

4.5 Epigenetics

4.6 Chromosomal abnormalities

5. Environmental Information

5.1 Chemical / toxicant exposures

5.2 Physical / mechanical

5.3 Lifestyle / demographic

5.4 Infectious agents

6. Mechanism / Pathophysiology

6.1 The causal chain (proposed pathophysiology nodes)

6.2 Additional cytokine mediators

6.3 Immune involvement

6.4 Tissue damage mechanisms

6.5 Molecular profiling

7. Anatomical Structures Affected

7.1 Organ level

7.2 Tissue and cell level

7.3 Subcellular level

7.4 Localization and laterality

8. Temporal Development

8.1 Onset

8.2 Progression

8.3 Patterns

9. Inheritance and Population

9.1 Epidemiology

9.2 Temporal trends and disparities

9.3 Inheritance

9.4 Demographics

10. Diagnostics

10.1 Diagnostic status

10.2 Imaging

10.3 Fetal monitoring

10.4 Laboratory

10.5 Histopathology (the reference standard)

10.6 Genetic and omics diagnostics

10.7 Differential diagnosis